Document_and_Entity_Informatio
Document and Entity Information | 9 Months Ended | |
Sep. 30, 2014 | Nov. 03, 2014 | |
Document and Entity Information | ' | ' |
Entity Registrant Name | 'RIVERSOURCE LIFE INSURANCE CO | ' |
Entity Central Index Key | '0000727892 | ' |
Current Fiscal Year End Date | '--12-31 | ' |
Entity Filer Category | 'Non-accelerated Filer | ' |
Document Type | '10-Q | ' |
Document Period End Date | 30-Sep-14 | ' |
Document Fiscal Year Focus | '2014 | ' |
Document Fiscal Period Focus | 'Q3 | ' |
Amendment Flag | 'false | ' |
Entity Common Stock, Shares Outstanding | ' | 100,000 |
CONSOLIDATED_BALANCE_SHEETS
CONSOLIDATED BALANCE SHEETS (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Available-for-Sale: | ' | ' |
Fixed maturities, at fair value (amortized cost: 2014, $21,660; 2013, $22,902) | $23,569 | $24,387 |
Common stocks, at fair value (cost: 2014 and 2013, $2) | 8 | 6 |
Mortgage loans, at amortized cost (less allowance for loan losses: 2014, $22; 2013, $24) | 3,300 | 3,326 |
Policy loans | 804 | 773 |
Other Investments | 968 | 915 |
Total investments | 28,649 | 29,407 |
Cash and cash equivalents | 286 | 344 |
Reinsurance recoverables | 2,233 | 2,177 |
Other receivables | 254 | 195 |
Accrued investment income | 256 | 275 |
Deferred acquisition costs | 2,573 | 2,633 |
Other assets | 4,378 | 4,357 |
Separate account assets | 78,313 | 77,616 |
Total assets | 116,942 | 117,004 |
Liabilities: | ' | ' |
Policyholder account balances, future policy benefits and claims | 29,312 | 29,149 |
Short-term borrowings | 200 | 500 |
Line of credit with Ameriprise Financial, Inc. | 0 | 150 |
Other liabilities | 4,582 | 5,431 |
Separate account liabilities | 78,313 | 77,616 |
Total liabilities | 112,407 | 112,846 |
Shareholder's equity: | ' | ' |
Common stock, $30 par value; 100,000 shares authorized, issued and outstanding | 3 | 3 |
Additional paid-in capital | 2,464 | 2,463 |
Retained earnings | 1,307 | 1,042 |
Accumulated other comprehensive income, net of tax | 761 | 650 |
Total shareholder's equity | 4,535 | 4,158 |
Total liabilities and shareholder's equity | $116,942 | $117,004 |
CONSOLIDATED_BALANCE_SHEETS_Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Millions, except Share data, unless otherwise specified | ||
Statement of Financial Position [Abstract] | ' | ' |
Fixed maturities, amortized cost | $21,660 | $22,902 |
Common stocks, cost | 2 | 2 |
Mortgage loans, allowance for loan losses | $22 | $24 |
Common stock, par value (in dollars per share) | $30 | $30 |
Common stock, shares authorized (in shares) | 100,000 | 100,000 |
Common stock, shares issued (in shares) | 100,000 | 100,000 |
Common stock, shares outstanding (in shares) | 100,000 | 100,000 |
CONSOLIDATED_STATEMENTS_OF_INC
CONSOLIDATED STATEMENTS OF INCOME (USD $) | 3 Months Ended | 9 Months Ended | ||
In Millions, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Revenues | ' | ' | ' | ' |
Premiums | $105 | $106 | $319 | $320 |
Net investment income | 319 | 350 | 975 | 1,067 |
Policy and contract charges | 445 | 424 | 1,357 | 1,274 |
Other revenues | 98 | 90 | 292 | 266 |
Net realized investment gains | 7 | 5 | 12 | 3 |
Total revenues | 974 | 975 | 2,955 | 2,930 |
Benefits and expenses | ' | ' | ' | ' |
Benefits, claims, losses and settlement expenses | 262 | 297 | 750 | 839 |
Interest credited to fixed accounts | 168 | 204 | 529 | 600 |
Amortization of deferred acquisition costs | 94 | -32 | 226 | 102 |
Other insurance and operating expenses | 188 | 182 | 560 | 555 |
Total benefits and expenses | 712 | 651 | 2,065 | 2,096 |
Pretax income | 262 | 324 | 890 | 834 |
Income tax provision | 38 | 59 | 125 | 143 |
Net income | 224 | 265 | 765 | 691 |
Supplemental Disclosures: | ' | ' | ' | ' |
Total other-than-temporary impairment losses on securities | -5 | -7 | -6 | -10 |
Portion of loss recognized in other comprehensive income (loss) (before taxes) | 1 | 5 | 1 | 6 |
Net impairment losses recognized in net realized investment gains | ($4) | ($2) | ($5) | ($4) |
CONSOLIDATED_STATEMENTS_OF_COM
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $) | 3 Months Ended | 9 Months Ended | ||
In Millions, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Statement of Comprehensive Income [Abstract] | ' | ' | ' | ' |
Net income | $224 | $265 | $765 | $691 |
Net unrealized gains (losses) on securities: | ' | ' | ' | ' |
Net unrealized securities gains (losses) arising during the period | -137 | -67 | 285 | -811 |
Reclassification of net securities gains included in net income | -6 | -3 | -9 | -2 |
Impact of DAC, DSIC, benefit reserves and reinsurance recoverables | -1 | 18 | -168 | 283 |
Total net unrealized gains (losses) on securities | -144 | -52 | 108 | -530 |
Net unrealized losses on derivatives: | ' | ' | ' | ' |
Reclassification of net derivative losses included in net income | 1 | 1 | 3 | 4 |
Total net unrealized losses on derivatives | 1 | 1 | 3 | 4 |
Total other comprehensive income (loss), net of tax | -143 | -51 | 111 | -526 |
Total comprehensive income | $81 | $214 | $876 | $165 |
CONSOLIDATED_STATEMENTS_OF_SHA
CONSOLIDATED STATEMENTS OF SHAREHOLDER'S EQUITY (USD $) | Total | Common shares [Member] | Additional paid-in capital [Member] | Retained earnings [Member] | Accumulated other comprehensive income [Member] |
In Millions, unless otherwise specified | |||||
Beginning balance at Dec. 31, 2012 | $4,699 | $3 | $2,462 | $1,000 | $1,234 |
Comprehensive income: | ' | ' | ' | ' | ' |
Net income | 691 | ' | ' | 691 | ' |
Other comprehensive income (loss), net of tax | -526 | ' | ' | ' | -526 |
Total comprehensive income | 165 | ' | ' | ' | ' |
Tax adjustment on share-based incentive compensation plan | 1 | ' | 1 | ' | ' |
Cash dividends to Ameriprise Financial, Inc. | -675 | ' | ' | -675 | ' |
Ending balance at Sep. 30, 2013 | 4,190 | 3 | 2,463 | 1,016 | 708 |
Beginning balance at Dec. 31, 2013 | 4,158 | 3 | 2,463 | 1,042 | 650 |
Comprehensive income: | ' | ' | ' | ' | ' |
Net income | 765 | ' | ' | 765 | ' |
Other comprehensive income (loss), net of tax | 111 | ' | ' | ' | 111 |
Total comprehensive income | 876 | ' | ' | ' | ' |
Tax adjustment on share-based incentive compensation plan | 1 | ' | 1 | ' | ' |
Cash dividends to Ameriprise Financial, Inc. | -500 | ' | ' | -500 | ' |
Ending balance at Sep. 30, 2014 | $4,535 | $3 | $2,464 | $1,307 | $761 |
CONSOLIDATED_STATEMENTS_OF_CAS
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) | 9 Months Ended | |
In Millions, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 |
Cash Flows from Operating Activities | ' | ' |
Net income | $765 | $691 |
Adjustments to reconcile net income to net cash provided by operating activities: | ' | ' |
Depreciation, amortization and accretion, net | 6 | -17 |
Deferred income tax benefit | -96 | -60 |
Contractholder and policyholder charges, non-cash | -246 | -211 |
Loss from equity method investments | 20 | 11 |
Net realized investment gains | -20 | -7 |
Other-than-temporary impairments and provision for loan losses recognized in net realized investment gains | 8 | 4 |
Change in operating assets and liabilities: | ' | ' |
Deferred acquisition costs | 30 | -98 |
Policyholder account balances, future policy benefits and claims, net | 735 | -837 |
Derivatives, net of collateral | -483 | 1,129 |
Reinsurance recoverables | -70 | -86 |
Other receivables | -23 | 10 |
Accrued investment income | 19 | 18 |
Other, net | -61 | 28 |
Net cash provided by operating activities | 584 | 575 |
Available-for-Sale securities: | ' | ' |
Proceeds from sales | 280 | 171 |
Maturities, sinking fund payments and calls | 1,843 | 2,773 |
Purchases | -827 | -2,668 |
Proceeds from maturities and repayments of mortgage loans | 407 | 534 |
Funding of mortgage loans | -373 | -467 |
Proceeds from sales and collections of other investments | 103 | 89 |
Purchase of other investments | -267 | -178 |
Purchase of land, buildings, equipment and software | -6 | -6 |
Change in policy loans, net | -31 | -16 |
Advance on line of credit to Ameriprise Financial, Inc. | -15 | 0 |
Repayment from Ameriprise Financial, Inc. on line of credit | 15 | 0 |
Other, net | 10 | 30 |
Net cash provided by investing activities | 1,139 | 262 |
Policyholder account balances: | ' | ' |
Deposits and other additions | 1,526 | 1,589 |
Net transfers to separate accounts | -167 | -54 |
Surrenders and other benefits | -1,896 | -1,479 |
Change in short-term borrowings, net | -301 | -2 |
Proceeds from line of credit with Ameriprise Financial, Inc. | 42 | 0 |
Payments on line of credit with Ameriprise Financial, Inc. | -192 | 0 |
Tax adjustment on share-based incentive compensation plan | 1 | 1 |
Cash received for purchased options with deferred premiums | 8 | 0 |
Cash paid for purchased options with deferred premiums | -302 | -312 |
Cash dividends to Ameriprise Financial, Inc. | -500 | -675 |
Net cash used in financing activities | -1,781 | -932 |
Net decrease in cash and cash equivalents | -58 | -95 |
Cash and cash equivalents at beginning of period | 344 | 336 |
Cash and cash equivalents at end of period | 286 | 241 |
Supplemental Disclosures: | ' | ' |
Income taxes paid, net | 393 | 110 |
Interest paid on borrowings | 1 | 3 |
Non-cash investing activity: | ' | ' |
Affordable housing partnership commitments not yet remitted | $0 | $26 |
Basis_of_Presentation
Basis of Presentation | 9 Months Ended |
Sep. 30, 2014 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Basis of Presentation | ' |
Basis of Presentation | |
RiverSource Life Insurance Company is a stock life insurance company with two wholly owned subsidiaries, RiverSource Life Insurance Co. of New York and RiverSource Tax Advantaged Investments, Inc. (“RTA”). RiverSource Life Insurance Company is a wholly owned subsidiary of Ameriprise Financial, Inc. (“Ameriprise Financial”). | |
The accompanying Consolidated Financial Statements include the accounts of RiverSource Life Insurance Company and companies in which it directly or indirectly has a controlling financial interest (collectively, the “Company”). All intercompany transactions and balances have been eliminated in consolidation. | |
The interim financial information in this report has not been audited. In the opinion of management, all adjustments necessary for a fair presentation of the consolidated financial position and results of operations for the interim periods have been made. All adjustments made were of a normal recurring nature. | |
The accompanying Consolidated Financial Statements are prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Results of operations reported for interim periods are not necessarily indicative of results for the entire year. These Consolidated Financial Statements and Notes should be read in conjunction with the Consolidated Financial Statements and Notes in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013, filed with the Securities and Exchange Commission on February 27, 2014. | |
In the Consolidated Statements of Cash Flows, within financing activities, the Company reclassified the increase in policyholder account balances for interest credited from “Policyholder account balances: Surrenders and other benefits” to “Policyholder account balances: Deposits and other additions” to improve the transparency of its cash flows. Total cash flows used in financing activities did not change as a result of this reclassification. | |
The Company evaluated events or transactions that may have occurred after the balance sheet date for potential recognition or disclosure through the date the financial statements were issued. |
Recent_Accounting_Pronouncemen
Recent Accounting Pronouncements | 9 Months Ended |
Sep. 30, 2014 | |
New Accounting Pronouncements and Changes in Accounting Principles [Abstract] | ' |
Recent Accounting Pronouncements | ' |
Recent Accounting Pronouncements | |
Adoption of New Accounting Standards | |
Income Taxes | |
In July 2013, the Financial Accounting Standards Board (“FASB”) updated the accounting standard for income taxes. The update provides guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. The standard is effective for interim and annual periods beginning after December 15, 2013 and should be applied prospectively to all unrecognized tax benefits that exist at the effective date. Retrospective application is permitted. The Company adopted the standard in the first quarter of 2014. The adoption of the standard did not have any effect on the Company’s consolidated financial condition and results of operations. | |
Future Adoption of New Accounting Standards | |
Presentation of Financial Statements - Going Concern | |
In August 2014, the FASB updated the accounting standard related to an entity’s assessment of its ability to continue as a going concern. The standard requires that management evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that the financial statements are issued. In situations where there is substantial doubt about an entity’s ability to continue as a going concern, disclosure should be made so that a reader can understand the conditions that raise substantial doubt, management’s assessment of those conditions and any plan management has to mitigate those conditions. The standard is effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early adoption is permitted. The adoption of the standard is not expected to have a material impact on the Company’s consolidated financial condition and results of operations. | |
Transfers and Servicing | |
In June 2014, the FASB updated the accounting standards related to transfers and servicing. The update requires repurchase-to-maturity transactions and linked repurchase financings to be accounted for as secured borrowings consistent with the accounting for other repurchase agreements. The standard requires disclosures related to transfers of financial assets accounted for as sales in transactions that are similar to repurchase agreements. The standard also requires disclosures on the remaining contractual maturity of the agreements, disaggregation of the gross obligation by class of collateral pledged and potential risks associated with the agreements and the related collateral pledged in repurchase agreements, securities lending transactions, and repurchase-to-maturity transactions accounted for as secured borrowings. The standard is effective for interim and annual periods beginning after December 15, 2014, except for the disclosure requirements for repurchase-to-maturity transactions accounted for as secured borrowings which are effective for interim periods beginning after March 15, 2015. Early adoption of the standard is prohibited. The standard requires entities to present changes in accounting for transactions outstanding at the effective date as a cumulative-effect adjustment to retained earnings as of the beginning of the period of adoption. As the Company does not have repurchase-to-maturity transactions, the adoption of the standard is not expected to have a material impact on the Company’s consolidated financial condition and results of operations. | |
Revenue from Contracts with Customers | |
In May 2014, the FASB updated the accounting standards for revenue from contracts with customers. The update provides a five step revenue recognition model for all revenue arising from contracts with customers and affects all entities that enter into contracts to provide goods or services to their customers (unless the contracts are in the scope of other standards). The standard also updates the accounting for certain costs associated with obtaining and fulfilling a customer contract. In addition, the standard requires disclosure of quantitative and qualitative information that enables users of financial statements to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The standard is effective for interim and annual periods beginning after December 15, 2016 and early adoption is prohibited. The standard may be applied retrospectively for all periods presented or retrospectively with a cumulative-effect adjustment at the date of adoption. The Company is currently evaluating the impact of the standard on its consolidated financial condition and results of operations. | |
Receivables - Troubled Debt Restructuring by Creditors | |
In January 2014, the FASB updated the accounting standard related to recognizing residential real estate obtained through a repossession or foreclosure from a troubled debtor. The update clarifies the criteria for derecognition of the loan receivable and recognition of the real estate property. The standard is effective for interim and annual periods beginning after December 15, 2014 and can be applied under a modified retrospective transition method or a prospective transition method. Early adoption is permitted. The adoption of the standard is not expected to have a material impact on the Company’s consolidated financial condition and results of operations. | |
Investments - Equity Method and Joint Ventures | |
In January 2014, the FASB updated the accounting standard related to investments in qualified affordable housing projects. The update allows for an accounting policy election to account for investments in qualified affordable housing projects using the proportional amortization method if certain conditions are met. Under the proportional amortization method, the investment in a qualified affordable housing project is amortized in proportion to the tax credits and other tax benefits received. The net investment performance is recognized as a component of income tax expense (benefit). The standard is effective for interim and annual periods beginning after December 15, 2014 and should be applied retrospectively to all periods presented. Early adoption is permitted. The Company is currently evaluating the impact of the standard on its consolidated financial condition and results of operations. |
Variable_Interest_Entities
Variable Interest Entities | 9 Months Ended |
Sep. 30, 2014 | |
Variable Interest Entity, Consolidated, Carrying Amount, Assets and Liabilities, Net [Abstract] | ' |
Variable Interest Entities | ' |
Variable Interest Entities | |
RTA, a subsidiary of RiverSource Life Insurance Company, has variable interests in affordable housing partnerships for which it is not the primary beneficiary and, therefore, does not consolidate. | |
RTA’s maximum exposure to loss as a result of its investments in the affordable housing partnerships is limited to the carrying values of these investments. The carrying values are reflected in other investments and were $471 million and $495 million as of September 30, 2014 and December 31, 2013, respectively. RTA has no obligation to provide financial or other support to the affordable housing partnerships in addition to liabilities already recorded for future funding commitments nor has it provided any additional support to the affordable housing partnerships. The Company had liabilities of $96 million and $137 million recorded in other liabilities as of September 30, 2014 and December 31, 2013, respectively, related to the future funding commitments for affordable housing partnerships. |
Investments
Investments | 9 Months Ended | |||||||||||||||||||||||||||||||||
Sep. 30, 2014 | ||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | ' | |||||||||||||||||||||||||||||||||
Investments | ' | |||||||||||||||||||||||||||||||||
Investments | ||||||||||||||||||||||||||||||||||
Available-for-Sale securities distributed by type were as follows: | ||||||||||||||||||||||||||||||||||
30-Sep-14 | ||||||||||||||||||||||||||||||||||
Description of Securities | Amortized | Gross | Gross | Fair | Noncredit | |||||||||||||||||||||||||||||
Cost | Unrealized | Unrealized | Value | OTTI(1) | ||||||||||||||||||||||||||||||
Gains | Losses | |||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||
Fixed maturities: | ||||||||||||||||||||||||||||||||||
Corporate debt securities | $ | 13,962 | $ | 1,539 | $ | (31 | ) | $ | 15,470 | $ | 3 | |||||||||||||||||||||||
Residential mortgage backed securities | 3,466 | 135 | (44 | ) | 3,557 | (9 | ) | |||||||||||||||||||||||||||
Commercial mortgage backed securities | 2,121 | 115 | (4 | ) | 2,232 | — | ||||||||||||||||||||||||||||
State and municipal obligations | 942 | 159 | (28 | ) | 1,073 | — | ||||||||||||||||||||||||||||
Asset backed securities | 896 | 49 | (1 | ) | 944 | — | ||||||||||||||||||||||||||||
Foreign government bonds and obligations | 237 | 21 | (5 | ) | 253 | — | ||||||||||||||||||||||||||||
U.S. government and agencies obligations | 36 | 4 | — | 40 | — | |||||||||||||||||||||||||||||
Total fixed maturities | 21,660 | 2,022 | (113 | ) | 23,569 | (6 | ) | |||||||||||||||||||||||||||
Common stocks | 2 | 6 | — | 8 | 3 | |||||||||||||||||||||||||||||
Total | $ | 21,662 | $ | 2,028 | $ | (113 | ) | $ | 23,577 | $ | (3 | ) | ||||||||||||||||||||||
31-Dec-13 | ||||||||||||||||||||||||||||||||||
Description of Securities | Amortized | Gross | Gross | Fair | Noncredit | |||||||||||||||||||||||||||||
Cost | Unrealized | Unrealized | Value | OTTI(1) | ||||||||||||||||||||||||||||||
Gains | Losses | |||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||
Fixed maturities: | ||||||||||||||||||||||||||||||||||
Corporate debt securities | $ | 14,658 | $ | 1,311 | $ | (96 | ) | $ | 15,873 | $ | 3 | |||||||||||||||||||||||
Residential mortgage backed securities | 3,773 | 133 | (95 | ) | 3,811 | (18 | ) | |||||||||||||||||||||||||||
Commercial mortgage backed securities | 2,309 | 136 | (11 | ) | 2,434 | — | ||||||||||||||||||||||||||||
State and municipal obligations | 950 | 87 | (39 | ) | 998 | — | ||||||||||||||||||||||||||||
Asset backed securities | 938 | 48 | (5 | ) | 981 | — | ||||||||||||||||||||||||||||
Foreign government bonds and obligations | 234 | 19 | (8 | ) | 245 | — | ||||||||||||||||||||||||||||
U.S. government and agencies obligations | 40 | 5 | — | 45 | — | |||||||||||||||||||||||||||||
Total fixed maturities | 22,902 | 1,739 | (254 | ) | 24,387 | (15 | ) | |||||||||||||||||||||||||||
Common stocks | 2 | 4 | — | 6 | 2 | |||||||||||||||||||||||||||||
Total | $ | 22,904 | $ | 1,743 | $ | (254 | ) | $ | 24,393 | $ | (13 | ) | ||||||||||||||||||||||
(1) | Represents the amount of other-than-temporary impairment (“OTTI”) losses in accumulated other comprehensive income. Amount includes unrealized gains and losses on impaired securities subsequent to the initial impairment measurement date. These amounts are included in gross unrealized gains and losses as of the end of the period. | |||||||||||||||||||||||||||||||||
As of September 30, 2014 and December 31, 2013, investment securities with a fair value of $1.6 billion and $2.3 billion, respectively, were pledged to meet contractual obligations under derivative contracts and short-term borrowings. | ||||||||||||||||||||||||||||||||||
At September 30, 2014 and December 31, 2013, fixed maturity securities comprised approximately 82% and 83%, respectively, of the Company’s total investments. Rating agency designations are based on the availability of ratings from Nationally Recognized Statistical Rating Organizations (“NRSROs”), including Moody’s Investors Service (“Moody’s”), Standard & Poor’s Ratings Services (“S&P”) and Fitch Ratings Ltd. (“Fitch”). The Company uses the median of available ratings from Moody’s, S&P and Fitch, or if fewer than three ratings are available, the lower rating is used. When ratings from Moody’s, S&P and Fitch are unavailable, the Company may utilize ratings from other NRSROs or rate the securities internally. At September 30, 2014 and December 31, 2013, approximately $1.1 billion and $1.3 billion, respectively, of securities were internally rated by Columbia Management Investment Advisers, LLC, an affiliate of the Company, using criteria similar to those used by NRSROs. | ||||||||||||||||||||||||||||||||||
A summary of fixed maturity securities by rating was as follows: | ||||||||||||||||||||||||||||||||||
30-Sep-14 | 31-Dec-13 | |||||||||||||||||||||||||||||||||
Ratings | Amortized | Fair | Percent of | Amortized | Fair | Percent of | ||||||||||||||||||||||||||||
Cost | Value | Total Fair | Cost | Value | Total Fair | |||||||||||||||||||||||||||||
Value | Value | |||||||||||||||||||||||||||||||||
(in millions, except percentages) | ||||||||||||||||||||||||||||||||||
AAA | $ | 5,183 | $ | 5,410 | 23 | % | $ | 5,557 | $ | 5,738 | 23 | % | ||||||||||||||||||||||
AA | 988 | 1,155 | 5 | 1,055 | 1,171 | 5 | ||||||||||||||||||||||||||||
A | 4,395 | 4,963 | 21 | 4,687 | 5,062 | 21 | ||||||||||||||||||||||||||||
BBB | 9,527 | 10,475 | 44 | 10,062 | 10,897 | 45 | ||||||||||||||||||||||||||||
Below investment grade | 1,567 | 1,566 | 7 | 1,541 | 1,519 | 6 | ||||||||||||||||||||||||||||
Total fixed maturities | $ | 21,660 | $ | 23,569 | 100 | % | $ | 22,902 | $ | 24,387 | 100 | % | ||||||||||||||||||||||
At September 30, 2014 and December 31, 2013, approximately 44% and 41%, respectively, of the securities rated AAA were GNMA, FNMA and FHLMC mortgage backed securities. No holdings of any other issuer were greater than 10% of total equity. | ||||||||||||||||||||||||||||||||||
The following tables provide information about Available-for-Sale securities with gross unrealized losses and the length of time that individual securities have been in a continuous unrealized loss position: | ||||||||||||||||||||||||||||||||||
30-Sep-14 | ||||||||||||||||||||||||||||||||||
Less than 12 months | 12 months or more | Total | ||||||||||||||||||||||||||||||||
Description of Securities | Number of | Fair | Unrealized | Number of | Fair | Unrealized | Number of | Fair | Unrealized | |||||||||||||||||||||||||
Securities | Value | Losses | Securities | Value | Losses | Securities | Value | Losses | ||||||||||||||||||||||||||
(in millions, except number of securities) | ||||||||||||||||||||||||||||||||||
Corporate debt securities | 83 | $ | 760 | $ | (10 | ) | 43 | $ | 736 | $ | (21 | ) | 126 | $ | 1,496 | $ | (31 | ) | ||||||||||||||||
Residential mortgage backed securities | 14 | 140 | (2 | ) | 59 | 822 | (42 | ) | 73 | 962 | (44 | ) | ||||||||||||||||||||||
Commercial mortgage backed securities | 5 | 41 | — | 9 | 96 | (4 | ) | 14 | 137 | (4 | ) | |||||||||||||||||||||||
State and municipal obligations | 1 | 5 | — | 2 | 100 | (28 | ) | 3 | 105 | (28 | ) | |||||||||||||||||||||||
Asset backed securities | 5 | 42 | — | 4 | 38 | (1 | ) | 9 | 80 | (1 | ) | |||||||||||||||||||||||
Foreign government bonds and obligations | 4 | 18 | — | 14 | 27 | (5 | ) | 18 | 45 | (5 | ) | |||||||||||||||||||||||
Total | 112 | $ | 1,006 | $ | (12 | ) | 131 | $ | 1,819 | $ | (101 | ) | 243 | $ | 2,825 | $ | (113 | ) | ||||||||||||||||
31-Dec-13 | ||||||||||||||||||||||||||||||||||
Less than 12 months | 12 months or more | Total | ||||||||||||||||||||||||||||||||
Description of Securities | Number of | Fair | Unrealized | Number of | Fair | Unrealized | Number of | Fair | Unrealized | |||||||||||||||||||||||||
Securities | Value | Losses | Securities | Value | Losses | Securities | Value | Losses | ||||||||||||||||||||||||||
(in millions, except number of securities) | ||||||||||||||||||||||||||||||||||
Corporate debt securities | 156 | $ | 2,567 | $ | (82 | ) | 10 | $ | 160 | $ | (14 | ) | 166 | $ | 2,727 | $ | (96 | ) | ||||||||||||||||
Residential mortgage backed securities | 52 | 1,411 | (54 | ) | 45 | 295 | (41 | ) | 97 | 1,706 | (95 | ) | ||||||||||||||||||||||
Commercial mortgage backed securities | 27 | 323 | (9 | ) | 3 | 22 | (2 | ) | 30 | 345 | (11 | ) | ||||||||||||||||||||||
State and municipal obligations | 4 | 38 | (2 | ) | 2 | 92 | (37 | ) | 6 | 130 | (39 | ) | ||||||||||||||||||||||
Asset backed securities | 17 | 219 | (4 | ) | 3 | 26 | (1 | ) | 20 | 245 | (5 | ) | ||||||||||||||||||||||
Foreign government bonds and obligations | 23 | 77 | (8 | ) | — | — | — | 23 | 77 | (8 | ) | |||||||||||||||||||||||
Total | 279 | $ | 4,635 | $ | (159 | ) | 63 | $ | 595 | $ | (95 | ) | 342 | $ | 5,230 | $ | (254 | ) | ||||||||||||||||
As part of the Company’s ongoing monitoring process, management determined that a majority of the change in gross unrealized losses on its Available-for-Sale securities is attributable to movement in interest rates. | ||||||||||||||||||||||||||||||||||
The following table presents a rollforward of the cumulative amounts recognized in the Consolidated Statements of Income for other-than-temporary impairments related to credit losses on Available-for-Sale securities for which a portion of the securities’ total other-than-temporary impairments was recognized in other comprehensive income (loss): | ||||||||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||
Beginning balance | $ | 54 | $ | 66 | $ | 54 | $ | 87 | ||||||||||||||||||||||||||
Credit losses for which an other-than-temporary impairment was not previously recognized | — | 1 | — | 1 | ||||||||||||||||||||||||||||||
Credit losses for which an other-than-temporary impairment was previously recognized | 1 | — | 1 | 2 | ||||||||||||||||||||||||||||||
Reductions for securities sold during the period (realized) | (22 | ) | — | (22 | ) | (23 | ) | |||||||||||||||||||||||||||
Ending balance | $ | 33 | $ | 67 | $ | 33 | $ | 67 | ||||||||||||||||||||||||||
The change in net unrealized securities gains (losses) in other comprehensive income (loss) includes three components, net of tax: (i) unrealized gains (losses) that arose from changes in the market value of securities that were held during the period; (ii) (gains) losses that were previously unrealized, but have been recognized in current period net income due to sales of Available-for-Sale securities and due to the reclassification of noncredit other-than-temporary impairment losses to credit losses; and (iii) other items primarily consisting of adjustments in asset and liability balances, such as deferred acquisition costs (“DAC”), deferred sales inducement costs (“DSIC”), benefit reserves and reinsurance recoverables, to reflect the expected impact on their carrying values had the unrealized gains (losses) been realized as of the respective balance sheet dates. | ||||||||||||||||||||||||||||||||||
The following table presents a rollforward of the net unrealized securities gains on Available-for-Sale securities included in accumulated other comprehensive income (“AOCI”): | ||||||||||||||||||||||||||||||||||
Net Unrealized Securities Gains | Deferred | AOCI Related to Net Unrealized Securities Gains | ||||||||||||||||||||||||||||||||
Income | ||||||||||||||||||||||||||||||||||
Tax | ||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||
Balance at January 1, 2013 | $ | 1,930 | $ | (675 | ) | $ | 1,255 | |||||||||||||||||||||||||||
Net unrealized securities losses arising during the period(1) | (1,234 | ) | 423 | (811 | ) | |||||||||||||||||||||||||||||
Reclassification of net securities gains included in net income | (3 | ) | 1 | (2 | ) | |||||||||||||||||||||||||||||
Impact of DAC, DSIC, benefit reserves and reinsurance recoverables | 436 | (153 | ) | 283 | ||||||||||||||||||||||||||||||
Balance at September 30, 2013 | $ | 1,129 | $ | (404 | ) | $ | 725 | (2) | ||||||||||||||||||||||||||
Balance at January 1, 2014 | $ | 1,033 | $ | (366 | ) | $ | 667 | |||||||||||||||||||||||||||
Net unrealized securities gains arising during the period(1) | 441 | (156 | ) | 285 | ||||||||||||||||||||||||||||||
Reclassification of net securities gains included in net income | (15 | ) | 6 | (9 | ) | |||||||||||||||||||||||||||||
Impact of DAC, DSIC, benefit reserves and reinsurance recoverables | (258 | ) | 90 | (168 | ) | |||||||||||||||||||||||||||||
Balance at September 30, 2014 | $ | 1,201 | $ | (426 | ) | $ | 775 | (2) | ||||||||||||||||||||||||||
-1 | Includes other-than-temporary impairment losses on Available-for-Sale securities related to factors other than credit that were recognized in other comprehensive income (loss) during the period. | |||||||||||||||||||||||||||||||||
(2) | Includes $2 million and $10 million of noncredit related impairments on securities and net unrealized securities losses on previously impaired securities at September 30, 2014 and 2013, respectively. | |||||||||||||||||||||||||||||||||
Net realized gains and losses on Available-for-Sale securities, determined using the specific identification method, recognized in net realized investment gains were as follows: | ||||||||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||
Gross realized investment gains | $ | 15 | $ | 6 | $ | 24 | $ | 8 | ||||||||||||||||||||||||||
Gross realized investment losses | (1 | ) | — | (4 | ) | (1 | ) | |||||||||||||||||||||||||||
Other-than-temporary impairments | (4 | ) | (2 | ) | (5 | ) | (4 | ) | ||||||||||||||||||||||||||
Total | $ | 10 | $ | 4 | $ | 15 | $ | 3 | ||||||||||||||||||||||||||
Other-than-temporary impairments for the three months and nine months ended September 30, 2014 primarily related to credit losses on non-agency residential mortgage backed securities and corporate debt securities. Other-than-temporary impairments for the three months and nine months ended September 30, 2013 primarily related to credit losses on non-agency residential mortgage backed securities. | ||||||||||||||||||||||||||||||||||
Available-for-Sale securities by contractual maturity at September 30, 2014 were as follows: | ||||||||||||||||||||||||||||||||||
Amortized Cost | Fair Value | |||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||
Due within one year | $ | 965 | $ | 984 | ||||||||||||||||||||||||||||||
Due after one year through five years | 5,938 | 6,521 | ||||||||||||||||||||||||||||||||
Due after five years through 10 years | 4,701 | 4,941 | ||||||||||||||||||||||||||||||||
Due after 10 years | 3,573 | 4,390 | ||||||||||||||||||||||||||||||||
15,177 | 16,836 | |||||||||||||||||||||||||||||||||
Residential mortgage backed securities | 3,466 | 3,557 | ||||||||||||||||||||||||||||||||
Commercial mortgage backed securities | 2,121 | 2,232 | ||||||||||||||||||||||||||||||||
Asset backed securities | 896 | 944 | ||||||||||||||||||||||||||||||||
Common stocks | 2 | 8 | ||||||||||||||||||||||||||||||||
Total | $ | 21,662 | $ | 23,577 | ||||||||||||||||||||||||||||||
Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations. Residential mortgage backed securities, commercial mortgage backed securities and asset backed securities are not due at a single maturity date. As such, these securities, as well as common stocks, were not included in the maturities distribution. | ||||||||||||||||||||||||||||||||||
Net investment income is summarized as follows: | ||||||||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||
Fixed maturities | $ | 277 | $ | 301 | $ | 841 | $ | 913 | ||||||||||||||||||||||||||
Mortgage loans | 46 | 50 | 137 | 153 | ||||||||||||||||||||||||||||||
Other investments | 3 | 8 | 20 | 25 | ||||||||||||||||||||||||||||||
326 | 359 | 998 | 1,091 | |||||||||||||||||||||||||||||||
Less: investment expenses | 7 | 9 | 23 | 24 | ||||||||||||||||||||||||||||||
Total | $ | 319 | $ | 350 | $ | 975 | $ | 1,067 | ||||||||||||||||||||||||||
Financing_Receivables
Financing Receivables | 9 Months Ended | ||||||||||||||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||||||||||||||
Receivables [Abstract] | ' | ||||||||||||||||||||||||||||
Financing Receivables | ' | ||||||||||||||||||||||||||||
Financing Receivables | |||||||||||||||||||||||||||||
The Company’s financing receivables include commercial and residential mortgage loans, syndicated loans and policy loans. Syndicated loans are reflected in other investments. | |||||||||||||||||||||||||||||
Allowance for Loan Losses | |||||||||||||||||||||||||||||
Policy loans do not exceed the cash surrender value of the policy at origination. As there is minimal risk of loss related to policy loans, the Company does not record an allowance for loan losses for policy loans. The Company does not currently have an allowance for loan losses for residential mortgage loans. | |||||||||||||||||||||||||||||
The following table presents a rollforward of the allowance for loan losses for the nine months ended and the ending balance of the allowance for loan losses by impairment method and type of loan: | |||||||||||||||||||||||||||||
30-Sep-14 | 30-Sep-13 | ||||||||||||||||||||||||||||
Commercial | Syndicated | Total | Commercial | Syndicated | Total | ||||||||||||||||||||||||
Mortgage | Loans | Mortgage | Loans | ||||||||||||||||||||||||||
Loans | Loans | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Beginning balance | $ | 24 | $ | 4 | $ | 28 | $ | 26 | $ | 4 | $ | 30 | |||||||||||||||||
Charge-offs | (2 | ) | (1 | ) | (3 | ) | (2 | ) | — | (2 | ) | ||||||||||||||||||
Provisions | — | 2 | 2 | — | — | — | |||||||||||||||||||||||
Ending balance | $ | 22 | $ | 5 | $ | 27 | $ | 24 | $ | 4 | $ | 28 | |||||||||||||||||
Individually evaluated for impairment | $ | 8 | $ | — | $ | 8 | $ | 7 | $ | — | $ | 7 | |||||||||||||||||
Collectively evaluated for impairment | 14 | 5 | 19 | 17 | 4 | 21 | |||||||||||||||||||||||
The recorded investment in financing receivables by impairment method and type of loan was as follows: | |||||||||||||||||||||||||||||
30-Sep-14 | |||||||||||||||||||||||||||||
Commercial | Residential | Syndicated | Total | ||||||||||||||||||||||||||
Mortgage | Mortgage | Loans | |||||||||||||||||||||||||||
Loans | Loans | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | 34 | $ | — | $ | 3 | $ | 37 | |||||||||||||||||||||
Collectively evaluated for impairment | 2,572 | 716 | 451 | 3,739 | |||||||||||||||||||||||||
Total | $ | 2,606 | $ | 716 | $ | 454 | $ | 3,776 | |||||||||||||||||||||
31-Dec-13 | |||||||||||||||||||||||||||||
Commercial | Residential | Syndicated | Total | ||||||||||||||||||||||||||
Mortgage | Mortgage | Loans | |||||||||||||||||||||||||||
Loans | Loans | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | 40 | $ | — | $ | 5 | $ | 45 | |||||||||||||||||||||
Collectively evaluated for impairment | 2,524 | 786 | 356 | 3,666 | |||||||||||||||||||||||||
Total | $ | 2,564 | $ | 786 | $ | 361 | $ | 3,711 | |||||||||||||||||||||
As of September 30, 2014 and December 31, 2013, the Company’s recorded investment in financing receivables individually evaluated for impairment for which there was no related allowance for loan losses was $9 million and $12 million, respectively. | |||||||||||||||||||||||||||||
Residential mortgage loans are presented net of unamortized discount of $39 million and $53 million as of September 30, 2014 and December 31, 2013, respectively. | |||||||||||||||||||||||||||||
During the three months ended September 30, 2014 and 2013, the Company purchased $71 million and $8 million, respectively, and sold $2 million and nil, respectively of syndicated loans. During the nine months ended September 30, 2014 and 2013, the Company purchased $161 million and $67 million, respectively, and sold $12 million and $1 million, respectively, of syndicated loans. | |||||||||||||||||||||||||||||
Credit Quality Information | |||||||||||||||||||||||||||||
Nonperforming loans, which are generally loans 90 days or more past due, were $10 million and $20 million as of September 30, 2014 and December 31, 2013, respectively. All other loans were considered to be performing. | |||||||||||||||||||||||||||||
Commercial Mortgage Loans | |||||||||||||||||||||||||||||
The Company reviews the credit worthiness of the borrower and the performance of the underlying properties in order to determine the risk of loss on commercial mortgage loans. Based on this review, the commercial mortgage loans are assigned an internal risk rating, which management updates as necessary. Commercial mortgage loans which management has assigned its highest risk rating were 1% and 2% of total commercial mortgage loans at September 30, 2014 and December 31, 2013, respectively. Loans with the highest risk rating represent distressed loans which the Company has identified as impaired or expects to become delinquent or enter into foreclosure within the next six months. In addition, the Company reviews the concentrations of credit risk by region and property type. | |||||||||||||||||||||||||||||
Concentrations of credit risk of commercial mortgage loans by U.S. region were as follows: | |||||||||||||||||||||||||||||
Loans | Percentage | ||||||||||||||||||||||||||||
September 30, 2014 | December 31, 2013 | September 30, 2014 | December 31, 2013 | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
South Atlantic | $ | 703 | $ | 679 | 27 | % | 26 | % | |||||||||||||||||||||
Pacific | 653 | 631 | 25 | 25 | |||||||||||||||||||||||||
Mountain | 252 | 248 | 10 | 10 | |||||||||||||||||||||||||
East North Central | 232 | 248 | 9 | 10 | |||||||||||||||||||||||||
Middle Atlantic | 213 | 202 | 8 | 8 | |||||||||||||||||||||||||
West North Central | 204 | 194 | 8 | 7 | |||||||||||||||||||||||||
West South Central | 153 | 153 | 6 | 6 | |||||||||||||||||||||||||
New England | 131 | 138 | 5 | 5 | |||||||||||||||||||||||||
East South Central | 65 | 71 | 2 | 3 | |||||||||||||||||||||||||
2,606 | 2,564 | 100 | % | 100 | % | ||||||||||||||||||||||||
Less: allowance for loan losses | 22 | 24 | |||||||||||||||||||||||||||
Total | $ | 2,584 | $ | 2,540 | |||||||||||||||||||||||||
Concentrations of credit risk of commercial mortgage loans by property type were as follows: | |||||||||||||||||||||||||||||
Loans | Percentage | ||||||||||||||||||||||||||||
September 30, 2014 | December 31, 2013 | September 30, 2014 | December 31, 2013 | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Retail | $ | 944 | $ | 917 | 36 | % | 36 | % | |||||||||||||||||||||
Office | 545 | 548 | 21 | 21 | |||||||||||||||||||||||||
Industrial | 460 | 431 | 18 | 17 | |||||||||||||||||||||||||
Apartments | 445 | 454 | 17 | 18 | |||||||||||||||||||||||||
Mixed use | 45 | 36 | 2 | 1 | |||||||||||||||||||||||||
Hotel | 33 | 32 | 1 | 1 | |||||||||||||||||||||||||
Other | 134 | 146 | 5 | 6 | |||||||||||||||||||||||||
2,606 | 2,564 | 100 | % | 100 | % | ||||||||||||||||||||||||
Less: allowance for loan losses | 22 | 24 | |||||||||||||||||||||||||||
Total | $ | 2,584 | $ | 2,540 | |||||||||||||||||||||||||
Residential Mortgage Loans | |||||||||||||||||||||||||||||
The Company considers the credit worthiness of borrowers (FICO score), collateral characteristics such as loan-to-value (“LTV”) and geographic concentration to determine when an amount for an allowance for loan losses for residential mortgage loans is appropriate. At a minimum, management updates FICO scores and LTV ratios semiannually. As of September 30, 2014 and December 31, 2013, no allowance for loan losses was recorded. | |||||||||||||||||||||||||||||
As of both September 30, 2014 and December 31, 2013, approximately 4% of residential mortgage loans had FICO scores below 640. As of both September 30, 2014 and December 31, 2013, approximately 1% of the Company’s residential mortgage loans had LTV ratios greater than 90%. The Company’s most significant geographic concentration for residential mortgage loans is in California representing 37% and 38% of the portfolio as of September 30, 2014 and December 31, 2013, respectively. No other state represents more than 10% of the total residential mortgage loan portfolio. | |||||||||||||||||||||||||||||
Syndicated Loans | |||||||||||||||||||||||||||||
The Company’s syndicated loan portfolio is diversified across industries and issuers. The primary credit indicator for syndicated loans is whether the loans are performing in accordance with the contractual terms of the syndication. Total nonperforming syndicated loans at both September 30, 2014 and December 31, 2013 were $3 million. | |||||||||||||||||||||||||||||
Troubled Debt Restructurings | |||||||||||||||||||||||||||||
The following table presents the number of loans restructured by the Company during the period and their recorded investment at the end of the period: | |||||||||||||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||||||||||||||
Number | Recorded | Number | Recorded | Number | Recorded | Number | Recorded | ||||||||||||||||||||||
of Loans | Investment | of Loans | Investment | of Loans | Investment | of Loans | Investment | ||||||||||||||||||||||
(in millions, except number of loans) | |||||||||||||||||||||||||||||
Commercial mortgage loans | 1 | $ | 6 | 3 | $ | 12 | 3 | $ | 14 | 6 | $ | 21 | |||||||||||||||||
Residential mortgage loans | — | — | — | — | 2 | — | 2 | — | |||||||||||||||||||||
Syndicated loans | — | — | — | — | 1 | — | — | — | |||||||||||||||||||||
Total | 1 | $ | 6 | 3 | $ | 12 | 6 | $ | 14 | 8 | $ | 21 | |||||||||||||||||
The troubled debt restructurings did not have a material impact to the Company’s allowance for loan losses or income recognized for the three months and nine months ended September 30, 2014 and 2013. There are no material commitments to lend additional funds to borrowers whose loans have been restructured. |
Deferred_Acquisition_Costs_and
Deferred Acquisition Costs and Deferred Sales Inducement Costs | 9 Months Ended | ||||||||
Sep. 30, 2014 | |||||||||
Deferred Acquisition Costs and Deferred Sales Inducement Costs | ' | ||||||||
Deferred Acquisition Costs and Deferred Sales Inducement Costs | ' | ||||||||
Deferred Acquisition Costs and Deferred Sales Inducement Costs | |||||||||
In the third quarter of the year, management conducts its annual review of insurance and annuity valuation assumptions relative to current experience and management expectations. To the extent that expectations change as a result of this review, management updates valuation assumptions. The impact in the third quarter of 2014 primarily reflected the difference between the Company’s previously assumed interest rates versus the continued low interest rate environment, partially offset by favorable persistency and mortality experience and a benefit from updating the Company's variable annuity living benefit withdrawal utilization assumption. The impact in the third quarter of 2013 primarily reflected the impact of assumed interest rates and changes in assumed policyholder behavior. | |||||||||
The balances of and changes in DAC were as follows: | |||||||||
2014 | 2013 | ||||||||
(in millions) | |||||||||
Balance at January 1 | $ | 2,633 | $ | 2,373 | |||||
Capitalization of acquisition costs | 196 | 200 | |||||||
Amortization, excluding the impact of valuation assumptions review | (219 | ) | (180 | ) | |||||
Amortization, impact of valuation assumptions review | (7 | ) | 78 | ||||||
Impact of change in net unrealized securities losses (gains) | (30 | ) | 112 | ||||||
Balance at September 30 | $ | 2,573 | $ | 2,583 | |||||
The balances of and changes in DSIC, which is included in other assets, were as follows: | |||||||||
2014 | 2013 | ||||||||
(in millions) | |||||||||
Balance at January 1 | $ | 409 | $ | 404 | |||||
Capitalization of sales inducement costs | 4 | 4 | |||||||
Amortization, excluding the impact of valuation assumptions review | (40 | ) | (39 | ) | |||||
Amortization, impact of valuation assumptions review | (2 | ) | 25 | ||||||
Impact of change in net unrealized securities losses (gains) | (3 | ) | 18 | ||||||
Balance at September 30 | $ | 368 | $ | 412 | |||||
Policyholder_Account_Balances_
Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities | 9 Months Ended | ||||||||
Sep. 30, 2014 | |||||||||
Policyholder Account Balances, Future Policy Benefits and Claims & Separate Account Liabilities | ' | ||||||||
Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities | ' | ||||||||
Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities | |||||||||
Policyholder account balances, future policy benefits and claims consisted of the following: | |||||||||
September 30, 2014 | December 31, 2013 | ||||||||
(in millions) | |||||||||
Policyholder account balances | |||||||||
Fixed annuities | $ | 12,922 | $ | 13,826 | |||||
Variable annuity fixed sub-accounts | 4,869 | 4,926 | |||||||
Variable universal life (“VUL”)/universal life (“UL”) insurance | 2,841 | 2,790 | |||||||
Indexed universal life (“IUL”) insurance | 475 | 315 | |||||||
Other life insurance | 846 | 878 | |||||||
Total policyholder account balances | 21,953 | 22,735 | |||||||
Future policy benefits | |||||||||
Variable annuity guaranteed minimum withdrawal benefits (“GMWB”)(1) | 145 | (383 | ) | ||||||
Variable annuity guaranteed minimum accumulation benefits (“GMAB”)(1) | (55 | ) | (62 | ) | |||||
Other annuity liabilities | 118 | 76 | |||||||
Fixed annuities life contingent liabilities | 1,518 | 1,523 | |||||||
Equity indexed annuities (“EIA”) | 29 | 29 | |||||||
Life, disability income and long term care insurance | 5,041 | 4,739 | |||||||
VUL/UL and other life insurance additional liabilities | 403 | 336 | |||||||
Total future policy benefits | 7,199 | 6,258 | |||||||
Policy claims and other policyholders’ funds | 160 | 156 | |||||||
Total policyholder account balances, future policy benefits and claims | $ | 29,312 | $ | 29,149 | |||||
-1 | Includes the value of GMWB and GMAB embedded derivatives that was a net asset at both September 30, 2014 and December 31, 2013 reported as a contra liability. | ||||||||
Separate account liabilities consisted of the following: | |||||||||
September 30, 2014 | December 31, 2013 | ||||||||
(in millions) | |||||||||
Variable annuity | $ | 71,345 | $ | 70,687 | |||||
VUL insurance | 6,925 | 6,885 | |||||||
Other insurance | 43 | 44 | |||||||
Total | $ | 78,313 | $ | 77,616 | |||||
Variable_Annuity_and_Insurance
Variable Annuity and Insurance Guarantees | 9 Months Ended | ||||||||||||||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||||||||||||||
Insurance [Abstract] | ' | ||||||||||||||||||||||||||||
Variable Annuity and Insurance Guarantees | ' | ||||||||||||||||||||||||||||
Variable Annuity and Insurance Guarantees | |||||||||||||||||||||||||||||
The majority of the variable annuity contracts offered by the Company contain guaranteed minimum death benefit (“GMDB”) provisions. The Company also offers variable annuities with death benefit provisions that gross up the amount payable by a certain percentage of contract earnings, which are referred to as gain gross-up (“GGU”) benefits. In addition, the Company offers contracts with GMWB and GMAB provisions. The Company previously offered contracts containing guaranteed minimum income benefit (“GMIB”) provisions. | |||||||||||||||||||||||||||||
Certain UL policies offered by the Company provide secondary guarantee benefits. The secondary guarantee ensures that, subject to specified conditions, the policy will not terminate and will continue to provide a death benefit even if there is insufficient policy value to cover the monthly deductions and charges. | |||||||||||||||||||||||||||||
The following table provides information related to variable annuity guarantees for which the Company has established additional liabilities: | |||||||||||||||||||||||||||||
30-Sep-14 | 31-Dec-13 | ||||||||||||||||||||||||||||
Variable Annuity Guarantees by | Total | Contract | Net | Weighted Average Attained Age | Total | Contract | Net | Weighted Average Attained Age | |||||||||||||||||||||
Benefit Type(1) | Contract | Value in | Amount | Contract | Value in | Amount | |||||||||||||||||||||||
Value | Separate | at Risk | Value | Separate | at Risk | ||||||||||||||||||||||||
Accounts | Accounts | ||||||||||||||||||||||||||||
(in millions, except age) | |||||||||||||||||||||||||||||
GMDB: | |||||||||||||||||||||||||||||
Return of premium | $ | 54,378 | $ | 52,566 | $ | 39 | 64 | $ | 52,616 | $ | 50,790 | $ | 28 | 64 | |||||||||||||||
Five/six-year reset | 10,465 | 7,925 | 36 | 64 | 11,220 | 8,663 | 42 | 64 | |||||||||||||||||||||
One-year ratchet | 7,424 | 7,030 | 64 | 66 | 7,676 | 7,261 | 38 | 65 | |||||||||||||||||||||
Five-year ratchet | 1,770 | 1,715 | 3 | 62 | 1,781 | 1,725 | 1 | 62 | |||||||||||||||||||||
Other | 965 | 947 | 40 | 70 | 1,015 | 996 | 36 | 69 | |||||||||||||||||||||
Total — GMDB | $ | 75,002 | $ | 70,183 | $ | 182 | 64 | $ | 74,308 | $ | 69,435 | $ | 145 | 64 | |||||||||||||||
GGU death benefit | $ | 1,058 | $ | 1,006 | $ | 121 | 67 | $ | 1,052 | $ | 998 | $ | 121 | 64 | |||||||||||||||
GMIB | $ | 359 | $ | 336 | $ | 9 | 67 | $ | 413 | $ | 389 | $ | 8 | 66 | |||||||||||||||
GMWB: | |||||||||||||||||||||||||||||
GMWB | $ | 3,702 | $ | 3,689 | $ | 1 | 68 | $ | 3,936 | $ | 3,921 | $ | 1 | 67 | |||||||||||||||
GMWB for life | 35,967 | 35,853 | 92 | 65 | 34,069 | 33,930 | 77 | 64 | |||||||||||||||||||||
Total — GMWB | $ | 39,669 | $ | 39,542 | $ | 93 | 65 | $ | 38,005 | $ | 37,851 | $ | 78 | 64 | |||||||||||||||
GMAB | $ | 4,188 | $ | 4,177 | $ | 3 | 58 | $ | 4,194 | $ | 4,181 | $ | 2 | 58 | |||||||||||||||
-1 | Individual variable annuity contracts may have more than one guarantee and therefore may be included in more than one benefit type. Variable annuity contracts for which the death benefit equals the account value are not shown in this table. | ||||||||||||||||||||||||||||
The net amount at risk for GMDB, GGU and GMAB guarantees is defined as the current guaranteed benefit amount in excess of the current contract value. The net amount at risk for GMIB and GMWB guarantees is defined as the greater of the present value of the minimum guaranteed withdrawal payments less the current contract value or zero. The present value is calculated using a discount rate that is consistent with assumptions embedded in the Company’s annuity pricing models. | |||||||||||||||||||||||||||||
The following table provides information related to insurance guarantees for which the Company has established additional liabilities: | |||||||||||||||||||||||||||||
30-Sep-14 | 31-Dec-13 | ||||||||||||||||||||||||||||
Net Amount at Risk | Weighted Average Attained Age | Net Amount at Risk | Weighted Average Attained Age | ||||||||||||||||||||||||||
(in millions, except age) | |||||||||||||||||||||||||||||
UL secondary guarantees | $ | 5,943 | 62 | $ | 5,674 | 62 | |||||||||||||||||||||||
The net amount at risk for UL secondary guarantees is defined as the current guaranteed death benefit amount in excess of the current policyholder value. | |||||||||||||||||||||||||||||
Changes in additional liabilities (contra liabilities) for variable annuity and insurance guarantees were as follows: | |||||||||||||||||||||||||||||
GMDB & GGU | GMIB | GMWB(1) | GMAB(1) | UL | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance at January 1, 2013 | $ | 4 | $ | 9 | $ | 799 | $ | 103 | $ | 155 | |||||||||||||||||||
Incurred claims | 2 | (2 | ) | (908 | ) | (127 | ) | 45 | |||||||||||||||||||||
Paid claims | (3 | ) | — | — | — | (11 | ) | ||||||||||||||||||||||
Balance at September 30, 2013 | $ | 3 | $ | 7 | $ | (109 | ) | $ | (24 | ) | $ | 189 | |||||||||||||||||
Balance at January 1, 2014 | $ | 4 | $ | 6 | $ | (383 | ) | $ | (62 | ) | $ | 206 | |||||||||||||||||
Incurred claims | 8 | 1 | 528 | 7 | 46 | ||||||||||||||||||||||||
Paid claims | (3 | ) | — | — | — | (5 | ) | ||||||||||||||||||||||
Balance at September 30, 2014 | $ | 9 | $ | 7 | $ | 145 | $ | (55 | ) | $ | 247 | ||||||||||||||||||
-1 | The incurred claims for GMWB and GMAB represent the total change in the liabilities (contra liabilities). | ||||||||||||||||||||||||||||
The liabilities for guaranteed benefits are supported by general account assets. | |||||||||||||||||||||||||||||
The following table summarizes the distribution of separate account balances by asset type for variable annuity contracts providing guaranteed benefits: | |||||||||||||||||||||||||||||
September 30, 2014 | December 31, 2013 | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Mutual funds: | |||||||||||||||||||||||||||||
Equity | $ | 40,751 | $ | 39,195 | |||||||||||||||||||||||||
Bond | 25,218 | 26,519 | |||||||||||||||||||||||||||
Other | 4,149 | 3,764 | |||||||||||||||||||||||||||
Total mutual funds | $ | 70,118 | $ | 69,478 | |||||||||||||||||||||||||
Lines_of_Credit
Lines of Credit | 9 Months Ended |
Sep. 30, 2014 | |
Line of Credit Facility [Abstract] | ' |
Line of Credit Arrangements with Parent [Text Block] | ' |
Lines of Credit | |
RiverSource Life Insurance Company, as the borrower, had an outstanding balance at September 30, 2014 and December 31, 2013 of nil and $150 million, respectively, under a revolving credit agreement with Ameriprise Financial as the lender. The aggregate amount outstanding under the line of credit may not exceed $800 million at any time. The interest rate for any borrowing under the agreement is established by reference to LIBOR plus 90 basis points, subject to adjustment based on debt ratings of the senior unsecured debt of Ameriprise Financial. Amounts borrowed may be repaid at any time with no prepayment penalty. | |
RiverSource Life Insurance Company, as the lender, has a revolving credit agreement with Ameriprise Financial as the borrower. This line of credit is not to exceed 3% of RiverSource Life Insurance Company’s statutory admitted assets as of the prior year end. The interest rate for any borrowing is established by reference to LIBOR plus 90 basis points, subject to adjustment based on debt ratings of the senior unsecured debt of Ameriprise Financial. In the event of default, an additional 1% interest will accrue during such period of default. There were no amounts outstanding on this revolving credit agreement as of September 30, 2014 and December 31, 2013. |
Shortterm_Borrowings
Short-term Borrowings | 9 Months Ended |
Sep. 30, 2014 | |
Short-term Debt [Abstract] | ' |
Short-term Borrowings | ' |
Short-term Borrowings | |
The Company enters into repurchase agreements in exchange for cash which it accounts for as secured borrowings. The Company has pledged Available-for-Sale securities consisting of agency residential mortgage backed securities and commercial mortgage backed securities to collateralize its obligation under the repurchase agreements. The fair value of the securities pledged is recorded in investments and was $52 million at both September 30, 2014 and December 31, 2013. The amount of the Company’s liability including accrued interest as of both September 30, 2014 and December 31, 2013 was $50 million. The weighted average annualized interest rate on the repurchase agreements held as of both September 30, 2014 and December 31, 2013 was 0.3%. | |
RiverSource Life Insurance Company is a member of the Federal Home Loan Bank (“FHLB”) of Des Moines which provides access to collateralized borrowings. In 2013, the Company began to borrow short-term funds under these FHLB borrowings. The Company has pledged Available-for-Sale securities consisting of commercial mortgage backed securities to collateralize its obligation under these borrowings. The fair value of the securities pledged is recorded in investments and was $456 million and $574 million at September 30, 2014 and December 31, 2013, respectively. The amount of the Company’s liability including accrued interest as of September 30, 2014 and December 31, 2013 was $150 million and $450 million, respectively. The weighted average annualized interest rate on the FHLB advances held as of both September 30, 2014 and December 31, 2013 was 0.3%. |
Fair_Values_of_Assets_and_Liab
Fair Values of Assets and Liabilities | 9 Months Ended | ||||||||||||||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ' | ||||||||||||||||||||||||||||
Fair Values of Assets and Liabilities | ' | ||||||||||||||||||||||||||||
Fair Values of Assets and Liabilities | |||||||||||||||||||||||||||||
GAAP defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date; that is, an exit price. The exit price assumes the asset or liability is not exchanged subject to a forced liquidation or distressed sale. | |||||||||||||||||||||||||||||
Valuation Hierarchy | |||||||||||||||||||||||||||||
The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company’s valuation techniques. A level is assigned to each fair value measurement based on the lowest level input that is significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows: | |||||||||||||||||||||||||||||
Level 1 | Unadjusted quoted prices for identical assets or liabilities in active markets that are accessible at the measurement date. | ||||||||||||||||||||||||||||
Level 2 | Prices or valuations based on observable inputs other than quoted prices in active markets for identical assets and liabilities. | ||||||||||||||||||||||||||||
Level 3 | Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. | ||||||||||||||||||||||||||||
The following tables present the balances of assets and liabilities measured at fair value on a recurring basis: | |||||||||||||||||||||||||||||
30-Sep-14 | |||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||
Available-for-Sale securities: Fixed maturities: | |||||||||||||||||||||||||||||
Corporate debt securities | $ | — | $ | 14,092 | $ | 1,378 | $ | 15,470 | |||||||||||||||||||||
Residential mortgage backed securities | — | 3,547 | 10 | 3,557 | |||||||||||||||||||||||||
Commercial mortgage backed securities | — | 2,139 | 93 | 2,232 | |||||||||||||||||||||||||
State and municipal obligations | — | 1,073 | — | 1,073 | |||||||||||||||||||||||||
Asset backed securities | — | 796 | 148 | 944 | |||||||||||||||||||||||||
Foreign government bonds and obligations | — | 253 | — | 253 | |||||||||||||||||||||||||
U.S. government and agencies obligations | 4 | 36 | — | 40 | |||||||||||||||||||||||||
Total Available-for-Sale securities: Fixed maturities | 4 | 21,936 | 1,629 | 23,569 | |||||||||||||||||||||||||
Common stocks | 3 | 5 | — | 8 | |||||||||||||||||||||||||
Cash equivalents | 2 | 261 | — | 263 | |||||||||||||||||||||||||
Other assets: | |||||||||||||||||||||||||||||
Interest rate derivative contracts | — | 1,512 | — | 1,512 | |||||||||||||||||||||||||
Equity derivative contracts | 314 | 1,512 | — | 1,826 | |||||||||||||||||||||||||
Credit derivative contracts | — | 4 | — | 4 | |||||||||||||||||||||||||
Foreign exchange derivative contracts | — | 4 | — | 4 | |||||||||||||||||||||||||
Other derivative contracts | — | — | 1 | 1 | |||||||||||||||||||||||||
Total other assets | 314 | 3,032 | 1 | 3,347 | |||||||||||||||||||||||||
Separate account assets | — | 78,313 | — | 78,313 | |||||||||||||||||||||||||
Total assets at fair value | $ | 323 | $ | 103,547 | $ | 1,630 | $ | 105,500 | |||||||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||
Policyholder account balances, future policy benefits and claims: | |||||||||||||||||||||||||||||
EIA embedded derivatives | $ | — | $ | 6 | $ | — | $ | 6 | |||||||||||||||||||||
IUL embedded derivatives | — | — | 202 | 202 | |||||||||||||||||||||||||
GMWB and GMAB embedded derivatives | — | — | (77 | ) | (77 | ) | (2) | ||||||||||||||||||||||
Total policyholder account balances, future policy benefits and claims | — | 6 | 125 | 131 | (1) | ||||||||||||||||||||||||
Other liabilities: | |||||||||||||||||||||||||||||
Interest rate derivative contracts | — | 1,208 | — | 1,208 | |||||||||||||||||||||||||
Equity derivative contracts | 472 | 2,171 | — | 2,643 | |||||||||||||||||||||||||
Other derivative contracts | — | 13 | — | 13 | |||||||||||||||||||||||||
Total other liabilities | 472 | 3,392 | — | 3,864 | |||||||||||||||||||||||||
Total liabilities at fair value | $ | 472 | $ | 3,398 | $ | 125 | $ | 3,995 | |||||||||||||||||||||
-1 | The Company’s adjustment for nonperformance risk resulted in a $238 million cumulative decrease to the embedded derivatives. | ||||||||||||||||||||||||||||
-2 | The fair value of the GMWB and GMAB embedded derivatives was a net asset at September 30, 2014 and the amount is reported as a contra liability. | ||||||||||||||||||||||||||||
31-Dec-13 | |||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||
Available-for-Sale securities: Fixed maturities: | |||||||||||||||||||||||||||||
Corporate debt securities | $ | — | $ | 14,357 | $ | 1,516 | $ | 15,873 | |||||||||||||||||||||
Residential mortgage backed securities | — | 3,753 | 58 | 3,811 | |||||||||||||||||||||||||
Commercial mortgage backed securities | — | 2,404 | 30 | 2,434 | |||||||||||||||||||||||||
State and municipal obligations | — | 998 | — | 998 | |||||||||||||||||||||||||
Asset backed securities | — | 763 | 218 | 981 | |||||||||||||||||||||||||
Foreign government bonds and obligations | — | 245 | — | 245 | |||||||||||||||||||||||||
U.S. government and agencies obligations | 9 | 36 | — | 45 | |||||||||||||||||||||||||
Total Available-for-Sale securities: Fixed maturities | 9 | 22,556 | 1,822 | 24,387 | |||||||||||||||||||||||||
Common stocks | 3 | 3 | — | 6 | |||||||||||||||||||||||||
Cash equivalents | 1 | 320 | — | 321 | |||||||||||||||||||||||||
Other assets: | |||||||||||||||||||||||||||||
Interest rate derivative contracts | — | 1,484 | — | 1,484 | |||||||||||||||||||||||||
Equity derivative contracts | 265 | 1,503 | — | 1,768 | |||||||||||||||||||||||||
Credit derivative contracts | — | 3 | — | 3 | |||||||||||||||||||||||||
Foreign exchange derivative contracts | — | 2 | — | 2 | |||||||||||||||||||||||||
Other derivative contracts | — | 4 | — | 4 | |||||||||||||||||||||||||
Total other assets | 265 | 2,996 | — | 3,261 | |||||||||||||||||||||||||
Separate account assets | — | 77,616 | — | 77,616 | |||||||||||||||||||||||||
Total assets at fair value | $ | 278 | $ | 103,491 | $ | 1,822 | $ | 105,591 | |||||||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||
Policyholder account balances, future policy benefits and claims: | |||||||||||||||||||||||||||||
EIA embedded derivatives | $ | — | $ | 5 | $ | — | $ | 5 | |||||||||||||||||||||
IUL embedded derivatives | — | — | 125 | 125 | |||||||||||||||||||||||||
GMWB and GMAB embedded derivatives | — | — | (575 | ) | (575 | ) | (2) | ||||||||||||||||||||||
Total policyholder account balances, future policy benefits and claims | — | 5 | (450 | ) | (445 | ) | (1) | ||||||||||||||||||||||
Other liabilities: | |||||||||||||||||||||||||||||
Interest rate derivative contracts | — | 1,672 | — | 1,672 | |||||||||||||||||||||||||
Equity derivative contracts | 549 | 2,382 | — | 2,931 | |||||||||||||||||||||||||
Other derivative contracts | — | 29 | — | 29 | |||||||||||||||||||||||||
Total other liabilities | 549 | 4,083 | — | 4,632 | |||||||||||||||||||||||||
Total liabilities at fair value | $ | 549 | $ | 4,088 | $ | (450 | ) | $ | 4,187 | ||||||||||||||||||||
-1 | The Company’s adjustment for nonperformance risk resulted in a $150 million cumulative increase to the embedded derivatives. | ||||||||||||||||||||||||||||
-2 | The fair value of the GMWB and GMAB embedded derivatives was a net asset at December 31, 2013 and the amount is reported as a contra liability. | ||||||||||||||||||||||||||||
The following tables provide a summary of changes in Level 3 assets and liabilities measured at fair value on a recurring basis: | |||||||||||||||||||||||||||||
Available-for-Sale Securities: Fixed Maturities | |||||||||||||||||||||||||||||
Corporate | Residential | Commercial | Asset | Total | Common Stocks | Other Assets: Other Derivatives Contracts | |||||||||||||||||||||||
Debt | Mortgage | Mortgage | Backed | ||||||||||||||||||||||||||
Securities | Backed | Backed | Securities | ||||||||||||||||||||||||||
Securities | Securities | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance, July 1, 2014 | $ | 1,376 | $ | 10 | $ | 15 | $ | 149 | $ | 1,550 | $ | 1 | $ | 1 | |||||||||||||||
Total gains (losses) included in: | |||||||||||||||||||||||||||||
Net income | — | — | — | 1 | 1 | (1) | — | (1 | ) | (2) | |||||||||||||||||||
Other comprehensive income | (11 | ) | — | — | (1 | ) | (12 | ) | — | — | |||||||||||||||||||
Purchases | 37 | — | — | — | 37 | — | 1 | ||||||||||||||||||||||
Settlements | (24 | ) | — | — | (1 | ) | (25 | ) | — | — | |||||||||||||||||||
Transfers into Level 3 | — | — | 78 | — | 78 | — | — | ||||||||||||||||||||||
Transfers out of Level 3 | — | — | — | — | — | (1 | ) | — | |||||||||||||||||||||
Balance, September 30, 2014 | $ | 1,378 | $ | 10 | $ | 93 | $ | 148 | $ | 1,629 | $ | — | $ | 1 | |||||||||||||||
Changes in unrealized gains (losses) relating to assets held at September 30, 2014 included in: | |||||||||||||||||||||||||||||
Net investment income | $ | — | $ | — | $ | — | $ | 1 | $ | 1 | $ | — | $ | — | |||||||||||||||
Benefits, claims, losses and settlement expenses | — | — | — | — | — | — | (1 | ) | |||||||||||||||||||||
-1 | Included in net investment income in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
-2 | Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
Policyholder Account Balances, | |||||||||||||||||||||||||||||
Future Policy Benefits and Claims | |||||||||||||||||||||||||||||
IUL | GMWB and | Total | |||||||||||||||||||||||||||
Embedded | GMAB | ||||||||||||||||||||||||||||
Derivatives | Embedded | ||||||||||||||||||||||||||||
Derivatives | |||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance, July 1, 2014 | $ | 184 | $ | (347 | ) | $ | (163 | ) | |||||||||||||||||||||
Total losses included in: | |||||||||||||||||||||||||||||
Net income | — | 207 | (1) | 207 | |||||||||||||||||||||||||
Issues | 21 | 65 | 86 | ||||||||||||||||||||||||||
Settlements | (3 | ) | (2 | ) | (5 | ) | |||||||||||||||||||||||
Balance, September 30, 2014 | $ | 202 | $ | (77 | ) | $ | 125 | ||||||||||||||||||||||
Changes in unrealized losses relating to liabilities held at September 30, 2014 included in: | |||||||||||||||||||||||||||||
Benefits, claims, losses and settlement expenses | $ | — | $ | 208 | $ | 208 | |||||||||||||||||||||||
-1 | Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
Available-for-Sale Securities: Fixed Maturities | |||||||||||||||||||||||||||||
Corporate | Residential | Commercial | Asset | Total | |||||||||||||||||||||||||
Debt | Mortgage | Mortgage | Backed | ||||||||||||||||||||||||||
Securities | Backed | Backed | Securities | ||||||||||||||||||||||||||
Securities | Securities | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance, July 1, 2013 | $ | 1,558 | $ | 50 | $ | 164 | $ | 154 | $ | 1,926 | |||||||||||||||||||
Total gains (losses) included in: | |||||||||||||||||||||||||||||
Other comprehensive loss | 2 | — | — | (2 | ) | — | |||||||||||||||||||||||
Purchases | — | 45 | — | 29 | 74 | ||||||||||||||||||||||||
Settlements | (37 | ) | (5 | ) | — | — | (42 | ) | |||||||||||||||||||||
Transfers out of Level 3 | — | — | (149 | ) | — | (149 | ) | ||||||||||||||||||||||
Balance, September 30, 2013 | $ | 1,523 | $ | 90 | $ | 15 | $ | 181 | $ | 1,809 | |||||||||||||||||||
Changes in unrealized gains (losses) relating to assets held at September 30, 2013 included in: | |||||||||||||||||||||||||||||
Net investment income | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||||
Policyholder Account Balances, | |||||||||||||||||||||||||||||
Future Policy Benefits and Claims | |||||||||||||||||||||||||||||
IUL Embedded | GMWB and GMAB | Total | |||||||||||||||||||||||||||
Derivatives | Embedded Derivatives | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance, July 1, 2013 | $ | 76 | $ | 11 | $ | 87 | |||||||||||||||||||||||
Total (gains) losses included in: | |||||||||||||||||||||||||||||
Net income | 2 | (1) | (322 | ) | (2) | (320 | ) | ||||||||||||||||||||||
Issues | 17 | 60 | 77 | ||||||||||||||||||||||||||
Settlements | 1 | (5 | ) | (4 | ) | ||||||||||||||||||||||||
Balance, September 30, 2013 | $ | 96 | $ | (256 | ) | $ | (160 | ) | |||||||||||||||||||||
Changes in unrealized (gains) losses relating to liabilities held at September 30, 2013 included in: | |||||||||||||||||||||||||||||
Benefits, claims, losses and settlement expenses | $ | — | $ | (321 | ) | $ | (321 | ) | |||||||||||||||||||||
Interest credited to fixed accounts | 2 | — | 2 | ||||||||||||||||||||||||||
-1 | Included in interest credited to fixed accounts in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
-2 | Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
Available-for-Sale Securities: Fixed Maturities | |||||||||||||||||||||||||||||
Corporate | Residential | Commercial | Asset | Total | Common Stocks | Other Assets: Other Derivatives Contracts | |||||||||||||||||||||||
Debt | Mortgage | Mortgage | Backed | ||||||||||||||||||||||||||
Securities | Backed | Backed | Securities | ||||||||||||||||||||||||||
Securities | Securities | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance, January 1, 2014 | $ | 1,516 | $ | 58 | $ | 30 | $ | 218 | $ | 1,822 | $ | — | $ | — | |||||||||||||||
Total gains (losses) included in: | |||||||||||||||||||||||||||||
Net income | 1 | — | — | 1 | 2 | (1) | — | (1 | ) | (2) | |||||||||||||||||||
Other comprehensive income | 3 | — | — | — | 3 | — | — | ||||||||||||||||||||||
Purchases | 94 | 11 | 39 | — | 144 | 1 | 2 | ||||||||||||||||||||||
Sales | (11 | ) | — | — | — | (11 | ) | — | — | ||||||||||||||||||||
Settlements | (225 | ) | (2 | ) | — | (2 | ) | (229 | ) | — | — | ||||||||||||||||||
Transfers into Level 3 | — | — | 78 | — | 78 | — | — | ||||||||||||||||||||||
Transfers out of Level 3 | — | (57 | ) | (54 | ) | (69 | ) | (180 | ) | (1 | ) | — | |||||||||||||||||
Balance, September 30, 2014 | $ | 1,378 | $ | 10 | $ | 93 | $ | 148 | $ | 1,629 | $ | — | $ | 1 | |||||||||||||||
Changes in unrealized gains (losses) relating to assets held at September 30, 2014 included in: | |||||||||||||||||||||||||||||
Net investment income | $ | (1 | ) | $ | — | $ | — | $ | 1 | $ | — | $ | — | $ | — | ||||||||||||||
Benefits, claims, losses and settlement expenses | — | — | — | — | — | — | (1 | ) | |||||||||||||||||||||
-1 | Included in net investment income in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
-2 | Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
Policyholder Account Balances, | |||||||||||||||||||||||||||||
Future Policy Benefits and Claims | |||||||||||||||||||||||||||||
IUL | GMWB and GMAB Embedded Derivatives | Total | |||||||||||||||||||||||||||
Embedded | |||||||||||||||||||||||||||||
Derivatives | |||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance, January 1, 2014 | $ | 125 | $ | (575 | ) | $ | (450 | ) | |||||||||||||||||||||
Total losses included in: | |||||||||||||||||||||||||||||
Net income | 14 | (1) | 327 | (2) | 341 | ||||||||||||||||||||||||
Issues | 69 | 184 | 253 | ||||||||||||||||||||||||||
Settlements | (6 | ) | (13 | ) | (19 | ) | |||||||||||||||||||||||
Balance, September 30, 2014 | $ | 202 | $ | (77 | ) | $ | 125 | ||||||||||||||||||||||
Changes in unrealized losses relating to liabilities held at September 30, 2014 included in: | |||||||||||||||||||||||||||||
Benefits, claims, losses and settlement expenses | $ | — | $ | 327 | $ | 327 | |||||||||||||||||||||||
Interest credited to fixed accounts | 14 | — | 14 | ||||||||||||||||||||||||||
-1 | Included in interest credited to fixed accounts in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
-2 | Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
Available-for-Sale Securities: Fixed Maturities | |||||||||||||||||||||||||||||
Corporate | Residential | Commercial | Asset | Total | |||||||||||||||||||||||||
Debt | Mortgage | Mortgage | Backed | ||||||||||||||||||||||||||
Securities | Backed | Backed | Securities | ||||||||||||||||||||||||||
Securities | Securities | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance, January 1, 2013 | $ | 1,654 | $ | 23 | $ | 170 | $ | 156 | $ | 2,003 | |||||||||||||||||||
Total gains (losses) included in: | |||||||||||||||||||||||||||||
Net income | (1 | ) | — | — | 1 | — | (1) | ||||||||||||||||||||||
Other comprehensive loss | (34 | ) | — | (6 | ) | 5 | (35 | ) | |||||||||||||||||||||
Purchases | 74 | 87 | — | 29 | 190 | ||||||||||||||||||||||||
Settlements | (170 | ) | (5 | ) | — | (1 | ) | (176 | ) | ||||||||||||||||||||
Transfers out of Level 3 | — | (15 | ) | (149 | ) | (9 | ) | (173 | ) | ||||||||||||||||||||
Balance, September 30, 2013 | $ | 1,523 | $ | 90 | $ | 15 | $ | 181 | $ | 1,809 | |||||||||||||||||||
Changes in unrealized gains (losses) relating to assets held at September 30, 2013 included in: | |||||||||||||||||||||||||||||
Net investment income | $ | (1 | ) | $ | — | $ | — | $ | 1 | $ | — | ||||||||||||||||||
-1 | Included in net investment income in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
Policyholder Account Balances, | |||||||||||||||||||||||||||||
Future Policy Benefits and Claims | |||||||||||||||||||||||||||||
IUL Embedded | GMWB and | Total | |||||||||||||||||||||||||||
Derivatives | GMAB | ||||||||||||||||||||||||||||
Embedded | |||||||||||||||||||||||||||||
Derivatives | |||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance, January 1, 2013 | $ | 45 | $ | 833 | $ | 878 | |||||||||||||||||||||||
Total (gains) losses included in: | |||||||||||||||||||||||||||||
Net income | 8 | (1) | (1,246 | ) | (2) | (1,238 | ) | ||||||||||||||||||||||
Issues | 42 | 163 | 205 | ||||||||||||||||||||||||||
Settlements | 1 | (6 | ) | (5 | ) | ||||||||||||||||||||||||
Balance, September 30, 2013 | $ | 96 | $ | (256 | ) | $ | (160 | ) | |||||||||||||||||||||
Changes in unrealized (gains) losses relating to liabilities held at September 30, 2013 included in: | |||||||||||||||||||||||||||||
Benefits, claims, losses and settlement expenses | $ | — | $ | (1,229 | ) | $ | (1,229 | ) | |||||||||||||||||||||
Interest credited to fixed accounts | 8 | — | 8 | ||||||||||||||||||||||||||
-1 | Included in interest credited to fixed accounts in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
-2 | Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
The impact to pretax income of the Company’s adjustment for nonperformance risk on the fair value of its embedded derivatives was $59 million and $(14) million, net of DAC, DSIC, unearned revenue amortization and the reinsurance accrual, for the three months ended September 30, 2014 and 2013, respectively. The impact to pretax income of the Company’s adjustment for nonperformance risk on the fair value of its embedded derivatives was $68 million and $(104) million, net of DAC, DSIC, unearned revenue amortization and the reinsurance accrual, for the nine months ended September 30, 2014 and 2013, respectively. | |||||||||||||||||||||||||||||
Securities transferred from Level 3 primarily represent securities with fair values that are now obtained from a third party pricing service with observable inputs. Securities transferred to Level 3 represent securities with fair values that are now based on a single non-binding broker quote. The Company recognizes transfers between levels of the fair value hierarchy as of the beginning of the quarter in which each transfer occurred. For assets and liabilities held at the end of the reporting periods that are measured at fair value on a recurring basis, there were no transfers between Level 1 and Level 2. | |||||||||||||||||||||||||||||
The following tables provide a summary of the significant unobservable inputs used in the fair value measurements developed by the Company or reasonably available to the Company of Level 3 assets and liabilities: | |||||||||||||||||||||||||||||
30-Sep-14 | |||||||||||||||||||||||||||||
Fair Value | Valuation Technique | Unobservable Input | Range | Weighted Average | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Corporate debt securities (private placements) | $ | 1,341 | Discounted cash flow | Yield/spread to U.S. Treasuries | 0.9 | % | - | 3.50% | 1.3 | % | |||||||||||||||||||
Other derivative contracts | $ | 1 | Option pricing model | Correlation(1) | (3.0 | )% | - | -84.00% | (60.0 | )% | |||||||||||||||||||
IUL embedded derivatives | $ | 202 | Discounted cash flow | Nonperformance risk(2) | 69 | bps | |||||||||||||||||||||||
GMWB and GMAB embedded derivatives | $ | (77 | ) | Discounted cash flow | Utilization of guaranteed withdrawals(3) | 0 | % | - | 51.10% | ||||||||||||||||||||
Surrender rate | 0 | % | - | 59.10% | |||||||||||||||||||||||||
Market volatility(4) | 4.9 | % | - | 19.40% | |||||||||||||||||||||||||
Nonperformance risk(2) | 69 | bps | |||||||||||||||||||||||||||
Elective contractholder strategy allocations(5) | 0 | % | - | 31.00% | |||||||||||||||||||||||||
31-Dec-13 | |||||||||||||||||||||||||||||
Fair Value | Valuation Technique | Unobservable Input | Range | Weighted Average | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Corporate debt securities (private placements) | $ | 1,487 | Discounted cash flow | Yield/spread to U.S. Treasuries | 0.9 | % | - | 5.30% | 1.60% | ||||||||||||||||||||
IUL embedded derivatives | $ | 125 | Discounted cash flow | Nonperformance risk(2) | 74 | bps | |||||||||||||||||||||||
GMWB and GMAB embedded derivatives | $ | (575 | ) | Discounted cash flow | Utilization of guaranteed withdrawals(3) | 0 | % | - | 51.10% | ||||||||||||||||||||
Surrender rate | 0.1 | % | - | 57.90% | |||||||||||||||||||||||||
Market volatility(4) | 4.9 | % | - | 18.80% | |||||||||||||||||||||||||
Nonperformance risk(2) | 74 | bps | |||||||||||||||||||||||||||
Elective contractholder strategy allocations(5) | 0 | % | - | 50.00% | |||||||||||||||||||||||||
-1 | Represents the correlation between equity returns and interest rates used in the valuation of the derivative contract. | ||||||||||||||||||||||||||||
-2 | The nonperformance risk is the spread added to the observable interest rates used in the valuation of the embedded derivatives. | ||||||||||||||||||||||||||||
-3 | The utilization of guaranteed withdrawals represents the percentage of contractholders that will begin withdrawing in any given year. | ||||||||||||||||||||||||||||
-4 | Market volatility is implied volatility of fund of funds and managed volatility funds. | ||||||||||||||||||||||||||||
-5 | The elective allocation represents the percentage of contractholders that are assumed to electively switch their investment allocation to a different allocation model. | ||||||||||||||||||||||||||||
Level 3 measurements not included in the table above are obtained from non-binding broker quotes where unobservable inputs are not reasonably available to the Company. | |||||||||||||||||||||||||||||
Sensitivity of Fair Value Measurements to Changes in Unobservable Inputs | |||||||||||||||||||||||||||||
Significant increases (decreases) in the yield/spread to U.S. Treasuries used in the fair value measurement of Level 3 corporate debt securities in isolation would result in a significantly lower (higher) fair value measurement. | |||||||||||||||||||||||||||||
Significant (decreases) increases in the correlation used in the fair value measurement of Level 3 derivatives in isolation would result in a significantly higher (lower) fair value measurement. | |||||||||||||||||||||||||||||
Significant increases (decreases) in nonperformance risk used in the fair value measurement of the IUL embedded derivatives in isolation would result in a significantly lower (higher) fair value measurement. | |||||||||||||||||||||||||||||
Significant increases (decreases) in utilization, surrender rate and volatility used in the fair value measurement of the GMWB and GMAB embedded derivatives in isolation would result in a significantly lower (higher) asset value, possibly creating a liability. Significant increases (decreases) in nonperformance risk and elective investment allocation model used in the fair value measurement of the GMWB and GMAB embedded derivatives in isolation would result in a significantly higher (lower) asset value. Utilization of guaranteed withdrawals and surrender rates vary with the type of rider, the duration of the policy, the age of the contractholder, the distribution system and whether the value of the guaranteed benefit exceeds the contract accumulation value. | |||||||||||||||||||||||||||||
Determination of Fair Value | |||||||||||||||||||||||||||||
The Company uses valuation techniques consistent with the market and income approaches to measure the fair value of its assets and liabilities. The Company’s market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. The Company’s income approach uses valuation techniques to convert future projected cash flows to a single discounted present value amount. When applying either approach, the Company maximizes the use of observable inputs and minimizes the use of unobservable inputs. | |||||||||||||||||||||||||||||
The following is a description of the valuation techniques used to measure fair value and the general classification of these instruments pursuant to the fair value hierarchy. | |||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||
Cash Equivalents | |||||||||||||||||||||||||||||
Cash equivalents include highly liquid investments with original maturities of 90 days or less. Actively traded money market funds are measured at their net asset value (“NAV”) and classified as Level 1. The Company’s remaining cash equivalents are classified as Level 2 and measured at amortized cost, which is a reasonable estimate of fair value because of the short time between the purchase of the instrument and its expected realization. | |||||||||||||||||||||||||||||
Available-for-Sale Securities | |||||||||||||||||||||||||||||
When available, the fair value of securities is based on quoted prices in active markets. If quoted prices are not available, fair values are obtained from third party pricing services, non-binding broker quotes, or other model-based valuation techniques. Level 1 securities include U.S. Treasuries. Level 2 securities include corporate bonds, residential mortgage backed securities, commercial mortgage backed securities, state and municipal obligations, asset backed securities and U.S. agency and foreign government securities. The fair value of these Level 2 securities is based on a market approach with prices obtained from third party pricing services. Observable inputs used to value these securities can include, but are not limited to, reported trades, benchmark yields, issuer spreads and non-binding broker quotes. Level 3 securities primarily include certain corporate bonds, non-agency residential mortgage backed securities, commercial mortgage backed securities and asset backed securities. The fair value of corporate bonds, non-agency residential mortgage backed securities, commercial mortgage backed securities and certain asset backed securities classified as Level 3 is typically based on a single non-binding broker quote. The underlying inputs used for some of the non-binding broker quotes are not readily available to the Company. The Company’s privately placed corporate bonds are typically based on a single non-binding broker quote. In addition to the general pricing controls, the Company reviews the broker prices to ensure that the broker quotes are reasonable and, when available, compares prices of privately issued securities to public issues from the same issuer to ensure that the implicit illiquidity premium applied to the privately placed investment is reasonable considering investment characteristics, maturity, and average life of the investment. | |||||||||||||||||||||||||||||
In consideration of the above, management is responsible for the fair values recorded on the financial statements. Prices received from third party pricing services are subjected to exception reporting that identifies investments with significant daily price movements as well as no movements. The Company reviews the exception reporting and resolves the exceptions through reaffirmation of the price or recording an appropriate fair value estimate. The Company also performs subsequent transaction testing. The Company performs annual due diligence of third party pricing services. The Company’s due diligence procedures include assessing the vendor’s valuation qualifications, control environment, analysis of asset-class specific valuation methodologies, and understanding of sources of market observable assumptions and unobservable assumptions, if any, employed in the valuation methodology. The Company also considers the results of its exception reporting controls and any resulting price challenges that arise. | |||||||||||||||||||||||||||||
Separate Account Assets | |||||||||||||||||||||||||||||
The fair value of assets held by separate accounts is determined by the NAV of the funds in which those separate accounts are invested. The NAV represents the exit price for the separate account. Separate account assets are classified as Level 2 as they are traded in principal-to-principal markets with little publicly released pricing information. | |||||||||||||||||||||||||||||
Other Assets | |||||||||||||||||||||||||||||
Derivatives that are measured using quoted prices in active markets, such as derivatives that are exchange-traded, are classified as Level 1 measurements. The fair value of derivatives that are traded in less active over-the-counter (“OTC”) markets is generally measured using pricing models with market observable inputs such as interest rates and equity index levels. These measurements are classified as Level 2 within the fair value hierarchy and include swaps and the majority of the Company's options. The fair value of certain derivatives measured using pricing models which include significant unobservable inputs are classified as Level 3 within the fair value hierarchy. Other derivative contracts consist of the Company's macro hedge program. See Note 13 for further information on the macro hedge program. The counterparties’ nonperformance risk associated with uncollateralized derivative assets was immaterial at September 30, 2014 and December 31, 2013. See Note 12 and Note 13 for further information on the credit risk of derivative instruments and related collateral. | |||||||||||||||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||
Policyholder Account Balances, Future Policy Benefits and Claims | |||||||||||||||||||||||||||||
The Company values the embedded derivatives attributable to the provisions of certain variable annuity riders using internal valuation models. These models calculate fair value by discounting expected cash flows from benefits plus margins for profit, risk and expenses less embedded derivative fees. The projected cash flows used by these models include observable capital market assumptions and incorporate significant unobservable inputs related to contractholder behavior assumptions, implied volatility, and margins for risk, profit and expenses that the Company believes an exit market participant would expect. The fair value also reflects a current estimate of the Company’s nonperformance risk specific to these embedded derivatives. Given the significant unobservable inputs to this valuation, these measurements are classified as Level 3. The embedded derivatives attributable to these provisions are recorded in policyholder account balances, future policy benefits and claims. | |||||||||||||||||||||||||||||
The Company uses various Black-Scholes calculations to determine the fair value of the embedded derivatives associated with the provisions of its EIA and IUL products. Significant inputs to the EIA calculation include observable interest rates, volatilities and equity index levels and, therefore, are classified as Level 2. The fair value of the IUL embedded derivatives includes significant observable interest rates, volatilities and equity index levels and the significant unobservable estimate of the Company’s nonperformance risk. Given the significance of the nonperformance risk assumption to the fair value, the IUL embedded derivatives are classified as Level 3. The embedded derivatives attributable to these provisions are recorded in policyholder account balances, future policy benefits and claims. | |||||||||||||||||||||||||||||
The Company’s Corporate Actuarial Department calculates the fair value of the embedded derivatives on a monthly basis. During this process, control checks are performed to validate the completeness of the data. Actuarial management approves various components of the valuation along with the final results. The change in the fair value of the embedded derivatives is reviewed monthly with senior management. The Level 3 inputs into the valuation are consistent with the pricing assumptions and updated as experience develops. Significant unobservable inputs that reflect policyholder behavior are reviewed quarterly along with other valuation assumptions. | |||||||||||||||||||||||||||||
Other Liabilities | |||||||||||||||||||||||||||||
Derivatives that are measured using quoted prices in active markets, such as derivatives that are exchange-traded, are classified as Level 1 measurements. The fair value of derivatives that are traded in less active OTC markets are generally measured using pricing models with market observable inputs such as interest rates and equity index levels. These measurements are classified as Level 2 within the fair value hierarchy and include swaps and the majority of options. Other derivative contracts consist of the Company's macro hedge program. See Note 13 for further information on the macro hedge program. The Company’s nonperformance risk associated with uncollateralized derivative liabilities was immaterial at September 30, 2014 and December 31, 2013. See Note 12 and Note 13 for further information on the credit risk of derivative instruments and related collateral. | |||||||||||||||||||||||||||||
During the reporting periods, there were no material assets or liabilities measured at fair value on a nonrecurring basis. | |||||||||||||||||||||||||||||
The following tables provide the carrying value and the estimated fair value of financial instruments that are not reported at fair value. All other financial instruments that are reported at fair value have been included above in the table with balances of assets and liabilities measured at fair value on a recurring basis. | |||||||||||||||||||||||||||||
30-Sep-14 | |||||||||||||||||||||||||||||
Carrying | Fair Value | ||||||||||||||||||||||||||||
Value | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Financial Assets | |||||||||||||||||||||||||||||
Mortgage loans, net | $ | 3,300 | $ | — | $ | — | $ | 3,386 | $ | 3,386 | |||||||||||||||||||
Policy loans | 804 | — | — | 788 | 788 | ||||||||||||||||||||||||
Other investments | 465 | — | 419 | 45 | 464 | ||||||||||||||||||||||||
Financial Liabilities | |||||||||||||||||||||||||||||
Policyholder account balances, future policy benefits and claims | $ | 13,203 | $ | — | $ | — | $ | 13,819 | $ | 13,819 | |||||||||||||||||||
Short-term borrowings | 200 | — | 200 | — | 200 | ||||||||||||||||||||||||
Other liabilities | 96 | — | — | 95 | 95 | ||||||||||||||||||||||||
Separate account liabilities | 394 | — | 394 | — | 394 | ||||||||||||||||||||||||
31-Dec-13 | |||||||||||||||||||||||||||||
Carrying | Fair Value | ||||||||||||||||||||||||||||
Value | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Financial Assets | |||||||||||||||||||||||||||||
Mortgage loans, net | $ | 3,326 | $ | — | $ | — | $ | 3,372 | $ | 3,372 | |||||||||||||||||||
Policy loans | 773 | — | — | 765 | 765 | ||||||||||||||||||||||||
Other investments | 385 | — | 346 | 42 | 388 | ||||||||||||||||||||||||
Financial Liabilities | |||||||||||||||||||||||||||||
Policyholder account balances, future policy benefits and claims | $ | 14,106 | $ | — | $ | — | $ | 14,724 | $ | 14,724 | |||||||||||||||||||
Short-term borrowings | 500 | — | 500 | — | 500 | ||||||||||||||||||||||||
Line of credit with Ameriprise Financial | 150 | — | — | 150 | 150 | ||||||||||||||||||||||||
Other liabilities | 137 | — | — | 134 | 134 | ||||||||||||||||||||||||
Separate account liabilities | 400 | — | 400 | — | 400 | ||||||||||||||||||||||||
Mortgage Loans, Net | |||||||||||||||||||||||||||||
The fair value of commercial mortgage loans, except those with significant credit deterioration, is determined by discounting contractual cash flows using discount rates that reflect current pricing for loans with similar remaining maturities, liquidity and characteristics including LTV ratio, occupancy rate, refinance risk, debt-service coverage, location, and property condition. For commercial mortgage loans with significant credit deterioration, fair value is determined using the same adjustments as above with an additional adjustment for the Company’s estimate of the amount recoverable on the loan. | |||||||||||||||||||||||||||||
The fair value of residential mortgage loans is determined by discounting estimated cash flows and incorporating adjustments for prepayment, administration expenses, loss severity and credit loss estimates, with discount rates based on the Company’s estimate of current market conditions. | |||||||||||||||||||||||||||||
Given the significant unobservable inputs to the valuation of mortgage loans, these measurements are classified as Level 3. | |||||||||||||||||||||||||||||
Policy Loans | |||||||||||||||||||||||||||||
Policy loans represent loans made against the cash surrender value of the underlying life insurance or annuity product. These loans and the related interest are usually realized at death of the policyholder or contractholder or at surrender of the contract and are not transferable without the underlying insurance or annuity contract. The fair value of policy loans is determined by estimating expected cash flows discounted at rates based on the U.S. Treasury curve. Policy loans are classified as Level 3 as the discount rate used may be adjusted for the underlying performance of individual policies. | |||||||||||||||||||||||||||||
Other Investments | |||||||||||||||||||||||||||||
Other investments primarily consist of syndicated loans and an investment in FHLB. The fair value of syndicated loans is obtained from a third party pricing service or non-binding broker quotes. Syndicated loans that are priced using a market approach with observable inputs are classified as Level 2 and syndicated loans priced using a single non-binding broker quote are classified as Level 3. The fair value of the investment in FHLB is approximated by the carrying value and classified as Level 3 due to restrictions on transfer and lack of liquidity in the primary market for this asset. | |||||||||||||||||||||||||||||
Policyholder Account Balances, Future Policy Benefits and Claims | |||||||||||||||||||||||||||||
The fair value of fixed annuities, in deferral status, is determined by discounting cash flows using a risk neutral discount rate with adjustments for profit margin, expense margin, early policy surrender behavior, a margin for adverse deviation from estimated early policy surrender behavior and the Company’s nonperformance risk specific to these liabilities. The fair value of non-life contingent fixed annuities in payout status, EIA host contracts and the fixed portion of a small number of variable annuity contracts classified as investment contracts is determined in a similar manner. Given the use of significant unobservable inputs to these valuations, the measurements are classified as Level 3. | |||||||||||||||||||||||||||||
Short-term Borrowings | |||||||||||||||||||||||||||||
The fair value of short-term borrowings is obtained from a third party pricing service. A nonperformance adjustment is not included as collateral requirements for these borrowings minimize the nonperformance risk. The fair value of short-term borrowings is classified as Level 2. | |||||||||||||||||||||||||||||
Line of Credit with Ameriprise Financial | |||||||||||||||||||||||||||||
The fair value of the line of credit is determined by discounting cash flows with an adjustment for the Company’s nonperformance risk specific to this liability. The fair value of the line of credit is classified as Level 3. | |||||||||||||||||||||||||||||
Other Liabilities | |||||||||||||||||||||||||||||
Other liabilities consist of future funding commitments to affordable housing partnerships. The fair value of these future funding commitments is determined by discounting cash flows. The fair value of these commitments includes an adjustment for the Company’s nonperformance risk and is classified as Level 3 due to the use of the significant unobservable input. | |||||||||||||||||||||||||||||
Separate Account Liabilities | |||||||||||||||||||||||||||||
Certain separate account liabilities are classified as investment contracts and are carried at an amount equal to the related separate account assets. The NAV of the related separate account assets represents the exit price for the separate account liabilities. Separate account liabilities are classified as Level 2 as they are traded in principal-to-principal markets with little publicly released pricing information. A nonperformance adjustment is not included as the related separate account assets act as collateral for these liabilities and minimize nonperformance risk. |
Offsetting_Assets_and_Liabilit
Offsetting Assets and Liabilities | 9 Months Ended | ||||||||||||||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||||||||||||||
Offsetting [Abstract] | ' | ||||||||||||||||||||||||||||
Offsetting Assets and Liabilities | ' | ||||||||||||||||||||||||||||
Offsetting Assets and Liabilities | |||||||||||||||||||||||||||||
Certain financial instruments and derivative instruments are eligible for offset in the Consolidated Balance Sheets. The Company’s derivative instruments and repurchase agreements are subject to master netting arrangements and collateral arrangements and qualify for offset. A master netting arrangement with a counterparty creates a right of offset for amounts due to and from that same counterparty that is enforceable in the event of a default or bankruptcy. The Company’s policy is to recognize amounts subject to master netting arrangements on a gross basis in the Consolidated Balance Sheets. | |||||||||||||||||||||||||||||
The following tables present the gross and net information about the Company’s assets subject to master netting arrangements: | |||||||||||||||||||||||||||||
30-Sep-14 | |||||||||||||||||||||||||||||
Gross Amounts of Recognized Assets | Gross Amounts Offset in the Consolidated Balance Sheets | Amounts of Assets Presented in the Consolidated Balance Sheets | Gross Amounts Not Offset | ||||||||||||||||||||||||||
in the Consolidated Balance Sheets | |||||||||||||||||||||||||||||
Financial Instruments(1) | Cash Collateral | Securities Collateral | Net Amount | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||
OTC | $ | 3,131 | $ | — | $ | 3,131 | $ | (2,834 | ) | $ | (107 | ) | $ | (176 | ) | $ | 14 | ||||||||||||
OTC cleared | 145 | — | 145 | (92 | ) | (53 | ) | — | — | ||||||||||||||||||||
Exchange-traded | 71 | — | 71 | — | — | — | 71 | ||||||||||||||||||||||
Total derivatives | $ | 3,347 | $ | — | $ | 3,347 | $ | (2,926 | ) | $ | (160 | ) | $ | (176 | ) | $ | 85 | ||||||||||||
December 31, 2013 | |||||||||||||||||||||||||||||
Gross Amounts of Recognized Assets | Gross Amounts Offset in the Consolidated Balance Sheets | Amounts of Assets Presented in the Consolidated Balance Sheets | Gross Amounts Not Offset | ||||||||||||||||||||||||||
in the Consolidated Balance Sheets | |||||||||||||||||||||||||||||
Financial Instruments(1) | Cash Collateral | Securities Collateral | Net Amount | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||
OTC | $ | 3,180 | $ | — | $ | 3,180 | $ | (3,134 | ) | $ | (17 | ) | $ | (16 | ) | $ | 13 | ||||||||||||
OTC cleared | 21 | — | 21 | (20 | ) | (1 | ) | — | — | ||||||||||||||||||||
Exchange-traded | 60 | — | 60 | — | — | — | 60 | ||||||||||||||||||||||
Total derivatives | $ | 3,261 | $ | — | $ | 3,261 | $ | (3,154 | ) | $ | (18 | ) | $ | (16 | ) | $ | 73 | ||||||||||||
-1 | Represents the amount of assets that could be offset by liabilities with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets. | ||||||||||||||||||||||||||||
The following tables present the gross and net information about the Company’s liabilities subject to master netting arrangements: | |||||||||||||||||||||||||||||
30-Sep-14 | |||||||||||||||||||||||||||||
Gross Amounts of Recognized Liabilities | Gross Amounts Offset in the Consolidated Balance Sheets | Amounts of Liabilities Presented in the Consolidated Balance Sheets | Gross Amounts Not Offset | ||||||||||||||||||||||||||
in the Consolidated Balance Sheets | |||||||||||||||||||||||||||||
Financial | Cash | Securities | Net | ||||||||||||||||||||||||||
Instruments(1) | Collateral | Collateral | Amount | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||
OTC | $ | 3,772 | $ | — | $ | 3,772 | $ | (2,834 | ) | $ | — | $ | (938 | ) | $ | — | |||||||||||||
OTC cleared | 92 | — | 92 | (92 | ) | — | — | — | |||||||||||||||||||||
Total derivatives | 3,864 | — | 3,864 | (2,926 | ) | — | (938 | ) | — | ||||||||||||||||||||
Repurchase agreements | 50 | — | 50 | — | — | (50 | ) | — | |||||||||||||||||||||
Total | $ | 3,914 | $ | — | $ | 3,914 | $ | (2,926 | ) | $ | — | $ | (988 | ) | $ | — | |||||||||||||
December 31, 2013 | |||||||||||||||||||||||||||||
Gross Amounts of Recognized Liabilities | Gross Amounts Offset in the Consolidated Balance Sheets | Amounts of Liabilities Presented in the Consolidated Balance Sheets | Gross Amounts Not Offset | ||||||||||||||||||||||||||
in the Consolidated Balance Sheets | |||||||||||||||||||||||||||||
Financial | Cash | Securities | Net | ||||||||||||||||||||||||||
Instruments(1) | Collateral | Collateral | Amount | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||
OTC | $ | 4,610 | $ | — | $ | 4,610 | $ | (3,134 | ) | $ | — | $ | (1,465 | ) | $ | 11 | |||||||||||||
OTC cleared | 22 | — | 22 | (20 | ) | (2 | ) | — | — | ||||||||||||||||||||
Total derivatives | 4,632 | — | 4,632 | (3,154 | ) | (2 | ) | (1,465 | ) | 11 | |||||||||||||||||||
Repurchase agreements | 50 | — | 50 | — | — | (50 | ) | — | |||||||||||||||||||||
Total | $ | 4,682 | $ | — | $ | 4,682 | $ | (3,154 | ) | $ | (2 | ) | $ | (1,515 | ) | $ | 11 | ||||||||||||
-1 | Represents the amount of liabilities that could be offset by assets with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets. | ||||||||||||||||||||||||||||
In the tables above, the amounts of assets or liabilities presented in the Consolidated Balance Sheets are offset first by financial instruments that have the right of offset under master netting or similar arrangements, then any remaining amount is reduced by the amount of cash and securities collateral. The actual collateral may be greater than amounts presented in the tables. | |||||||||||||||||||||||||||||
The Company’s freestanding derivative instruments are reflected in other assets and other liabilities. Repurchase agreements are reflected in short-term borrowings. See Note 13 for additional disclosures related to the Company’s derivative instruments and Note 10 for additional disclosures related to the Company’s repurchase agreements. |
Derivatives_and_Hedging_Activi
Derivatives and Hedging Activities | 9 Months Ended | ||||||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ' | ||||||||||||||||||||
Derivatives and Hedging Activities | ' | ||||||||||||||||||||
Derivatives and Hedging Activities | |||||||||||||||||||||
Derivative instruments enable the Company to manage its exposure to various market risks. The value of such instruments is derived from an underlying variable or multiple variables, including equity and interest rate indices or prices. The Company primarily enters into derivative agreements for risk management purposes related to the Company’s products and operations. | |||||||||||||||||||||
The Company’s freestanding derivatives are recorded at fair value and are reflected in other assets or other liabilities. The Company’s freestanding derivative instruments are all subject to master netting arrangements. The Company’s policy on the recognition of derivatives on the Consolidated Balance Sheets is to not offset fair value amounts recognized for derivatives and collateral arrangements executed with the same counterparty under the same master netting arrangement. See Note 12 for additional information regarding the estimated fair value of the Company’s freestanding derivatives after considering the effect of master netting arrangements and collateral. | |||||||||||||||||||||
The Company currently uses derivatives as economic hedges and accounting hedges. The following table presents the balance sheet location and the gross fair value of derivative instruments, including embedded derivatives: | |||||||||||||||||||||
Assets | Liabilities | ||||||||||||||||||||
Derivatives not designated | Balance Sheet | September 30, | December 31, | Balance Sheet Location | September 30, | December 31, | |||||||||||||||
as hedging instruments | Location | 2014 | 2013 | 2014 | 2013 | ||||||||||||||||
(in millions) | (in millions) | ||||||||||||||||||||
GMWB and GMAB | |||||||||||||||||||||
Interest rate contracts | Other assets | $ | 1,512 | $ | 1,484 | Other liabilities | $ | 1,208 | $ | 1,672 | |||||||||||
Equity contracts | Other assets | 1,798 | 1,741 | Other liabilities | 2,636 | 2,918 | |||||||||||||||
Credit contracts | Other assets | 4 | 3 | Other liabilities | — | — | |||||||||||||||
Foreign exchange contracts | Other assets | 4 | 2 | Other liabilities | — | — | |||||||||||||||
Embedded derivatives(1) | N/A | — | — | Policyholder account balances, future policy benefits and claims(2) | (77 | ) | (575 | ) | |||||||||||||
Total GMWB and GMAB | 3,318 | 3,230 | 3,767 | 4,015 | |||||||||||||||||
Other derivatives: | |||||||||||||||||||||
Equity | |||||||||||||||||||||
EIA embedded derivatives | N/A | — | — | Policyholder account balances, future policy benefits and claims | 6 | 5 | |||||||||||||||
IUL | Other assets | 28 | 27 | Other liabilities | 7 | 13 | |||||||||||||||
IUL embedded derivatives | N/A | — | — | Policyholder account balances, future policy benefits and claims | 202 | 125 | |||||||||||||||
Other | |||||||||||||||||||||
Macro hedge program | Other assets | 1 | 4 | Other liabilities | 13 | 29 | |||||||||||||||
Total other derivatives | 29 | 31 | 228 | 172 | |||||||||||||||||
Total derivatives | $ | 3,347 | $ | 3,261 | $ | 3,995 | $ | 4,187 | |||||||||||||
N/A | Not applicable. | ||||||||||||||||||||
-1 | The fair values of GMWB and GMAB embedded derivatives fluctuate based on changes in equity, interest rate and credit markets. | ||||||||||||||||||||
-2 | The fair value of the GMWB and GMAB embedded derivatives was a net asset at September 30, 2014 and December 31, 2013 and the amount is reported as a contra liability. | ||||||||||||||||||||
See Note 11 for additional information regarding the Company’s fair value measurement of derivative instruments. | |||||||||||||||||||||
The following table presents a summary of the impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income: | |||||||||||||||||||||
Amount of Gain (Loss) on Derivatives | |||||||||||||||||||||
Recognized in Income | |||||||||||||||||||||
Derivatives not designated as hedging instruments | Location of Gain (Loss) on Derivatives Recognized in Income | Three Months Ended September 30, | Nine Months Ended | ||||||||||||||||||
September 30, | |||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||||||
(in millions) | |||||||||||||||||||||
GMWB and GMAB | |||||||||||||||||||||
Interest rate contracts | Benefits, claims, losses and settlement expenses | $ | 100 | $ | (63 | ) | $ | 609 | $ | (575 | ) | ||||||||||
Equity contracts | Benefits, claims, losses and settlement expenses | 143 | (323 | ) | (244 | ) | (803 | ) | |||||||||||||
Credit contracts | Benefits, claims, losses and settlement expenses | (1 | ) | (3 | ) | (23 | ) | 5 | |||||||||||||
Foreign exchange contracts | Benefits, claims, losses and settlement expenses | (13 | ) | 8 | (14 | ) | 15 | ||||||||||||||
Embedded derivatives(1) | Benefits, claims, losses and settlement expenses | (270 | ) | 267 | (498 | ) | 1,089 | ||||||||||||||
Total GMWB and GMAB | (41 | ) | (114 | ) | (170 | ) | (269 | ) | |||||||||||||
Other derivatives: | |||||||||||||||||||||
Interest rate | |||||||||||||||||||||
Tax hedge | Net investment income | — | — | 3 | — | ||||||||||||||||
Equity | |||||||||||||||||||||
EIA | Interest credited to fixed accounts | — | 1 | 1 | 2 | ||||||||||||||||
EIA embedded derivatives | Interest credited to fixed accounts | — | — | (1 | ) | (1 | ) | ||||||||||||||
IUL | Interest credited to fixed accounts | 2 | 2 | 13 | 8 | ||||||||||||||||
IUL embedded derivatives | Interest credited to fixed accounts | (2 | ) | 3 | 9 | 8 | |||||||||||||||
Other | |||||||||||||||||||||
Macro hedge program | Benefits, claims, losses and settlement expenses | (1 | ) | — | 2 | — | |||||||||||||||
Total other derivatives | (1 | ) | 6 | 27 | 17 | ||||||||||||||||
Total derivatives | $ | (42 | ) | $ | (108 | ) | $ | (143 | ) | $ | (252 | ) | |||||||||
-1 | The fair values of GMWB and GMAB embedded derivatives fluctuate based on changes in equity, interest rate and credit markets. | ||||||||||||||||||||
The Company holds derivative instruments that either do not qualify or are not designated for hedge accounting treatment. These derivative instruments are used as economic hedges of equity, interest rate, credit and foreign currency exchange rate risk related to various products and transactions of the Company. | |||||||||||||||||||||
Certain annuity contracts contain GMWB or GMAB provisions, which guarantee the right to make limited partial withdrawals each contract year regardless of the volatility inherent in the underlying investments or guarantee a minimum accumulation value of consideration received at the beginning of the contract period, after a specified holding period, respectively. The Company economically hedges the exposure related to non-life contingent GMWB and GMAB provisions primarily using various futures, options, interest rate swaptions, interest rate swaps, total return swaps and variance swaps. At September 30, 2014 and December 31, 2013, the gross notional amount of derivative contracts for the Company’s GMWB and GMAB provisions was $135.8 billion and $142.4 billion, respectively. | |||||||||||||||||||||
The deferred premium associated with certain of the above options is paid or received semi-annually over the life of the option contract or at maturity. The following is a summary of the payments the Company is scheduled to make and receive for these options: | |||||||||||||||||||||
Premiums Payable | Premiums Receivable | ||||||||||||||||||||
(in millions) | |||||||||||||||||||||
2014(1) | $ | 109 | $ | 49 | |||||||||||||||||
2015 | 349 | 69 | |||||||||||||||||||
2016 | 316 | 53 | |||||||||||||||||||
2017 | 240 | 69 | |||||||||||||||||||
2018 | 190 | 68 | |||||||||||||||||||
2019-2026 | 526 | 132 | |||||||||||||||||||
Total | $ | 1,730 | $ | 440 | |||||||||||||||||
-1 | 2014 amounts represent the amounts payable and receivable for the period from October 1, 2014 to December 31, 2014. | ||||||||||||||||||||
Actual timing and payment amounts may differ due to future contract settlements, modifications or exercises of options prior to the full premium being paid or received. | |||||||||||||||||||||
During 2013, the Company transferred net derivative liabilities with a fair value of $94 million, consisting of long-dated options, along with cash payment of the same amount to Ameriprise Financial. The transaction improves the risk management profile of statutory tail scenario risk for the Company’s variable annuities. | |||||||||||||||||||||
The Company has a macro hedge program to provide protection against the statutory tail scenario risk arising from variable annuity reserves on its statutory surplus and to cover some of the residual risks not covered by other hedging activities. As a means of economically hedging these risks, the Company uses a combination of options and/or swaps. Certain of the macro hedge derivatives used contain settlement provisions linked to both equity returns and interest rates; the remaining are interest rate contracts or equity contracts. The gross notional amount of these derivative contracts was $1.2 billion and $710 million at September 30, 2014 and December 31, 2013, respectively. | |||||||||||||||||||||
EIA and IUL products have returns tied to the performance of equity markets. As a result of fluctuations in equity markets, the obligation incurred by the Company related to EIA and IUL products will positively or negatively impact earnings over the life of these products. As a means of economically hedging its obligations under the provisions of these products, the Company enters into index options and futures contracts. The gross notional amount of these derivative contracts was $804 million and $512 million at September 30, 2014 and December 31, 2013, respectively. | |||||||||||||||||||||
Embedded Derivatives | |||||||||||||||||||||
Certain annuities contain GMAB and non-life contingent GMWB provisions, which are considered embedded derivatives. In addition, the equity component of the EIA and IUL product obligations are also considered embedded derivatives. These embedded derivatives are bifurcated from their host contracts for valuation purposes and reported on the Consolidated Balance Sheets at fair value with changes in fair value reported in earnings. As discussed above, the Company uses derivatives to mitigate the financial statement impact of these embedded derivatives. | |||||||||||||||||||||
Cash Flow Hedges | |||||||||||||||||||||
The Company has amounts classified in AOCI related to gains and losses associated with the effective portion of previously designated cash flow hedges. The Company reclassifies these amounts into income as the forecasted transactions impact earnings. During the nine months ended September 30, 2014, the Company held no derivatives that were designated as cash flow hedges. | |||||||||||||||||||||
At September 30, 2014, the Company expects to reclassify $6 million of deferred loss on derivative instruments from AOCI to earnings during the next 12 months that will be recorded in net investment income. These were originally losses on derivative instruments related to interest rate swaptions. During the nine months ended September 30, 2014 and 2013, no hedge relationships were discontinued due to forecasted transactions no longer being expected to occur according to the original hedge strategy. For the nine months ended September 30, 2014 and 2013, amounts recognized in earnings on derivative transactions that were ineffective were not material. | |||||||||||||||||||||
The following table presents a rollforward of unrealized derivative losses related to cash flow hedges included in accumulated other comprehensive income (loss): | |||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||
(in millions) | |||||||||||||||||||||
Net unrealized derivative losses at January 1 | $ | (17 | ) | $ | (21 | ) | |||||||||||||||
Reclassification of realized losses(1) | 5 | 6 | |||||||||||||||||||
Income tax benefit | (2 | ) | (2 | ) | |||||||||||||||||
Net unrealized derivative losses at September 30 | $ | (14 | ) | $ | (17 | ) | |||||||||||||||
-1 | Loss reclassified from AOCI to net investment income on the Consolidated Statements of Income. | ||||||||||||||||||||
Currently, the longest period of time over which the Company is hedging exposure to the variability in future cash flows is four years and relates to interest credited on forecasted fixed premium product sales. | |||||||||||||||||||||
Credit Risk | |||||||||||||||||||||
Credit risk associated with the Company’s derivatives is the risk that a derivative counterparty will not perform in accordance with the terms of the applicable derivative contract. To mitigate such risk, the Company has established guidelines and oversight of credit risk through a comprehensive enterprise risk management program that includes members of senior management. Key components of this program are to require preapproval of counterparties and the use of master netting arrangements and collateral arrangements whenever practical. See Note 12 for additional information on the Company’s credit exposure related to derivative assets. | |||||||||||||||||||||
Certain of the Company’s derivative contracts contain provisions that adjust the level of collateral the Company is required to post based on the Company’s financial strength rating (or based on the debt rating of the Company’s parent, Ameriprise Financial). Additionally, certain of the Company’s derivative contracts contain provisions that allow the counterparty to terminate the contract if the Company does not maintain a specific financial strength rating or Ameriprise Financial’s debt does not maintain a specific credit rating (generally an investment grade rating). If these termination provisions were to be triggered, the Company’s counterparty could require immediate settlement of any net liability position. At September 30, 2014 and December 31, 2013, the aggregate fair value of derivative contracts in a net liability position containing such credit contingent provisions was $494 million and $950 million, respectively. The aggregate fair value of assets posted as collateral for such instruments as of September 30, 2014 and December 31, 2013 was $494 million and $940 million, respectively. If the credit contingent provisions of derivative contracts in a net liability position at September 30, 2014 and December 31, 2013 were triggered, the aggregate fair value of additional assets that would be required to be posted as collateral or needed to settle the instruments immediately would have been nil and $10 million, respectively. |
Shareholders_Equity
Shareholder's Equity | 9 Months Ended | ||||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||||
Stockholders' Equity Note [Abstract] | ' | ||||||||||||||||||
Shareholder's Equity | ' | ||||||||||||||||||
Shareholder’s Equity | |||||||||||||||||||
The following table provides information related to amounts reclassified from AOCI: | |||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended | ||||||||||||||||||
September 30, | |||||||||||||||||||
AOCI Reclassification | Location of (Gain) Loss Recognized in Income | 2014 | 2013 | 2014 | 2013 | ||||||||||||||
(in millions) | |||||||||||||||||||
Net unrealized gains on Available-for-Sale securities | Net realized investment gains | $ | (10 | ) | $ | (4 | ) | $ | (15 | ) | $ | (3 | ) | ||||||
Tax expense | Income tax provision | 4 | 1 | 6 | 1 | ||||||||||||||
Net of tax | $ | (6 | ) | $ | (3 | ) | $ | (9 | ) | $ | (2 | ) | |||||||
Losses on cash flow hedges: | |||||||||||||||||||
Swaptions | Net investment income | $ | 2 | $ | 2 | $ | 5 | $ | 6 | ||||||||||
Tax benefit | Income tax provision | (1 | ) | (1 | ) | (2 | ) | (2 | ) | ||||||||||
Net of tax | $ | 1 | $ | 1 | $ | 3 | $ | 4 | |||||||||||
See Note 4 for additional information related to the impact of DAC, DSIC, benefit reserves and reinsurance recoverable on net unrealized securities gains/losses included in AOCI. See Note 13 for additional information regarding the Company’s cash flow hedges. |
Income_Taxes
Income Taxes | 9 Months Ended |
Sep. 30, 2014 | |
Income Tax Disclosure [Abstract] | ' |
Income Taxes | ' |
Income Taxes | |
The Company’s effective tax rate was 14.5% and 18.2% for the three months ended September 30, 2014 and 2013, respectively. The Company’s effective tax rate was 14.0% and 17.1% for the nine months ended September 30, 2014 and 2013, respectively. The effective tax rates are lower than the statutory rate as a result of tax preferred items including the dividends received deduction and low income housing tax credits. The decrease in the effective tax rate for the three months ended September 30, 2014 compared to the prior year period was primarily due to lower pretax income. The decrease in the effective tax rate for the nine months ended September 30, 2014 compared to the prior year period was the result of an $18 million benefit in the first quarter of 2014 related to the completion of an Internal Revenue Service (“IRS”) audit. | |
Included in the Company’s deferred income tax assets are tax benefits related to state net operating losses of $6 million which will expire beginning December 31, 2014. | |
The Company is required to establish a valuation allowance for any portion of the deferred tax assets that management believes will not be realized. Included in deferred tax assets is a significant deferred tax asset relating to capital losses that have been recognized for financial statement purposes but not yet for tax return purposes as well as future deductible capital losses realized for tax return purposes. Under current U.S. federal income tax law, capital losses generally must be used against capital gain income within five years of the year in which the capital losses are recognized for tax purposes. Significant judgment is required in determining if a valuation allowance should be established, and the amount of such allowance if required. Factors used in making this determination include estimates relating to the performance of the business including the ability to generate capital gains. Consideration is given to, among other things in making this determination, (i) future taxable income exclusive of reversing temporary differences and carryforwards, (ii) future reversals of existing taxable temporary differences, (iii) taxable income in prior carryback years, and (iv) tax planning strategies. Based on analysis of the Company’s tax position, management believes it is more likely than not that the results of future operations and implementation of tax planning strategies will not allow the Company to realize certain state deferred tax assets and state net operating losses and therefore a valuation allowance of $6 million was established as of both September 30, 2014 and December 31, 2013. | |
As of September 30, 2014 and December 31, 2013, the Company had $155 million and $144 million, respectively, of gross unrecognized tax benefits. If recognized, approximately $6 million and $23 million, net of federal tax benefits, of unrecognized tax benefits as of September 30, 2014 and December 31, 2013, respectively, would affect the effective tax rate. | |
It is reasonably possible that the total amounts of unrecognized tax benefits will change in the next 12 months. Based on the current audit position of the Company, it is estimated that the total amount of gross unrecognized tax benefits may decrease by $140 million to $150 million in the next 12 months due to resolution of IRS examinations. | |
The Company recognizes interest and penalties related to unrecognized tax benefits as a component of the income tax provision. The Company recognized a net increase of $1 million and $3 million in interest and penalties for the three months and nine months ended September 30, 2014, respectively. The Company recognized a net increase of $2 million and $5 million in interest and penalties for the three months and nine months ended September 30, 2013, respectively. As of September 30, 2014 and December 31, 2013, the Company had a payable of $39 million and $36 million, respectively, related to accrued interest and penalties. | |
The Company or one or more of its subsidiaries files income tax returns as part of its inclusion in the consolidated federal income tax returns of Ameriprise Financial in the U.S. federal jurisdiction and various state jurisdictions. The IRS had previously completed its field examination of the 1997 through 2007 tax returns in recent years. However, for federal income tax purposes, these years except for 2007, continue to remain open as a consequence of certain unagreed-upon issues. The IRS completed the audits of the Company’s 2008 and 2009 tax returns in the first quarter of 2014. The IRS is in the process of completing the audits of the Company’s income tax returns for 2010 through 2011 and expects these audits to be completed in 2014. The Company or certain of its subsidiaries’ state income tax returns are currently under examination by various jurisdictions for years ranging from 1997 through 2011 and remain open for the years after 2011. |
Guarantees_and_Contingencies
Guarantees and Contingencies | 9 Months Ended |
Sep. 30, 2014 | |
Commitments and Contingencies Disclosure [Abstract] | ' |
Guarantees and Contingencies | ' |
Guarantees and Contingencies | |
Guarantees | |
The Company is required by law to be a member of the guaranty fund association in every state where it is licensed to do business. In the event of insolvency of one or more unaffiliated insurance companies, the Company could be adversely affected by the requirement to pay assessments to the guaranty fund associations. Uncertainty and volatility in the U.S. economy and financial markets in recent years have weakened the financial condition of numerous insurers, including insurers currently in receiverships, increasing the risk of triggering guaranty fund assessments. | |
The Company projects its cost of future guaranty fund assessments based on estimates of insurance company insolvencies provided by the National Organization of Life and Health Insurance Guaranty Associations (“NOLHGA”) and the amount of its premiums written relative to the industry-wide premium in each state. The Company accrues the estimated cost of future guaranty fund assessments when it is considered probable that an assessment will be imposed, the event obligating the Company to pay the assessment has occurred and the amount of the assessment can be reasonably estimated. | |
The Company has a liability for estimated guaranty fund assessments and a related premium tax asset. At September 30, 2014 and December 31, 2013, the estimated liability was $13 million and $14 million, respectively. At both September 30, 2014 and December 31, 2013, the related premium tax asset was $11 million. The expected period over which guaranty fund assessments will be made and the related tax credits recovered is not known. | |
Contingencies | |
Insurance companies have been the subject of increasing regulatory, legislative and judicial scrutiny. Numerous state and federal regulatory agencies have commenced examinations and other inquiries of insurance companies regarding sales and marketing practices (including sales to older consumers and disclosure practices), claims handling, and unclaimed property and escheatment practices and procedures. With regard to an industry-wide investigation of unclaimed property and escheatment practices and procedures, the Company is responding to regulatory audits, market conduct examinations and other inquiries (including inquiries from the State of Minnesota and a multistate insurance department examination). The Company has cooperated and will continue to cooperate with the applicable regulators regarding their inquiries. | |
The Company is involved in the normal course of business in a number of other legal and arbitration proceedings concerning matters arising in connection with the conduct of its business activities. The Company believes that it is not a party to, nor are any of its properties the subject of, any pending legal, arbitration or regulatory investigation, examination or proceeding that is likely to have a material adverse effect on its consolidated financial condition, results of operations or liquidity. | |
Notwithstanding the foregoing, it is possible that the outcome of any current or future legal, arbitration or regulatory proceeding could have a material impact on results of operations in any particular reporting period as the proceedings are resolved. | |
Uncertain economic conditions, heightened and sustained volatility in the financial markets and significant financial reform legislation may increase the likelihood that clients and other persons or regulators may present or threaten legal claims or that regulators increase the scope or frequency of examinations of the Company or the insurance industry generally. | |
In September 2010, the California Department of Insurance (“CA DOI”) issued an Order to Show Cause administrative action against RiverSource Life Insurance Company alleging that certain claims handling practices reviewed in connection with a 2007-2008 market conduct exam did not comply with applicable law. In August 2014, RiverSource Life Insurance Company and the CA DOI reached agreement in principle to settle all pending allegations for $800,000, with the exception of a single allegation related to certain coverage determinations made under long term care insurance policies issued between 1989-1992. An administrative hearing on this remaining allegation is scheduled to conclude in November 2014. The Company cannot reasonably estimate the range of loss, if any, that may result from this matter given the procedural status of the matter, the lack of specific penalty allegations, and the difficulty of predicting outcomes in these administrative proceedings which involve multiple phases and appellate procedures. |
Investments_Tables
Investments (Tables) | 9 Months Ended | |||||||||||||||||||||||||||||||||
Sep. 30, 2014 | ||||||||||||||||||||||||||||||||||
Investments, Debt and Equity Securities [Abstract] | ' | |||||||||||||||||||||||||||||||||
Available-for-Sale Securities Disclosure | ' | |||||||||||||||||||||||||||||||||
Available-for-Sale securities distributed by type were as follows: | ||||||||||||||||||||||||||||||||||
30-Sep-14 | ||||||||||||||||||||||||||||||||||
Description of Securities | Amortized | Gross | Gross | Fair | Noncredit | |||||||||||||||||||||||||||||
Cost | Unrealized | Unrealized | Value | OTTI(1) | ||||||||||||||||||||||||||||||
Gains | Losses | |||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||
Fixed maturities: | ||||||||||||||||||||||||||||||||||
Corporate debt securities | $ | 13,962 | $ | 1,539 | $ | (31 | ) | $ | 15,470 | $ | 3 | |||||||||||||||||||||||
Residential mortgage backed securities | 3,466 | 135 | (44 | ) | 3,557 | (9 | ) | |||||||||||||||||||||||||||
Commercial mortgage backed securities | 2,121 | 115 | (4 | ) | 2,232 | — | ||||||||||||||||||||||||||||
State and municipal obligations | 942 | 159 | (28 | ) | 1,073 | — | ||||||||||||||||||||||||||||
Asset backed securities | 896 | 49 | (1 | ) | 944 | — | ||||||||||||||||||||||||||||
Foreign government bonds and obligations | 237 | 21 | (5 | ) | 253 | — | ||||||||||||||||||||||||||||
U.S. government and agencies obligations | 36 | 4 | — | 40 | — | |||||||||||||||||||||||||||||
Total fixed maturities | 21,660 | 2,022 | (113 | ) | 23,569 | (6 | ) | |||||||||||||||||||||||||||
Common stocks | 2 | 6 | — | 8 | 3 | |||||||||||||||||||||||||||||
Total | $ | 21,662 | $ | 2,028 | $ | (113 | ) | $ | 23,577 | $ | (3 | ) | ||||||||||||||||||||||
31-Dec-13 | ||||||||||||||||||||||||||||||||||
Description of Securities | Amortized | Gross | Gross | Fair | Noncredit | |||||||||||||||||||||||||||||
Cost | Unrealized | Unrealized | Value | OTTI(1) | ||||||||||||||||||||||||||||||
Gains | Losses | |||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||
Fixed maturities: | ||||||||||||||||||||||||||||||||||
Corporate debt securities | $ | 14,658 | $ | 1,311 | $ | (96 | ) | $ | 15,873 | $ | 3 | |||||||||||||||||||||||
Residential mortgage backed securities | 3,773 | 133 | (95 | ) | 3,811 | (18 | ) | |||||||||||||||||||||||||||
Commercial mortgage backed securities | 2,309 | 136 | (11 | ) | 2,434 | — | ||||||||||||||||||||||||||||
State and municipal obligations | 950 | 87 | (39 | ) | 998 | — | ||||||||||||||||||||||||||||
Asset backed securities | 938 | 48 | (5 | ) | 981 | — | ||||||||||||||||||||||||||||
Foreign government bonds and obligations | 234 | 19 | (8 | ) | 245 | — | ||||||||||||||||||||||||||||
U.S. government and agencies obligations | 40 | 5 | — | 45 | — | |||||||||||||||||||||||||||||
Total fixed maturities | 22,902 | 1,739 | (254 | ) | 24,387 | (15 | ) | |||||||||||||||||||||||||||
Common stocks | 2 | 4 | — | 6 | 2 | |||||||||||||||||||||||||||||
Total | $ | 22,904 | $ | 1,743 | $ | (254 | ) | $ | 24,393 | $ | (13 | ) | ||||||||||||||||||||||
(1) | Represents the amount of other-than-temporary impairment (“OTTI”) losses in accumulated other comprehensive income. Amount includes unrealized gains and losses on impaired securities subsequent to the initial impairment measurement date. These amounts are included in gross unrealized gains and losses as of the end of the period. | |||||||||||||||||||||||||||||||||
Investments with Fixed Maturities Disclosure | ' | |||||||||||||||||||||||||||||||||
A summary of fixed maturity securities by rating was as follows: | ||||||||||||||||||||||||||||||||||
30-Sep-14 | 31-Dec-13 | |||||||||||||||||||||||||||||||||
Ratings | Amortized | Fair | Percent of | Amortized | Fair | Percent of | ||||||||||||||||||||||||||||
Cost | Value | Total Fair | Cost | Value | Total Fair | |||||||||||||||||||||||||||||
Value | Value | |||||||||||||||||||||||||||||||||
(in millions, except percentages) | ||||||||||||||||||||||||||||||||||
AAA | $ | 5,183 | $ | 5,410 | 23 | % | $ | 5,557 | $ | 5,738 | 23 | % | ||||||||||||||||||||||
AA | 988 | 1,155 | 5 | 1,055 | 1,171 | 5 | ||||||||||||||||||||||||||||
A | 4,395 | 4,963 | 21 | 4,687 | 5,062 | 21 | ||||||||||||||||||||||||||||
BBB | 9,527 | 10,475 | 44 | 10,062 | 10,897 | 45 | ||||||||||||||||||||||||||||
Below investment grade | 1,567 | 1,566 | 7 | 1,541 | 1,519 | 6 | ||||||||||||||||||||||||||||
Total fixed maturities | $ | 21,660 | $ | 23,569 | 100 | % | $ | 22,902 | $ | 24,387 | 100 | % | ||||||||||||||||||||||
Available-for-Sale Securities Continuous Unrealized Loss Disclosure | ' | |||||||||||||||||||||||||||||||||
The following tables provide information about Available-for-Sale securities with gross unrealized losses and the length of time that individual securities have been in a continuous unrealized loss position: | ||||||||||||||||||||||||||||||||||
30-Sep-14 | ||||||||||||||||||||||||||||||||||
Less than 12 months | 12 months or more | Total | ||||||||||||||||||||||||||||||||
Description of Securities | Number of | Fair | Unrealized | Number of | Fair | Unrealized | Number of | Fair | Unrealized | |||||||||||||||||||||||||
Securities | Value | Losses | Securities | Value | Losses | Securities | Value | Losses | ||||||||||||||||||||||||||
(in millions, except number of securities) | ||||||||||||||||||||||||||||||||||
Corporate debt securities | 83 | $ | 760 | $ | (10 | ) | 43 | $ | 736 | $ | (21 | ) | 126 | $ | 1,496 | $ | (31 | ) | ||||||||||||||||
Residential mortgage backed securities | 14 | 140 | (2 | ) | 59 | 822 | (42 | ) | 73 | 962 | (44 | ) | ||||||||||||||||||||||
Commercial mortgage backed securities | 5 | 41 | — | 9 | 96 | (4 | ) | 14 | 137 | (4 | ) | |||||||||||||||||||||||
State and municipal obligations | 1 | 5 | — | 2 | 100 | (28 | ) | 3 | 105 | (28 | ) | |||||||||||||||||||||||
Asset backed securities | 5 | 42 | — | 4 | 38 | (1 | ) | 9 | 80 | (1 | ) | |||||||||||||||||||||||
Foreign government bonds and obligations | 4 | 18 | — | 14 | 27 | (5 | ) | 18 | 45 | (5 | ) | |||||||||||||||||||||||
Total | 112 | $ | 1,006 | $ | (12 | ) | 131 | $ | 1,819 | $ | (101 | ) | 243 | $ | 2,825 | $ | (113 | ) | ||||||||||||||||
31-Dec-13 | ||||||||||||||||||||||||||||||||||
Less than 12 months | 12 months or more | Total | ||||||||||||||||||||||||||||||||
Description of Securities | Number of | Fair | Unrealized | Number of | Fair | Unrealized | Number of | Fair | Unrealized | |||||||||||||||||||||||||
Securities | Value | Losses | Securities | Value | Losses | Securities | Value | Losses | ||||||||||||||||||||||||||
(in millions, except number of securities) | ||||||||||||||||||||||||||||||||||
Corporate debt securities | 156 | $ | 2,567 | $ | (82 | ) | 10 | $ | 160 | $ | (14 | ) | 166 | $ | 2,727 | $ | (96 | ) | ||||||||||||||||
Residential mortgage backed securities | 52 | 1,411 | (54 | ) | 45 | 295 | (41 | ) | 97 | 1,706 | (95 | ) | ||||||||||||||||||||||
Commercial mortgage backed securities | 27 | 323 | (9 | ) | 3 | 22 | (2 | ) | 30 | 345 | (11 | ) | ||||||||||||||||||||||
State and municipal obligations | 4 | 38 | (2 | ) | 2 | 92 | (37 | ) | 6 | 130 | (39 | ) | ||||||||||||||||||||||
Asset backed securities | 17 | 219 | (4 | ) | 3 | 26 | (1 | ) | 20 | 245 | (5 | ) | ||||||||||||||||||||||
Foreign government bonds and obligations | 23 | 77 | (8 | ) | — | — | — | 23 | 77 | (8 | ) | |||||||||||||||||||||||
Total | 279 | $ | 4,635 | $ | (159 | ) | 63 | $ | 595 | $ | (95 | ) | 342 | $ | 5,230 | $ | (254 | ) | ||||||||||||||||
Credit Losses on Available-for-Sale Securities Disclosure | ' | |||||||||||||||||||||||||||||||||
The following table presents a rollforward of the cumulative amounts recognized in the Consolidated Statements of Income for other-than-temporary impairments related to credit losses on Available-for-Sale securities for which a portion of the securities’ total other-than-temporary impairments was recognized in other comprehensive income (loss): | ||||||||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||
Beginning balance | $ | 54 | $ | 66 | $ | 54 | $ | 87 | ||||||||||||||||||||||||||
Credit losses for which an other-than-temporary impairment was not previously recognized | — | 1 | — | 1 | ||||||||||||||||||||||||||||||
Credit losses for which an other-than-temporary impairment was previously recognized | 1 | — | 1 | 2 | ||||||||||||||||||||||||||||||
Reductions for securities sold during the period (realized) | (22 | ) | — | (22 | ) | (23 | ) | |||||||||||||||||||||||||||
Ending balance | $ | 33 | $ | 67 | $ | 33 | $ | 67 | ||||||||||||||||||||||||||
Other Comprehensive Income Available-for-Sale Securities Disclosure | ' | |||||||||||||||||||||||||||||||||
The following table presents a rollforward of the net unrealized securities gains on Available-for-Sale securities included in accumulated other comprehensive income (“AOCI”): | ||||||||||||||||||||||||||||||||||
Net Unrealized Securities Gains | Deferred | AOCI Related to Net Unrealized Securities Gains | ||||||||||||||||||||||||||||||||
Income | ||||||||||||||||||||||||||||||||||
Tax | ||||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||
Balance at January 1, 2013 | $ | 1,930 | $ | (675 | ) | $ | 1,255 | |||||||||||||||||||||||||||
Net unrealized securities losses arising during the period(1) | (1,234 | ) | 423 | (811 | ) | |||||||||||||||||||||||||||||
Reclassification of net securities gains included in net income | (3 | ) | 1 | (2 | ) | |||||||||||||||||||||||||||||
Impact of DAC, DSIC, benefit reserves and reinsurance recoverables | 436 | (153 | ) | 283 | ||||||||||||||||||||||||||||||
Balance at September 30, 2013 | $ | 1,129 | $ | (404 | ) | $ | 725 | (2) | ||||||||||||||||||||||||||
Balance at January 1, 2014 | $ | 1,033 | $ | (366 | ) | $ | 667 | |||||||||||||||||||||||||||
Net unrealized securities gains arising during the period(1) | 441 | (156 | ) | 285 | ||||||||||||||||||||||||||||||
Reclassification of net securities gains included in net income | (15 | ) | 6 | (9 | ) | |||||||||||||||||||||||||||||
Impact of DAC, DSIC, benefit reserves and reinsurance recoverables | (258 | ) | 90 | (168 | ) | |||||||||||||||||||||||||||||
Balance at September 30, 2014 | $ | 1,201 | $ | (426 | ) | $ | 775 | (2) | ||||||||||||||||||||||||||
-1 | Includes other-than-temporary impairment losses on Available-for-Sale securities related to factors other than credit that were recognized in other comprehensive income (loss) during the period. | |||||||||||||||||||||||||||||||||
(2) | Includes $2 million and $10 million of noncredit related impairments on securities and net unrealized securities losses on previously impaired securities at September 30, 2014 and 2013, respectively. | |||||||||||||||||||||||||||||||||
Available-for-Sale Securities Recognized in Earnings Disclosure | ' | |||||||||||||||||||||||||||||||||
Net realized gains and losses on Available-for-Sale securities, determined using the specific identification method, recognized in net realized investment gains were as follows: | ||||||||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||
Gross realized investment gains | $ | 15 | $ | 6 | $ | 24 | $ | 8 | ||||||||||||||||||||||||||
Gross realized investment losses | (1 | ) | — | (4 | ) | (1 | ) | |||||||||||||||||||||||||||
Other-than-temporary impairments | (4 | ) | (2 | ) | (5 | ) | (4 | ) | ||||||||||||||||||||||||||
Total | $ | 10 | $ | 4 | $ | 15 | $ | 3 | ||||||||||||||||||||||||||
Available-for-Sale Securities Contractual Maturity Disclosure | ' | |||||||||||||||||||||||||||||||||
Available-for-Sale securities by contractual maturity at September 30, 2014 were as follows: | ||||||||||||||||||||||||||||||||||
Amortized Cost | Fair Value | |||||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||
Due within one year | $ | 965 | $ | 984 | ||||||||||||||||||||||||||||||
Due after one year through five years | 5,938 | 6,521 | ||||||||||||||||||||||||||||||||
Due after five years through 10 years | 4,701 | 4,941 | ||||||||||||||||||||||||||||||||
Due after 10 years | 3,573 | 4,390 | ||||||||||||||||||||||||||||||||
15,177 | 16,836 | |||||||||||||||||||||||||||||||||
Residential mortgage backed securities | 3,466 | 3,557 | ||||||||||||||||||||||||||||||||
Commercial mortgage backed securities | 2,121 | 2,232 | ||||||||||||||||||||||||||||||||
Asset backed securities | 896 | 944 | ||||||||||||||||||||||||||||||||
Common stocks | 2 | 8 | ||||||||||||||||||||||||||||||||
Total | $ | 21,662 | $ | 23,577 | ||||||||||||||||||||||||||||||
Schedule of Net Investment Income | ' | |||||||||||||||||||||||||||||||||
Net investment income is summarized as follows: | ||||||||||||||||||||||||||||||||||
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||||||||||||
September 30, | September 30, | |||||||||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||||||||||||
(in millions) | ||||||||||||||||||||||||||||||||||
Fixed maturities | $ | 277 | $ | 301 | $ | 841 | $ | 913 | ||||||||||||||||||||||||||
Mortgage loans | 46 | 50 | 137 | 153 | ||||||||||||||||||||||||||||||
Other investments | 3 | 8 | 20 | 25 | ||||||||||||||||||||||||||||||
326 | 359 | 998 | 1,091 | |||||||||||||||||||||||||||||||
Less: investment expenses | 7 | 9 | 23 | 24 | ||||||||||||||||||||||||||||||
Total | $ | 319 | $ | 350 | $ | 975 | $ | 1,067 | ||||||||||||||||||||||||||
Financing_Receivables_Tables
Financing Receivables (Tables) | 9 Months Ended | ||||||||||||||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||||||||||||||
Receivables [Abstract] | ' | ||||||||||||||||||||||||||||
Rollforward of the allowance for loan losses | ' | ||||||||||||||||||||||||||||
The following table presents a rollforward of the allowance for loan losses for the nine months ended and the ending balance of the allowance for loan losses by impairment method and type of loan: | |||||||||||||||||||||||||||||
30-Sep-14 | 30-Sep-13 | ||||||||||||||||||||||||||||
Commercial | Syndicated | Total | Commercial | Syndicated | Total | ||||||||||||||||||||||||
Mortgage | Loans | Mortgage | Loans | ||||||||||||||||||||||||||
Loans | Loans | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Beginning balance | $ | 24 | $ | 4 | $ | 28 | $ | 26 | $ | 4 | $ | 30 | |||||||||||||||||
Charge-offs | (2 | ) | (1 | ) | (3 | ) | (2 | ) | — | (2 | ) | ||||||||||||||||||
Provisions | — | 2 | 2 | — | — | — | |||||||||||||||||||||||
Ending balance | $ | 22 | $ | 5 | $ | 27 | $ | 24 | $ | 4 | $ | 28 | |||||||||||||||||
Individually evaluated for impairment | $ | 8 | $ | — | $ | 8 | $ | 7 | $ | — | $ | 7 | |||||||||||||||||
Collectively evaluated for impairment | 14 | 5 | 19 | 17 | 4 | 21 | |||||||||||||||||||||||
Schedule of recorded investment in financing receivables by impairment method and type of loan | ' | ||||||||||||||||||||||||||||
The recorded investment in financing receivables by impairment method and type of loan was as follows: | |||||||||||||||||||||||||||||
30-Sep-14 | |||||||||||||||||||||||||||||
Commercial | Residential | Syndicated | Total | ||||||||||||||||||||||||||
Mortgage | Mortgage | Loans | |||||||||||||||||||||||||||
Loans | Loans | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | 34 | $ | — | $ | 3 | $ | 37 | |||||||||||||||||||||
Collectively evaluated for impairment | 2,572 | 716 | 451 | 3,739 | |||||||||||||||||||||||||
Total | $ | 2,606 | $ | 716 | $ | 454 | $ | 3,776 | |||||||||||||||||||||
31-Dec-13 | |||||||||||||||||||||||||||||
Commercial | Residential | Syndicated | Total | ||||||||||||||||||||||||||
Mortgage | Mortgage | Loans | |||||||||||||||||||||||||||
Loans | Loans | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Individually evaluated for impairment | $ | 40 | $ | — | $ | 5 | $ | 45 | |||||||||||||||||||||
Collectively evaluated for impairment | 2,524 | 786 | 356 | 3,666 | |||||||||||||||||||||||||
Total | $ | 2,564 | $ | 786 | $ | 361 | $ | 3,711 | |||||||||||||||||||||
Schedule of commercial mortgage loans by geographic region | ' | ||||||||||||||||||||||||||||
Concentrations of credit risk of commercial mortgage loans by U.S. region were as follows: | |||||||||||||||||||||||||||||
Loans | Percentage | ||||||||||||||||||||||||||||
September 30, 2014 | December 31, 2013 | September 30, 2014 | December 31, 2013 | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
South Atlantic | $ | 703 | $ | 679 | 27 | % | 26 | % | |||||||||||||||||||||
Pacific | 653 | 631 | 25 | 25 | |||||||||||||||||||||||||
Mountain | 252 | 248 | 10 | 10 | |||||||||||||||||||||||||
East North Central | 232 | 248 | 9 | 10 | |||||||||||||||||||||||||
Middle Atlantic | 213 | 202 | 8 | 8 | |||||||||||||||||||||||||
West North Central | 204 | 194 | 8 | 7 | |||||||||||||||||||||||||
West South Central | 153 | 153 | 6 | 6 | |||||||||||||||||||||||||
New England | 131 | 138 | 5 | 5 | |||||||||||||||||||||||||
East South Central | 65 | 71 | 2 | 3 | |||||||||||||||||||||||||
2,606 | 2,564 | 100 | % | 100 | % | ||||||||||||||||||||||||
Less: allowance for loan losses | 22 | 24 | |||||||||||||||||||||||||||
Total | $ | 2,584 | $ | 2,540 | |||||||||||||||||||||||||
Schedule of commercial mortgage loans by property type | ' | ||||||||||||||||||||||||||||
Concentrations of credit risk of commercial mortgage loans by property type were as follows: | |||||||||||||||||||||||||||||
Loans | Percentage | ||||||||||||||||||||||||||||
September 30, 2014 | December 31, 2013 | September 30, 2014 | December 31, 2013 | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Retail | $ | 944 | $ | 917 | 36 | % | 36 | % | |||||||||||||||||||||
Office | 545 | 548 | 21 | 21 | |||||||||||||||||||||||||
Industrial | 460 | 431 | 18 | 17 | |||||||||||||||||||||||||
Apartments | 445 | 454 | 17 | 18 | |||||||||||||||||||||||||
Mixed use | 45 | 36 | 2 | 1 | |||||||||||||||||||||||||
Hotel | 33 | 32 | 1 | 1 | |||||||||||||||||||||||||
Other | 134 | 146 | 5 | 6 | |||||||||||||||||||||||||
2,606 | 2,564 | 100 | % | 100 | % | ||||||||||||||||||||||||
Less: allowance for loan losses | 22 | 24 | |||||||||||||||||||||||||||
Total | $ | 2,584 | $ | 2,540 | |||||||||||||||||||||||||
Schedule of troubled debt restructurings | ' | ||||||||||||||||||||||||||||
The following table presents the number of loans restructured by the Company during the period and their recorded investment at the end of the period: | |||||||||||||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||||||||||||||
Number | Recorded | Number | Recorded | Number | Recorded | Number | Recorded | ||||||||||||||||||||||
of Loans | Investment | of Loans | Investment | of Loans | Investment | of Loans | Investment | ||||||||||||||||||||||
(in millions, except number of loans) | |||||||||||||||||||||||||||||
Commercial mortgage loans | 1 | $ | 6 | 3 | $ | 12 | 3 | $ | 14 | 6 | $ | 21 | |||||||||||||||||
Residential mortgage loans | — | — | — | — | 2 | — | 2 | — | |||||||||||||||||||||
Syndicated loans | — | — | — | — | 1 | — | — | — | |||||||||||||||||||||
Total | 1 | $ | 6 | 3 | $ | 12 | 6 | $ | 14 | 8 | $ | 21 | |||||||||||||||||
Deferred_Acquisition_Costs_and1
Deferred Acquisition Costs and Deferred Sales Inducement Costs (Tables) | 9 Months Ended | ||||||||
Sep. 30, 2014 | |||||||||
Deferred Acquisition Costs and Deferred Sales Inducement Costs | ' | ||||||||
Schedule of balances of and changes in DAC | ' | ||||||||
The balances of and changes in DAC were as follows: | |||||||||
2014 | 2013 | ||||||||
(in millions) | |||||||||
Balance at January 1 | $ | 2,633 | $ | 2,373 | |||||
Capitalization of acquisition costs | 196 | 200 | |||||||
Amortization, excluding the impact of valuation assumptions review | (219 | ) | (180 | ) | |||||
Amortization, impact of valuation assumptions review | (7 | ) | 78 | ||||||
Impact of change in net unrealized securities losses (gains) | (30 | ) | 112 | ||||||
Balance at September 30 | $ | 2,573 | $ | 2,583 | |||||
Schedule of balances of and changes in DSIC | ' | ||||||||
The balances of and changes in DSIC, which is included in other assets, were as follows: | |||||||||
2014 | 2013 | ||||||||
(in millions) | |||||||||
Balance at January 1 | $ | 409 | $ | 404 | |||||
Capitalization of sales inducement costs | 4 | 4 | |||||||
Amortization, excluding the impact of valuation assumptions review | (40 | ) | (39 | ) | |||||
Amortization, impact of valuation assumptions review | (2 | ) | 25 | ||||||
Impact of change in net unrealized securities losses (gains) | (3 | ) | 18 | ||||||
Balance at September 30 | $ | 368 | $ | 412 | |||||
Policyholder_Account_Balances_1
Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities (Tables) | 9 Months Ended | ||||||||
Sep. 30, 2014 | |||||||||
Policyholder Account Balances, Future Policy Benefits and Claims & Separate Account Liabilities | ' | ||||||||
Policyholder account balances, future policy benefits and unpaid claims disclosure | ' | ||||||||
Policyholder account balances, future policy benefits and claims consisted of the following: | |||||||||
September 30, 2014 | December 31, 2013 | ||||||||
(in millions) | |||||||||
Policyholder account balances | |||||||||
Fixed annuities | $ | 12,922 | $ | 13,826 | |||||
Variable annuity fixed sub-accounts | 4,869 | 4,926 | |||||||
Variable universal life (“VUL”)/universal life (“UL”) insurance | 2,841 | 2,790 | |||||||
Indexed universal life (“IUL”) insurance | 475 | 315 | |||||||
Other life insurance | 846 | 878 | |||||||
Total policyholder account balances | 21,953 | 22,735 | |||||||
Future policy benefits | |||||||||
Variable annuity guaranteed minimum withdrawal benefits (“GMWB”)(1) | 145 | (383 | ) | ||||||
Variable annuity guaranteed minimum accumulation benefits (“GMAB”)(1) | (55 | ) | (62 | ) | |||||
Other annuity liabilities | 118 | 76 | |||||||
Fixed annuities life contingent liabilities | 1,518 | 1,523 | |||||||
Equity indexed annuities (“EIA”) | 29 | 29 | |||||||
Life, disability income and long term care insurance | 5,041 | 4,739 | |||||||
VUL/UL and other life insurance additional liabilities | 403 | 336 | |||||||
Total future policy benefits | 7,199 | 6,258 | |||||||
Policy claims and other policyholders’ funds | 160 | 156 | |||||||
Total policyholder account balances, future policy benefits and claims | $ | 29,312 | $ | 29,149 | |||||
-1 | Includes the value of GMWB and GMAB embedded derivatives that was a net asset at both September 30, 2014 and December 31, 2013 reported as a contra liability. | ||||||||
Schedule of Separate Account Liabilities by Policy Type | ' | ||||||||
Separate account liabilities consisted of the following: | |||||||||
September 30, 2014 | December 31, 2013 | ||||||||
(in millions) | |||||||||
Variable annuity | $ | 71,345 | $ | 70,687 | |||||
VUL insurance | 6,925 | 6,885 | |||||||
Other insurance | 43 | 44 | |||||||
Total | $ | 78,313 | $ | 77,616 | |||||
Variable_Annuity_and_Insurance1
Variable Annuity and Insurance Guarantees (Tables) | 9 Months Ended | ||||||||||||||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||||||||||||||
Insurance [Abstract] | ' | ||||||||||||||||||||||||||||
Schedule of Variable Annuity Guarantees | ' | ||||||||||||||||||||||||||||
The following table provides information related to variable annuity guarantees for which the Company has established additional liabilities: | |||||||||||||||||||||||||||||
30-Sep-14 | 31-Dec-13 | ||||||||||||||||||||||||||||
Variable Annuity Guarantees by | Total | Contract | Net | Weighted Average Attained Age | Total | Contract | Net | Weighted Average Attained Age | |||||||||||||||||||||
Benefit Type(1) | Contract | Value in | Amount | Contract | Value in | Amount | |||||||||||||||||||||||
Value | Separate | at Risk | Value | Separate | at Risk | ||||||||||||||||||||||||
Accounts | Accounts | ||||||||||||||||||||||||||||
(in millions, except age) | |||||||||||||||||||||||||||||
GMDB: | |||||||||||||||||||||||||||||
Return of premium | $ | 54,378 | $ | 52,566 | $ | 39 | 64 | $ | 52,616 | $ | 50,790 | $ | 28 | 64 | |||||||||||||||
Five/six-year reset | 10,465 | 7,925 | 36 | 64 | 11,220 | 8,663 | 42 | 64 | |||||||||||||||||||||
One-year ratchet | 7,424 | 7,030 | 64 | 66 | 7,676 | 7,261 | 38 | 65 | |||||||||||||||||||||
Five-year ratchet | 1,770 | 1,715 | 3 | 62 | 1,781 | 1,725 | 1 | 62 | |||||||||||||||||||||
Other | 965 | 947 | 40 | 70 | 1,015 | 996 | 36 | 69 | |||||||||||||||||||||
Total — GMDB | $ | 75,002 | $ | 70,183 | $ | 182 | 64 | $ | 74,308 | $ | 69,435 | $ | 145 | 64 | |||||||||||||||
GGU death benefit | $ | 1,058 | $ | 1,006 | $ | 121 | 67 | $ | 1,052 | $ | 998 | $ | 121 | 64 | |||||||||||||||
GMIB | $ | 359 | $ | 336 | $ | 9 | 67 | $ | 413 | $ | 389 | $ | 8 | 66 | |||||||||||||||
GMWB: | |||||||||||||||||||||||||||||
GMWB | $ | 3,702 | $ | 3,689 | $ | 1 | 68 | $ | 3,936 | $ | 3,921 | $ | 1 | 67 | |||||||||||||||
GMWB for life | 35,967 | 35,853 | 92 | 65 | 34,069 | 33,930 | 77 | 64 | |||||||||||||||||||||
Total — GMWB | $ | 39,669 | $ | 39,542 | $ | 93 | 65 | $ | 38,005 | $ | 37,851 | $ | 78 | 64 | |||||||||||||||
GMAB | $ | 4,188 | $ | 4,177 | $ | 3 | 58 | $ | 4,194 | $ | 4,181 | $ | 2 | 58 | |||||||||||||||
-1 | Individual variable annuity contracts may have more than one guarantee and therefore may be included in more than one benefit type. Variable annuity contracts for which the death benefit equals the account value are not shown in this table. | ||||||||||||||||||||||||||||
Schedule Of Net Amount Of Risk UL Secondary Guarantees [Table Text Block] | ' | ||||||||||||||||||||||||||||
The following table provides information related to insurance guarantees for which the Company has established additional liabilities: | |||||||||||||||||||||||||||||
30-Sep-14 | 31-Dec-13 | ||||||||||||||||||||||||||||
Net Amount at Risk | Weighted Average Attained Age | Net Amount at Risk | Weighted Average Attained Age | ||||||||||||||||||||||||||
(in millions, except age) | |||||||||||||||||||||||||||||
UL secondary guarantees | $ | 5,943 | 62 | $ | 5,674 | 62 | |||||||||||||||||||||||
Schedule of Changes in Additional Liabilities for Variable Annuity and Insurance Guarantees | ' | ||||||||||||||||||||||||||||
Changes in additional liabilities (contra liabilities) for variable annuity and insurance guarantees were as follows: | |||||||||||||||||||||||||||||
GMDB & GGU | GMIB | GMWB(1) | GMAB(1) | UL | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance at January 1, 2013 | $ | 4 | $ | 9 | $ | 799 | $ | 103 | $ | 155 | |||||||||||||||||||
Incurred claims | 2 | (2 | ) | (908 | ) | (127 | ) | 45 | |||||||||||||||||||||
Paid claims | (3 | ) | — | — | — | (11 | ) | ||||||||||||||||||||||
Balance at September 30, 2013 | $ | 3 | $ | 7 | $ | (109 | ) | $ | (24 | ) | $ | 189 | |||||||||||||||||
Balance at January 1, 2014 | $ | 4 | $ | 6 | $ | (383 | ) | $ | (62 | ) | $ | 206 | |||||||||||||||||
Incurred claims | 8 | 1 | 528 | 7 | 46 | ||||||||||||||||||||||||
Paid claims | (3 | ) | — | — | — | (5 | ) | ||||||||||||||||||||||
Balance at September 30, 2014 | $ | 9 | $ | 7 | $ | 145 | $ | (55 | ) | $ | 247 | ||||||||||||||||||
-1 | The incurred claims for GMWB and GMAB represent the total change in the liabilities (contra liabilities). | ||||||||||||||||||||||||||||
Schedule of Separate Account Balances By Asset Type | ' | ||||||||||||||||||||||||||||
The following table summarizes the distribution of separate account balances by asset type for variable annuity contracts providing guaranteed benefits: | |||||||||||||||||||||||||||||
September 30, 2014 | December 31, 2013 | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Mutual funds: | |||||||||||||||||||||||||||||
Equity | $ | 40,751 | $ | 39,195 | |||||||||||||||||||||||||
Bond | 25,218 | 26,519 | |||||||||||||||||||||||||||
Other | 4,149 | 3,764 | |||||||||||||||||||||||||||
Total mutual funds | $ | 70,118 | $ | 69,478 | |||||||||||||||||||||||||
Fair_Values_of_Assets_and_Liab1
Fair Values of Assets and Liabilities (Tables) | 9 Months Ended | ||||||||||||||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | ' | ||||||||||||||||||||||||||||
Schedule of balances of assets and liabilities measured at fair value on a recurring basis | ' | ||||||||||||||||||||||||||||
The following tables present the balances of assets and liabilities measured at fair value on a recurring basis: | |||||||||||||||||||||||||||||
30-Sep-14 | |||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||
Available-for-Sale securities: Fixed maturities: | |||||||||||||||||||||||||||||
Corporate debt securities | $ | — | $ | 14,092 | $ | 1,378 | $ | 15,470 | |||||||||||||||||||||
Residential mortgage backed securities | — | 3,547 | 10 | 3,557 | |||||||||||||||||||||||||
Commercial mortgage backed securities | — | 2,139 | 93 | 2,232 | |||||||||||||||||||||||||
State and municipal obligations | — | 1,073 | — | 1,073 | |||||||||||||||||||||||||
Asset backed securities | — | 796 | 148 | 944 | |||||||||||||||||||||||||
Foreign government bonds and obligations | — | 253 | — | 253 | |||||||||||||||||||||||||
U.S. government and agencies obligations | 4 | 36 | — | 40 | |||||||||||||||||||||||||
Total Available-for-Sale securities: Fixed maturities | 4 | 21,936 | 1,629 | 23,569 | |||||||||||||||||||||||||
Common stocks | 3 | 5 | — | 8 | |||||||||||||||||||||||||
Cash equivalents | 2 | 261 | — | 263 | |||||||||||||||||||||||||
Other assets: | |||||||||||||||||||||||||||||
Interest rate derivative contracts | — | 1,512 | — | 1,512 | |||||||||||||||||||||||||
Equity derivative contracts | 314 | 1,512 | — | 1,826 | |||||||||||||||||||||||||
Credit derivative contracts | — | 4 | — | 4 | |||||||||||||||||||||||||
Foreign exchange derivative contracts | — | 4 | — | 4 | |||||||||||||||||||||||||
Other derivative contracts | — | — | 1 | 1 | |||||||||||||||||||||||||
Total other assets | 314 | 3,032 | 1 | 3,347 | |||||||||||||||||||||||||
Separate account assets | — | 78,313 | — | 78,313 | |||||||||||||||||||||||||
Total assets at fair value | $ | 323 | $ | 103,547 | $ | 1,630 | $ | 105,500 | |||||||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||
Policyholder account balances, future policy benefits and claims: | |||||||||||||||||||||||||||||
EIA embedded derivatives | $ | — | $ | 6 | $ | — | $ | 6 | |||||||||||||||||||||
IUL embedded derivatives | — | — | 202 | 202 | |||||||||||||||||||||||||
GMWB and GMAB embedded derivatives | — | — | (77 | ) | (77 | ) | (2) | ||||||||||||||||||||||
Total policyholder account balances, future policy benefits and claims | — | 6 | 125 | 131 | (1) | ||||||||||||||||||||||||
Other liabilities: | |||||||||||||||||||||||||||||
Interest rate derivative contracts | — | 1,208 | — | 1,208 | |||||||||||||||||||||||||
Equity derivative contracts | 472 | 2,171 | — | 2,643 | |||||||||||||||||||||||||
Other derivative contracts | — | 13 | — | 13 | |||||||||||||||||||||||||
Total other liabilities | 472 | 3,392 | — | 3,864 | |||||||||||||||||||||||||
Total liabilities at fair value | $ | 472 | $ | 3,398 | $ | 125 | $ | 3,995 | |||||||||||||||||||||
-1 | The Company’s adjustment for nonperformance risk resulted in a $238 million cumulative decrease to the embedded derivatives. | ||||||||||||||||||||||||||||
-2 | The fair value of the GMWB and GMAB embedded derivatives was a net asset at September 30, 2014 and the amount is reported as a contra liability. | ||||||||||||||||||||||||||||
31-Dec-13 | |||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Assets | |||||||||||||||||||||||||||||
Available-for-Sale securities: Fixed maturities: | |||||||||||||||||||||||||||||
Corporate debt securities | $ | — | $ | 14,357 | $ | 1,516 | $ | 15,873 | |||||||||||||||||||||
Residential mortgage backed securities | — | 3,753 | 58 | 3,811 | |||||||||||||||||||||||||
Commercial mortgage backed securities | — | 2,404 | 30 | 2,434 | |||||||||||||||||||||||||
State and municipal obligations | — | 998 | — | 998 | |||||||||||||||||||||||||
Asset backed securities | — | 763 | 218 | 981 | |||||||||||||||||||||||||
Foreign government bonds and obligations | — | 245 | — | 245 | |||||||||||||||||||||||||
U.S. government and agencies obligations | 9 | 36 | — | 45 | |||||||||||||||||||||||||
Total Available-for-Sale securities: Fixed maturities | 9 | 22,556 | 1,822 | 24,387 | |||||||||||||||||||||||||
Common stocks | 3 | 3 | — | 6 | |||||||||||||||||||||||||
Cash equivalents | 1 | 320 | — | 321 | |||||||||||||||||||||||||
Other assets: | |||||||||||||||||||||||||||||
Interest rate derivative contracts | — | 1,484 | — | 1,484 | |||||||||||||||||||||||||
Equity derivative contracts | 265 | 1,503 | — | 1,768 | |||||||||||||||||||||||||
Credit derivative contracts | — | 3 | — | 3 | |||||||||||||||||||||||||
Foreign exchange derivative contracts | — | 2 | — | 2 | |||||||||||||||||||||||||
Other derivative contracts | — | 4 | — | 4 | |||||||||||||||||||||||||
Total other assets | 265 | 2,996 | — | 3,261 | |||||||||||||||||||||||||
Separate account assets | — | 77,616 | — | 77,616 | |||||||||||||||||||||||||
Total assets at fair value | $ | 278 | $ | 103,491 | $ | 1,822 | $ | 105,591 | |||||||||||||||||||||
Liabilities | |||||||||||||||||||||||||||||
Policyholder account balances, future policy benefits and claims: | |||||||||||||||||||||||||||||
EIA embedded derivatives | $ | — | $ | 5 | $ | — | $ | 5 | |||||||||||||||||||||
IUL embedded derivatives | — | — | 125 | 125 | |||||||||||||||||||||||||
GMWB and GMAB embedded derivatives | — | — | (575 | ) | (575 | ) | (2) | ||||||||||||||||||||||
Total policyholder account balances, future policy benefits and claims | — | 5 | (450 | ) | (445 | ) | (1) | ||||||||||||||||||||||
Other liabilities: | |||||||||||||||||||||||||||||
Interest rate derivative contracts | — | 1,672 | — | 1,672 | |||||||||||||||||||||||||
Equity derivative contracts | 549 | 2,382 | — | 2,931 | |||||||||||||||||||||||||
Other derivative contracts | — | 29 | — | 29 | |||||||||||||||||||||||||
Total other liabilities | 549 | 4,083 | — | 4,632 | |||||||||||||||||||||||||
Total liabilities at fair value | $ | 549 | $ | 4,088 | $ | (450 | ) | $ | 4,187 | ||||||||||||||||||||
-1 | The Company’s adjustment for nonperformance risk resulted in a $150 million cumulative increase to the embedded derivatives. | ||||||||||||||||||||||||||||
-2 | The fair value of the GMWB and GMAB embedded derivatives was a net asset at December 31, 2013 and the amount is reported as a contra liability. | ||||||||||||||||||||||||||||
Summary of changes in Level 3 assets and liabilities measured at fair value on a recurring basis | ' | ||||||||||||||||||||||||||||
The following tables provide a summary of changes in Level 3 assets and liabilities measured at fair value on a recurring basis: | |||||||||||||||||||||||||||||
Available-for-Sale Securities: Fixed Maturities | |||||||||||||||||||||||||||||
Corporate | Residential | Commercial | Asset | Total | Common Stocks | Other Assets: Other Derivatives Contracts | |||||||||||||||||||||||
Debt | Mortgage | Mortgage | Backed | ||||||||||||||||||||||||||
Securities | Backed | Backed | Securities | ||||||||||||||||||||||||||
Securities | Securities | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance, July 1, 2014 | $ | 1,376 | $ | 10 | $ | 15 | $ | 149 | $ | 1,550 | $ | 1 | $ | 1 | |||||||||||||||
Total gains (losses) included in: | |||||||||||||||||||||||||||||
Net income | — | — | — | 1 | 1 | (1) | — | (1 | ) | (2) | |||||||||||||||||||
Other comprehensive income | (11 | ) | — | — | (1 | ) | (12 | ) | — | — | |||||||||||||||||||
Purchases | 37 | — | — | — | 37 | — | 1 | ||||||||||||||||||||||
Settlements | (24 | ) | — | — | (1 | ) | (25 | ) | — | — | |||||||||||||||||||
Transfers into Level 3 | — | — | 78 | — | 78 | — | — | ||||||||||||||||||||||
Transfers out of Level 3 | — | — | — | — | — | (1 | ) | — | |||||||||||||||||||||
Balance, September 30, 2014 | $ | 1,378 | $ | 10 | $ | 93 | $ | 148 | $ | 1,629 | $ | — | $ | 1 | |||||||||||||||
Changes in unrealized gains (losses) relating to assets held at September 30, 2014 included in: | |||||||||||||||||||||||||||||
Net investment income | $ | — | $ | — | $ | — | $ | 1 | $ | 1 | $ | — | $ | — | |||||||||||||||
Benefits, claims, losses and settlement expenses | — | — | — | — | — | — | (1 | ) | |||||||||||||||||||||
-1 | Included in net investment income in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
-2 | Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
Policyholder Account Balances, | |||||||||||||||||||||||||||||
Future Policy Benefits and Claims | |||||||||||||||||||||||||||||
IUL | GMWB and | Total | |||||||||||||||||||||||||||
Embedded | GMAB | ||||||||||||||||||||||||||||
Derivatives | Embedded | ||||||||||||||||||||||||||||
Derivatives | |||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance, July 1, 2014 | $ | 184 | $ | (347 | ) | $ | (163 | ) | |||||||||||||||||||||
Total losses included in: | |||||||||||||||||||||||||||||
Net income | — | 207 | (1) | 207 | |||||||||||||||||||||||||
Issues | 21 | 65 | 86 | ||||||||||||||||||||||||||
Settlements | (3 | ) | (2 | ) | (5 | ) | |||||||||||||||||||||||
Balance, September 30, 2014 | $ | 202 | $ | (77 | ) | $ | 125 | ||||||||||||||||||||||
Changes in unrealized losses relating to liabilities held at September 30, 2014 included in: | |||||||||||||||||||||||||||||
Benefits, claims, losses and settlement expenses | $ | — | $ | 208 | $ | 208 | |||||||||||||||||||||||
-1 | Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
Available-for-Sale Securities: Fixed Maturities | |||||||||||||||||||||||||||||
Corporate | Residential | Commercial | Asset | Total | |||||||||||||||||||||||||
Debt | Mortgage | Mortgage | Backed | ||||||||||||||||||||||||||
Securities | Backed | Backed | Securities | ||||||||||||||||||||||||||
Securities | Securities | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance, July 1, 2013 | $ | 1,558 | $ | 50 | $ | 164 | $ | 154 | $ | 1,926 | |||||||||||||||||||
Total gains (losses) included in: | |||||||||||||||||||||||||||||
Other comprehensive loss | 2 | — | — | (2 | ) | — | |||||||||||||||||||||||
Purchases | — | 45 | — | 29 | 74 | ||||||||||||||||||||||||
Settlements | (37 | ) | (5 | ) | — | — | (42 | ) | |||||||||||||||||||||
Transfers out of Level 3 | — | — | (149 | ) | — | (149 | ) | ||||||||||||||||||||||
Balance, September 30, 2013 | $ | 1,523 | $ | 90 | $ | 15 | $ | 181 | $ | 1,809 | |||||||||||||||||||
Changes in unrealized gains (losses) relating to assets held at September 30, 2013 included in: | |||||||||||||||||||||||||||||
Net investment income | $ | — | $ | — | $ | — | $ | — | $ | — | |||||||||||||||||||
Policyholder Account Balances, | |||||||||||||||||||||||||||||
Future Policy Benefits and Claims | |||||||||||||||||||||||||||||
IUL Embedded | GMWB and GMAB | Total | |||||||||||||||||||||||||||
Derivatives | Embedded Derivatives | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance, July 1, 2013 | $ | 76 | $ | 11 | $ | 87 | |||||||||||||||||||||||
Total (gains) losses included in: | |||||||||||||||||||||||||||||
Net income | 2 | (1) | (322 | ) | (2) | (320 | ) | ||||||||||||||||||||||
Issues | 17 | 60 | 77 | ||||||||||||||||||||||||||
Settlements | 1 | (5 | ) | (4 | ) | ||||||||||||||||||||||||
Balance, September 30, 2013 | $ | 96 | $ | (256 | ) | $ | (160 | ) | |||||||||||||||||||||
Changes in unrealized (gains) losses relating to liabilities held at September 30, 2013 included in: | |||||||||||||||||||||||||||||
Benefits, claims, losses and settlement expenses | $ | — | $ | (321 | ) | $ | (321 | ) | |||||||||||||||||||||
Interest credited to fixed accounts | 2 | — | 2 | ||||||||||||||||||||||||||
-1 | Included in interest credited to fixed accounts in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
-2 | Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
Available-for-Sale Securities: Fixed Maturities | |||||||||||||||||||||||||||||
Corporate | Residential | Commercial | Asset | Total | Common Stocks | Other Assets: Other Derivatives Contracts | |||||||||||||||||||||||
Debt | Mortgage | Mortgage | Backed | ||||||||||||||||||||||||||
Securities | Backed | Backed | Securities | ||||||||||||||||||||||||||
Securities | Securities | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance, January 1, 2014 | $ | 1,516 | $ | 58 | $ | 30 | $ | 218 | $ | 1,822 | $ | — | $ | — | |||||||||||||||
Total gains (losses) included in: | |||||||||||||||||||||||||||||
Net income | 1 | — | — | 1 | 2 | (1) | — | (1 | ) | (2) | |||||||||||||||||||
Other comprehensive income | 3 | — | — | — | 3 | — | — | ||||||||||||||||||||||
Purchases | 94 | 11 | 39 | — | 144 | 1 | 2 | ||||||||||||||||||||||
Sales | (11 | ) | — | — | — | (11 | ) | — | — | ||||||||||||||||||||
Settlements | (225 | ) | (2 | ) | — | (2 | ) | (229 | ) | — | — | ||||||||||||||||||
Transfers into Level 3 | — | — | 78 | — | 78 | — | — | ||||||||||||||||||||||
Transfers out of Level 3 | — | (57 | ) | (54 | ) | (69 | ) | (180 | ) | (1 | ) | — | |||||||||||||||||
Balance, September 30, 2014 | $ | 1,378 | $ | 10 | $ | 93 | $ | 148 | $ | 1,629 | $ | — | $ | 1 | |||||||||||||||
Changes in unrealized gains (losses) relating to assets held at September 30, 2014 included in: | |||||||||||||||||||||||||||||
Net investment income | $ | (1 | ) | $ | — | $ | — | $ | 1 | $ | — | $ | — | $ | — | ||||||||||||||
Benefits, claims, losses and settlement expenses | — | — | — | — | — | — | (1 | ) | |||||||||||||||||||||
-1 | Included in net investment income in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
-2 | Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
Policyholder Account Balances, | |||||||||||||||||||||||||||||
Future Policy Benefits and Claims | |||||||||||||||||||||||||||||
IUL | GMWB and GMAB Embedded Derivatives | Total | |||||||||||||||||||||||||||
Embedded | |||||||||||||||||||||||||||||
Derivatives | |||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance, January 1, 2014 | $ | 125 | $ | (575 | ) | $ | (450 | ) | |||||||||||||||||||||
Total losses included in: | |||||||||||||||||||||||||||||
Net income | 14 | (1) | 327 | (2) | 341 | ||||||||||||||||||||||||
Issues | 69 | 184 | 253 | ||||||||||||||||||||||||||
Settlements | (6 | ) | (13 | ) | (19 | ) | |||||||||||||||||||||||
Balance, September 30, 2014 | $ | 202 | $ | (77 | ) | $ | 125 | ||||||||||||||||||||||
Changes in unrealized losses relating to liabilities held at September 30, 2014 included in: | |||||||||||||||||||||||||||||
Benefits, claims, losses and settlement expenses | $ | — | $ | 327 | $ | 327 | |||||||||||||||||||||||
Interest credited to fixed accounts | 14 | — | 14 | ||||||||||||||||||||||||||
-1 | Included in interest credited to fixed accounts in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
-2 | Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
Available-for-Sale Securities: Fixed Maturities | |||||||||||||||||||||||||||||
Corporate | Residential | Commercial | Asset | Total | |||||||||||||||||||||||||
Debt | Mortgage | Mortgage | Backed | ||||||||||||||||||||||||||
Securities | Backed | Backed | Securities | ||||||||||||||||||||||||||
Securities | Securities | ||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance, January 1, 2013 | $ | 1,654 | $ | 23 | $ | 170 | $ | 156 | $ | 2,003 | |||||||||||||||||||
Total gains (losses) included in: | |||||||||||||||||||||||||||||
Net income | (1 | ) | — | — | 1 | — | (1) | ||||||||||||||||||||||
Other comprehensive loss | (34 | ) | — | (6 | ) | 5 | (35 | ) | |||||||||||||||||||||
Purchases | 74 | 87 | — | 29 | 190 | ||||||||||||||||||||||||
Settlements | (170 | ) | (5 | ) | — | (1 | ) | (176 | ) | ||||||||||||||||||||
Transfers out of Level 3 | — | (15 | ) | (149 | ) | (9 | ) | (173 | ) | ||||||||||||||||||||
Balance, September 30, 2013 | $ | 1,523 | $ | 90 | $ | 15 | $ | 181 | $ | 1,809 | |||||||||||||||||||
Changes in unrealized gains (losses) relating to assets held at September 30, 2013 included in: | |||||||||||||||||||||||||||||
Net investment income | $ | (1 | ) | $ | — | $ | — | $ | 1 | $ | — | ||||||||||||||||||
-1 | Included in net investment income in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
Policyholder Account Balances, | |||||||||||||||||||||||||||||
Future Policy Benefits and Claims | |||||||||||||||||||||||||||||
IUL Embedded | GMWB and | Total | |||||||||||||||||||||||||||
Derivatives | GMAB | ||||||||||||||||||||||||||||
Embedded | |||||||||||||||||||||||||||||
Derivatives | |||||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Balance, January 1, 2013 | $ | 45 | $ | 833 | $ | 878 | |||||||||||||||||||||||
Total (gains) losses included in: | |||||||||||||||||||||||||||||
Net income | 8 | (1) | (1,246 | ) | (2) | (1,238 | ) | ||||||||||||||||||||||
Issues | 42 | 163 | 205 | ||||||||||||||||||||||||||
Settlements | 1 | (6 | ) | (5 | ) | ||||||||||||||||||||||||
Balance, September 30, 2013 | $ | 96 | $ | (256 | ) | $ | (160 | ) | |||||||||||||||||||||
Changes in unrealized (gains) losses relating to liabilities held at September 30, 2013 included in: | |||||||||||||||||||||||||||||
Benefits, claims, losses and settlement expenses | $ | — | $ | (1,229 | ) | $ | (1,229 | ) | |||||||||||||||||||||
Interest credited to fixed accounts | 8 | — | 8 | ||||||||||||||||||||||||||
-1 | Included in interest credited to fixed accounts in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
-2 | Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income. | ||||||||||||||||||||||||||||
Significant unobservable inputs used in the fair value measurements | ' | ||||||||||||||||||||||||||||
The following tables provide a summary of the significant unobservable inputs used in the fair value measurements developed by the Company or reasonably available to the Company of Level 3 assets and liabilities: | |||||||||||||||||||||||||||||
30-Sep-14 | |||||||||||||||||||||||||||||
Fair Value | Valuation Technique | Unobservable Input | Range | Weighted Average | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Corporate debt securities (private placements) | $ | 1,341 | Discounted cash flow | Yield/spread to U.S. Treasuries | 0.9 | % | - | 3.50% | 1.3 | % | |||||||||||||||||||
Other derivative contracts | $ | 1 | Option pricing model | Correlation(1) | (3.0 | )% | - | -84.00% | (60.0 | )% | |||||||||||||||||||
IUL embedded derivatives | $ | 202 | Discounted cash flow | Nonperformance risk(2) | 69 | bps | |||||||||||||||||||||||
GMWB and GMAB embedded derivatives | $ | (77 | ) | Discounted cash flow | Utilization of guaranteed withdrawals(3) | 0 | % | - | 51.10% | ||||||||||||||||||||
Surrender rate | 0 | % | - | 59.10% | |||||||||||||||||||||||||
Market volatility(4) | 4.9 | % | - | 19.40% | |||||||||||||||||||||||||
Nonperformance risk(2) | 69 | bps | |||||||||||||||||||||||||||
Elective contractholder strategy allocations(5) | 0 | % | - | 31.00% | |||||||||||||||||||||||||
31-Dec-13 | |||||||||||||||||||||||||||||
Fair Value | Valuation Technique | Unobservable Input | Range | Weighted Average | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Corporate debt securities (private placements) | $ | 1,487 | Discounted cash flow | Yield/spread to U.S. Treasuries | 0.9 | % | - | 5.30% | 1.60% | ||||||||||||||||||||
IUL embedded derivatives | $ | 125 | Discounted cash flow | Nonperformance risk(2) | 74 | bps | |||||||||||||||||||||||
GMWB and GMAB embedded derivatives | $ | (575 | ) | Discounted cash flow | Utilization of guaranteed withdrawals(3) | 0 | % | - | 51.10% | ||||||||||||||||||||
Surrender rate | 0.1 | % | - | 57.90% | |||||||||||||||||||||||||
Market volatility(4) | 4.9 | % | - | 18.80% | |||||||||||||||||||||||||
Nonperformance risk(2) | 74 | bps | |||||||||||||||||||||||||||
Elective contractholder strategy allocations(5) | 0 | % | - | 50.00% | |||||||||||||||||||||||||
-1 | Represents the correlation between equity returns and interest rates used in the valuation of the derivative contract. | ||||||||||||||||||||||||||||
-2 | The nonperformance risk is the spread added to the observable interest rates used in the valuation of the embedded derivatives. | ||||||||||||||||||||||||||||
-3 | The utilization of guaranteed withdrawals represents the percentage of contractholders that will begin withdrawing in any given year. | ||||||||||||||||||||||||||||
-4 | Market volatility is implied volatility of fund of funds and managed volatility funds. | ||||||||||||||||||||||||||||
-5 | The elective allocation represents the percentage of contractholders that are assumed to electively switch their investment allocation to a different allocation model. | ||||||||||||||||||||||||||||
Schedule of carrying value and the estimated fair value of financial instruments that are not reported at fair value | ' | ||||||||||||||||||||||||||||
The following tables provide the carrying value and the estimated fair value of financial instruments that are not reported at fair value. All other financial instruments that are reported at fair value have been included above in the table with balances of assets and liabilities measured at fair value on a recurring basis. | |||||||||||||||||||||||||||||
30-Sep-14 | |||||||||||||||||||||||||||||
Carrying | Fair Value | ||||||||||||||||||||||||||||
Value | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Financial Assets | |||||||||||||||||||||||||||||
Mortgage loans, net | $ | 3,300 | $ | — | $ | — | $ | 3,386 | $ | 3,386 | |||||||||||||||||||
Policy loans | 804 | — | — | 788 | 788 | ||||||||||||||||||||||||
Other investments | 465 | — | 419 | 45 | 464 | ||||||||||||||||||||||||
Financial Liabilities | |||||||||||||||||||||||||||||
Policyholder account balances, future policy benefits and claims | $ | 13,203 | $ | — | $ | — | $ | 13,819 | $ | 13,819 | |||||||||||||||||||
Short-term borrowings | 200 | — | 200 | — | 200 | ||||||||||||||||||||||||
Other liabilities | 96 | — | — | 95 | 95 | ||||||||||||||||||||||||
Separate account liabilities | 394 | — | 394 | — | 394 | ||||||||||||||||||||||||
31-Dec-13 | |||||||||||||||||||||||||||||
Carrying | Fair Value | ||||||||||||||||||||||||||||
Value | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Financial Assets | |||||||||||||||||||||||||||||
Mortgage loans, net | $ | 3,326 | $ | — | $ | — | $ | 3,372 | $ | 3,372 | |||||||||||||||||||
Policy loans | 773 | — | — | 765 | 765 | ||||||||||||||||||||||||
Other investments | 385 | — | 346 | 42 | 388 | ||||||||||||||||||||||||
Financial Liabilities | |||||||||||||||||||||||||||||
Policyholder account balances, future policy benefits and claims | $ | 14,106 | $ | — | $ | — | $ | 14,724 | $ | 14,724 | |||||||||||||||||||
Short-term borrowings | 500 | — | 500 | — | 500 | ||||||||||||||||||||||||
Line of credit with Ameriprise Financial | 150 | — | — | 150 | 150 | ||||||||||||||||||||||||
Other liabilities | 137 | — | — | 134 | 134 | ||||||||||||||||||||||||
Separate account liabilities | 400 | — | 400 | — | 400 | ||||||||||||||||||||||||
Offsetting_Assets_and_Liabilit1
Offsetting Assets and Liabilities (Tables) | 9 Months Ended | ||||||||||||||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||||||||||||||
Offsetting [Abstract] | ' | ||||||||||||||||||||||||||||
Schedule of gross and net information about the Company's assets subject to master netting arrangements | ' | ||||||||||||||||||||||||||||
The following tables present the gross and net information about the Company’s assets subject to master netting arrangements: | |||||||||||||||||||||||||||||
30-Sep-14 | |||||||||||||||||||||||||||||
Gross Amounts of Recognized Assets | Gross Amounts Offset in the Consolidated Balance Sheets | Amounts of Assets Presented in the Consolidated Balance Sheets | Gross Amounts Not Offset | ||||||||||||||||||||||||||
in the Consolidated Balance Sheets | |||||||||||||||||||||||||||||
Financial Instruments(1) | Cash Collateral | Securities Collateral | Net Amount | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||
OTC | $ | 3,131 | $ | — | $ | 3,131 | $ | (2,834 | ) | $ | (107 | ) | $ | (176 | ) | $ | 14 | ||||||||||||
OTC cleared | 145 | — | 145 | (92 | ) | (53 | ) | — | — | ||||||||||||||||||||
Exchange-traded | 71 | — | 71 | — | — | — | 71 | ||||||||||||||||||||||
Total derivatives | $ | 3,347 | $ | — | $ | 3,347 | $ | (2,926 | ) | $ | (160 | ) | $ | (176 | ) | $ | 85 | ||||||||||||
December 31, 2013 | |||||||||||||||||||||||||||||
Gross Amounts of Recognized Assets | Gross Amounts Offset in the Consolidated Balance Sheets | Amounts of Assets Presented in the Consolidated Balance Sheets | Gross Amounts Not Offset | ||||||||||||||||||||||||||
in the Consolidated Balance Sheets | |||||||||||||||||||||||||||||
Financial Instruments(1) | Cash Collateral | Securities Collateral | Net Amount | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||
OTC | $ | 3,180 | $ | — | $ | 3,180 | $ | (3,134 | ) | $ | (17 | ) | $ | (16 | ) | $ | 13 | ||||||||||||
OTC cleared | 21 | — | 21 | (20 | ) | (1 | ) | — | — | ||||||||||||||||||||
Exchange-traded | 60 | — | 60 | — | — | — | 60 | ||||||||||||||||||||||
Total derivatives | $ | 3,261 | $ | — | $ | 3,261 | $ | (3,154 | ) | $ | (18 | ) | $ | (16 | ) | $ | 73 | ||||||||||||
-1 | Represents the amount of assets that could be offset by liabilities with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets. | ||||||||||||||||||||||||||||
Schedule of gross and net information about the Company's liabilities subject to master netting arrangements | ' | ||||||||||||||||||||||||||||
The following tables present the gross and net information about the Company’s liabilities subject to master netting arrangements: | |||||||||||||||||||||||||||||
30-Sep-14 | |||||||||||||||||||||||||||||
Gross Amounts of Recognized Liabilities | Gross Amounts Offset in the Consolidated Balance Sheets | Amounts of Liabilities Presented in the Consolidated Balance Sheets | Gross Amounts Not Offset | ||||||||||||||||||||||||||
in the Consolidated Balance Sheets | |||||||||||||||||||||||||||||
Financial | Cash | Securities | Net | ||||||||||||||||||||||||||
Instruments(1) | Collateral | Collateral | Amount | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||
OTC | $ | 3,772 | $ | — | $ | 3,772 | $ | (2,834 | ) | $ | — | $ | (938 | ) | $ | — | |||||||||||||
OTC cleared | 92 | — | 92 | (92 | ) | — | — | — | |||||||||||||||||||||
Total derivatives | 3,864 | — | 3,864 | (2,926 | ) | — | (938 | ) | — | ||||||||||||||||||||
Repurchase agreements | 50 | — | 50 | — | — | (50 | ) | — | |||||||||||||||||||||
Total | $ | 3,914 | $ | — | $ | 3,914 | $ | (2,926 | ) | $ | — | $ | (988 | ) | $ | — | |||||||||||||
December 31, 2013 | |||||||||||||||||||||||||||||
Gross Amounts of Recognized Liabilities | Gross Amounts Offset in the Consolidated Balance Sheets | Amounts of Liabilities Presented in the Consolidated Balance Sheets | Gross Amounts Not Offset | ||||||||||||||||||||||||||
in the Consolidated Balance Sheets | |||||||||||||||||||||||||||||
Financial | Cash | Securities | Net | ||||||||||||||||||||||||||
Instruments(1) | Collateral | Collateral | Amount | ||||||||||||||||||||||||||
(in millions) | |||||||||||||||||||||||||||||
Derivatives: | |||||||||||||||||||||||||||||
OTC | $ | 4,610 | $ | — | $ | 4,610 | $ | (3,134 | ) | $ | — | $ | (1,465 | ) | $ | 11 | |||||||||||||
OTC cleared | 22 | — | 22 | (20 | ) | (2 | ) | — | — | ||||||||||||||||||||
Total derivatives | 4,632 | — | 4,632 | (3,154 | ) | (2 | ) | (1,465 | ) | 11 | |||||||||||||||||||
Repurchase agreements | 50 | — | 50 | — | — | (50 | ) | — | |||||||||||||||||||||
Total | $ | 4,682 | $ | — | $ | 4,682 | $ | (3,154 | ) | $ | (2 | ) | $ | (1,515 | ) | $ | 11 | ||||||||||||
-1 | Represents the amount of liabilities that could be offset by assets with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets. |
Derivatives_and_Hedging_Activi1
Derivatives and Hedging Activities (Tables) | 9 Months Ended | ||||||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | ' | ||||||||||||||||||||
Schedule of gross fair value of derivative instruments, including embedded derivatives | ' | ||||||||||||||||||||
The Company currently uses derivatives as economic hedges and accounting hedges. The following table presents the balance sheet location and the gross fair value of derivative instruments, including embedded derivatives: | |||||||||||||||||||||
Assets | Liabilities | ||||||||||||||||||||
Derivatives not designated | Balance Sheet | September 30, | December 31, | Balance Sheet Location | September 30, | December 31, | |||||||||||||||
as hedging instruments | Location | 2014 | 2013 | 2014 | 2013 | ||||||||||||||||
(in millions) | (in millions) | ||||||||||||||||||||
GMWB and GMAB | |||||||||||||||||||||
Interest rate contracts | Other assets | $ | 1,512 | $ | 1,484 | Other liabilities | $ | 1,208 | $ | 1,672 | |||||||||||
Equity contracts | Other assets | 1,798 | 1,741 | Other liabilities | 2,636 | 2,918 | |||||||||||||||
Credit contracts | Other assets | 4 | 3 | Other liabilities | — | — | |||||||||||||||
Foreign exchange contracts | Other assets | 4 | 2 | Other liabilities | — | — | |||||||||||||||
Embedded derivatives(1) | N/A | — | — | Policyholder account balances, future policy benefits and claims(2) | (77 | ) | (575 | ) | |||||||||||||
Total GMWB and GMAB | 3,318 | 3,230 | 3,767 | 4,015 | |||||||||||||||||
Other derivatives: | |||||||||||||||||||||
Equity | |||||||||||||||||||||
EIA embedded derivatives | N/A | — | — | Policyholder account balances, future policy benefits and claims | 6 | 5 | |||||||||||||||
IUL | Other assets | 28 | 27 | Other liabilities | 7 | 13 | |||||||||||||||
IUL embedded derivatives | N/A | — | — | Policyholder account balances, future policy benefits and claims | 202 | 125 | |||||||||||||||
Other | |||||||||||||||||||||
Macro hedge program | Other assets | 1 | 4 | Other liabilities | 13 | 29 | |||||||||||||||
Total other derivatives | 29 | 31 | 228 | 172 | |||||||||||||||||
Total derivatives | $ | 3,347 | $ | 3,261 | $ | 3,995 | $ | 4,187 | |||||||||||||
N/A | Not applicable. | ||||||||||||||||||||
-1 | The fair values of GMWB and GMAB embedded derivatives fluctuate based on changes in equity, interest rate and credit markets. | ||||||||||||||||||||
-2 | The fair value of the GMWB and GMAB embedded derivatives was a net asset at September 30, 2014 and December 31, 2013 and the amount is reported as a contra liability. | ||||||||||||||||||||
Schedule of gain (loss) on derivative instruments | ' | ||||||||||||||||||||
The following table presents a summary of the impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income: | |||||||||||||||||||||
Amount of Gain (Loss) on Derivatives | |||||||||||||||||||||
Recognized in Income | |||||||||||||||||||||
Derivatives not designated as hedging instruments | Location of Gain (Loss) on Derivatives Recognized in Income | Three Months Ended September 30, | Nine Months Ended | ||||||||||||||||||
September 30, | |||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||||||
(in millions) | |||||||||||||||||||||
GMWB and GMAB | |||||||||||||||||||||
Interest rate contracts | Benefits, claims, losses and settlement expenses | $ | 100 | $ | (63 | ) | $ | 609 | $ | (575 | ) | ||||||||||
Equity contracts | Benefits, claims, losses and settlement expenses | 143 | (323 | ) | (244 | ) | (803 | ) | |||||||||||||
Credit contracts | Benefits, claims, losses and settlement expenses | (1 | ) | (3 | ) | (23 | ) | 5 | |||||||||||||
Foreign exchange contracts | Benefits, claims, losses and settlement expenses | (13 | ) | 8 | (14 | ) | 15 | ||||||||||||||
Embedded derivatives(1) | Benefits, claims, losses and settlement expenses | (270 | ) | 267 | (498 | ) | 1,089 | ||||||||||||||
Total GMWB and GMAB | (41 | ) | (114 | ) | (170 | ) | (269 | ) | |||||||||||||
Other derivatives: | |||||||||||||||||||||
Interest rate | |||||||||||||||||||||
Tax hedge | Net investment income | — | — | 3 | — | ||||||||||||||||
Equity | |||||||||||||||||||||
EIA | Interest credited to fixed accounts | — | 1 | 1 | 2 | ||||||||||||||||
EIA embedded derivatives | Interest credited to fixed accounts | — | — | (1 | ) | (1 | ) | ||||||||||||||
IUL | Interest credited to fixed accounts | 2 | 2 | 13 | 8 | ||||||||||||||||
IUL embedded derivatives | Interest credited to fixed accounts | (2 | ) | 3 | 9 | 8 | |||||||||||||||
Other | |||||||||||||||||||||
Macro hedge program | Benefits, claims, losses and settlement expenses | (1 | ) | — | 2 | — | |||||||||||||||
Total other derivatives | (1 | ) | 6 | 27 | 17 | ||||||||||||||||
Total derivatives | $ | (42 | ) | $ | (108 | ) | $ | (143 | ) | $ | (252 | ) | |||||||||
-1 | The fair values of GMWB and GMAB embedded derivatives fluctuate based on changes in equity, interest rate and credit markets. | ||||||||||||||||||||
Schedule of payments to make and receive for options | ' | ||||||||||||||||||||
The deferred premium associated with certain of the above options is paid or received semi-annually over the life of the option contract or at maturity. The following is a summary of the payments the Company is scheduled to make and receive for these options: | |||||||||||||||||||||
Premiums Payable | Premiums Receivable | ||||||||||||||||||||
(in millions) | |||||||||||||||||||||
2014(1) | $ | 109 | $ | 49 | |||||||||||||||||
2015 | 349 | 69 | |||||||||||||||||||
2016 | 316 | 53 | |||||||||||||||||||
2017 | 240 | 69 | |||||||||||||||||||
2018 | 190 | 68 | |||||||||||||||||||
2019-2026 | 526 | 132 | |||||||||||||||||||
Total | $ | 1,730 | $ | 440 | |||||||||||||||||
-1 | 2014 amounts represent the amounts payable and receivable for the period from October 1, 2014 to December 31, 2014. | ||||||||||||||||||||
Summary of unrealized derivative losses included in accumulated other comprehensive income (loss) related to cash flow hedges | ' | ||||||||||||||||||||
The following table presents a rollforward of unrealized derivative losses related to cash flow hedges included in accumulated other comprehensive income (loss): | |||||||||||||||||||||
2014 | 2013 | ||||||||||||||||||||
(in millions) | |||||||||||||||||||||
Net unrealized derivative losses at January 1 | $ | (17 | ) | $ | (21 | ) | |||||||||||||||
Reclassification of realized losses(1) | 5 | 6 | |||||||||||||||||||
Income tax benefit | (2 | ) | (2 | ) | |||||||||||||||||
Net unrealized derivative losses at September 30 | $ | (14 | ) | $ | (17 | ) | |||||||||||||||
-1 | Loss reclassified from AOCI to net investment income on the Consolidated Statements of Income. |
Shareholders_Equity_Tables
Shareholder's Equity (Tables) | 9 Months Ended | ||||||||||||||||||
Sep. 30, 2014 | |||||||||||||||||||
Stockholders' Equity Note [Abstract] | ' | ||||||||||||||||||
Schedule of information related to amounts reclassified from AOCI | ' | ||||||||||||||||||
The following table provides information related to amounts reclassified from AOCI: | |||||||||||||||||||
Three Months Ended September 30, | Nine Months Ended | ||||||||||||||||||
September 30, | |||||||||||||||||||
AOCI Reclassification | Location of (Gain) Loss Recognized in Income | 2014 | 2013 | 2014 | 2013 | ||||||||||||||
(in millions) | |||||||||||||||||||
Net unrealized gains on Available-for-Sale securities | Net realized investment gains | $ | (10 | ) | $ | (4 | ) | $ | (15 | ) | $ | (3 | ) | ||||||
Tax expense | Income tax provision | 4 | 1 | 6 | 1 | ||||||||||||||
Net of tax | $ | (6 | ) | $ | (3 | ) | $ | (9 | ) | $ | (2 | ) | |||||||
Losses on cash flow hedges: | |||||||||||||||||||
Swaptions | Net investment income | $ | 2 | $ | 2 | $ | 5 | $ | 6 | ||||||||||
Tax benefit | Income tax provision | (1 | ) | (1 | ) | (2 | ) | (2 | ) | ||||||||||
Net of tax | $ | 1 | $ | 1 | $ | 3 | $ | 4 | |||||||||||
Basis_of_Presentation_Details
Basis of Presentation (Details) | Sep. 30, 2014 |
item | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ' |
Number of wholly owned subsidiaries | 2 |
Variable_Interest_Entities_Det
Variable Interest Entities (Details) (Variable interests in affordable housing partnerships [Member], RTA [Member], USD $) | 9 Months Ended | |
In Millions, unless otherwise specified | Sep. 30, 2014 | Dec. 31, 2013 |
Variable interests in affordable housing partnerships [Member] | RTA [Member] | ' | ' |
Variable Interest Entities | ' | ' |
Carrying values of investments reflected in other investments | $471 | $495 |
Obligation to provide financial or other support to the affordable housing partnerships | 0 | ' |
Liabilities related to the future funding commitments recorded in other liabilities | $96 | $137 |
Investments_AFS_by_type_Detail
Investments (AFS by type) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 | ||
Investments | ' | ' | ||
Amortized cost | $21,662,000,000 | $22,904,000,000 | ||
Gross unrealized gains | 2,028,000,000 | 1,743,000,000 | ||
Gross unrealized losses | -113,000,000 | -254,000,000 | ||
Fair value | 23,577,000,000 | 24,393,000,000 | ||
Noncredit OTTI | -3,000,000 | [1] | -13,000,000 | [1] |
Security owned and pledged as collateral, fair value | 1,600,000,000 | 2,300,000,000 | ||
Corporate debt securities [Member] | ' | ' | ||
Investments | ' | ' | ||
Amortized cost | 13,962,000,000 | 14,658,000,000 | ||
Gross unrealized gains | 1,539,000,000 | 1,311,000,000 | ||
Gross unrealized losses | -31,000,000 | -96,000,000 | ||
Fair value | 15,470,000,000 | 15,873,000,000 | ||
Noncredit OTTI | 3,000,000 | [1] | 3,000,000 | [1] |
Residential mortgage backed securities [Member] | ' | ' | ||
Investments | ' | ' | ||
Amortized cost | 3,466,000,000 | 3,773,000,000 | ||
Gross unrealized gains | 135,000,000 | 133,000,000 | ||
Gross unrealized losses | -44,000,000 | -95,000,000 | ||
Fair value | 3,557,000,000 | 3,811,000,000 | ||
Noncredit OTTI | -9,000,000 | [1] | -18,000,000 | [1] |
Commercial mortgage backed securities [Member] | ' | ' | ||
Investments | ' | ' | ||
Amortized cost | 2,121,000,000 | 2,309,000,000 | ||
Gross unrealized gains | 115,000,000 | 136,000,000 | ||
Gross unrealized losses | -4,000,000 | -11,000,000 | ||
Fair value | 2,232,000,000 | 2,434,000,000 | ||
State and municipal obligations [Member] | ' | ' | ||
Investments | ' | ' | ||
Amortized cost | 942,000,000 | 950,000,000 | ||
Gross unrealized gains | 159,000,000 | 87,000,000 | ||
Gross unrealized losses | -28,000,000 | -39,000,000 | ||
Fair value | 1,073,000,000 | 998,000,000 | ||
Asset backed securities [Member] | ' | ' | ||
Investments | ' | ' | ||
Amortized cost | 896,000,000 | 938,000,000 | ||
Gross unrealized gains | 49,000,000 | 48,000,000 | ||
Gross unrealized losses | -1,000,000 | -5,000,000 | ||
Fair value | 944,000,000 | 981,000,000 | ||
Foreign government bonds and obligations [Member] | ' | ' | ||
Investments | ' | ' | ||
Amortized cost | 237,000,000 | 234,000,000 | ||
Gross unrealized gains | 21,000,000 | 19,000,000 | ||
Gross unrealized losses | -5,000,000 | -8,000,000 | ||
Fair value | 253,000,000 | 245,000,000 | ||
U.S. government and agencies obligations [Member] | ' | ' | ||
Investments | ' | ' | ||
Amortized cost | 36,000,000 | 40,000,000 | ||
Gross unrealized gains | 4,000,000 | 5,000,000 | ||
Gross unrealized losses | 0 | 0 | ||
Fair value | 40,000,000 | 45,000,000 | ||
Total fixed maturities [Member] | ' | ' | ||
Investments | ' | ' | ||
Amortized cost | 21,660,000,000 | 22,902,000,000 | ||
Gross unrealized gains | 2,022,000,000 | 1,739,000,000 | ||
Gross unrealized losses | -113,000,000 | -254,000,000 | ||
Fair value | 23,569,000,000 | 24,387,000,000 | ||
Noncredit OTTI | -6,000,000 | [1] | -15,000,000 | [1] |
Common stocks [Member] | ' | ' | ||
Investments | ' | ' | ||
Amortized cost | 2,000,000 | 2,000,000 | ||
Gross unrealized gains | 6,000,000 | 4,000,000 | ||
Gross unrealized losses | 0 | 0 | ||
Fair value | 8,000,000 | 6,000,000 | ||
Noncredit OTTI | $3,000,000 | [1] | $2,000,000 | [1] |
[1] | Represents the amount of other-than-temporary impairment (bOTTIb) losses in accumulated other comprehensive income. Amount includes unrealized gains and losses on impaired securities subsequent to the initial impairment measurement date. These amounts are included in gross unrealized gains and losses as of the end of the period. |
Investments_Rating_info_Detail
Investments (Rating info) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
item | ||
Investments | ' | ' |
Amortized cost | $21,662,000,000 | $22,904,000,000 |
Fair value | 23,577,000,000 | 24,393,000,000 |
Percentage of GNMA, FNMA and FHLMC securities rated AAA | 44.00% | 41.00% |
Number of holdings of other than GNMA, FNMA and FHLMC having greater than 10% of total equity | 0 | ' |
AAA [Member] | ' | ' |
Investments | ' | ' |
Amortized cost | 5,183,000,000 | 5,557,000,000 |
Fair value | 5,410,000,000 | 5,738,000,000 |
Percent of total fair value | 23.00% | 23.00% |
AA [Member] | ' | ' |
Investments | ' | ' |
Amortized cost | 988,000,000 | 1,055,000,000 |
Fair value | 1,155,000,000 | 1,171,000,000 |
Percent of total fair value | 5.00% | 5.00% |
A [Member] | ' | ' |
Investments | ' | ' |
Amortized cost | 4,395,000,000 | 4,687,000,000 |
Fair value | 4,963,000,000 | 5,062,000,000 |
Percent of total fair value | 21.00% | 21.00% |
BBB [Member] | ' | ' |
Investments | ' | ' |
Amortized cost | 9,527,000,000 | 10,062,000,000 |
Fair value | 10,475,000,000 | 10,897,000,000 |
Percent of total fair value | 44.00% | 45.00% |
Below Investment Grade [Member] | ' | ' |
Investments | ' | ' |
Amortized cost | 1,567,000,000 | 1,541,000,000 |
Fair value | 1,566,000,000 | 1,519,000,000 |
Percent of total fair value | 7.00% | 6.00% |
Total fixed maturities [Member] | ' | ' |
Investments | ' | ' |
Amortized cost | 21,660,000,000 | 22,902,000,000 |
Fair value | 23,569,000,000 | 24,387,000,000 |
Percent of total fair value | 100.00% | 100.00% |
Fixed maturity securities as percentage of the entity's total investments | 82.00% | 83.00% |
Amount of securities internally rated | $1,100,000,000 | $1,300,000,000 |
Investments_EITF_info_Details
Investments (EITF info) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | item | item |
Number of Securities | ' | ' |
Less than 12 months | 112 | 279 |
12 months or more | 131 | 63 |
Total | 243 | 342 |
Fair Value | ' | ' |
Less than 12 months | $1,006 | $4,635 |
12 months or more | 1,819 | 595 |
Total | 2,825 | 5,230 |
Unrealized Losses | ' | ' |
Less than 12 months | -12 | -159 |
12 months or more | -101 | -95 |
Total | -113 | -254 |
Corporate debt securities [Member] | ' | ' |
Number of Securities | ' | ' |
Less than 12 months | 83 | 156 |
12 months or more | 43 | 10 |
Total | 126 | 166 |
Fair Value | ' | ' |
Less than 12 months | 760 | 2,567 |
12 months or more | 736 | 160 |
Total | 1,496 | 2,727 |
Unrealized Losses | ' | ' |
Less than 12 months | -10 | -82 |
12 months or more | -21 | -14 |
Total | -31 | -96 |
Residential mortgage backed securities [Member] | ' | ' |
Number of Securities | ' | ' |
Less than 12 months | 14 | 52 |
12 months or more | 59 | 45 |
Total | 73 | 97 |
Fair Value | ' | ' |
Less than 12 months | 140 | 1,411 |
12 months or more | 822 | 295 |
Total | 962 | 1,706 |
Unrealized Losses | ' | ' |
Less than 12 months | -2 | -54 |
12 months or more | -42 | -41 |
Total | -44 | -95 |
Commercial mortgage backed securities [Member] | ' | ' |
Number of Securities | ' | ' |
Less than 12 months | 5 | 27 |
12 months or more | 9 | 3 |
Total | 14 | 30 |
Fair Value | ' | ' |
Less than 12 months | 41 | 323 |
12 months or more | 96 | 22 |
Total | 137 | 345 |
Unrealized Losses | ' | ' |
Less than 12 months | 0 | -9 |
12 months or more | -4 | -2 |
Total | -4 | -11 |
State and municipal obligations [Member] | ' | ' |
Number of Securities | ' | ' |
Less than 12 months | 1 | 4 |
12 months or more | 2 | 2 |
Total | 3 | 6 |
Fair Value | ' | ' |
Less than 12 months | 5 | 38 |
12 months or more | 100 | 92 |
Total | 105 | 130 |
Unrealized Losses | ' | ' |
Less than 12 months | 0 | -2 |
12 months or more | -28 | -37 |
Total | -28 | -39 |
Asset backed securities [Member] | ' | ' |
Number of Securities | ' | ' |
Less than 12 months | 5 | 17 |
12 months or more | 4 | 3 |
Total | 9 | 20 |
Fair Value | ' | ' |
Less than 12 months | 42 | 219 |
12 months or more | 38 | 26 |
Total | 80 | 245 |
Unrealized Losses | ' | ' |
Less than 12 months | 0 | -4 |
12 months or more | -1 | -1 |
Total | -1 | -5 |
Foreign government bonds and obligations [Member] | ' | ' |
Number of Securities | ' | ' |
Less than 12 months | 4 | 23 |
12 months or more | 14 | 0 |
Total | 18 | 23 |
Fair Value | ' | ' |
Less than 12 months | 18 | 77 |
12 months or more | 27 | 0 |
Total | 45 | 77 |
Unrealized Losses | ' | ' |
Less than 12 months | 0 | -8 |
12 months or more | -5 | 0 |
Total | ($5) | ($8) |
Investments_Investments_OTTI_r
Investments Investments (OTTI rollforward) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Millions, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Rollforward of the cumulative amounts recognized in the Consolidated Statements of Income for other-than-temporary impairments related to credit losses on securities | ' | ' | ' | ' |
Beginning balance | $54 | $66 | $54 | $87 |
Credit losses for which an other-than-temporary impairment was not previously recognized | 0 | 1 | 0 | 1 |
Credit losses for which an other-than-temporary impairment was previously recognized | 1 | 0 | 1 | 2 |
Reductions for securities sold during the period (realized) | -22 | 0 | -22 | -23 |
Ending balance | $33 | $67 | $33 | $67 |
Investments_OCI_rollforward_De
Investments (OCI rollforward) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||||||
In Millions, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | ||||
Rollforward of the net unrealized securities gains (losses) on Available-for-Sale securities included in accumulated other comprehensive income | ' | ' | ' | ' | ||||
Net unrealized securities gains (losses) arising during the period, net of tax | ($137) | ($67) | $285 | ($811) | ||||
Reclassification of net securities (gains) losses included in net income, net of tax | -6 | -3 | -9 | -2 | ||||
Impact of DAC, DSIC, benefit reserves and reinsurance recoverables, net of tax | -1 | 18 | -168 | 283 | ||||
Net unrealized securities gains/losses, gross [Member] | ' | ' | ' | ' | ||||
Rollforward of the net unrealized securities gains (losses) on Available-for-Sale securities included in accumulated other comprehensive income | ' | ' | ' | ' | ||||
Balance at the beginning of the period | ' | ' | 1,033 | 1,930 | ||||
Net unrealized securities gains (losses) arising during the period | ' | ' | 441 | [1] | -1,234 | [1] | ||
Reclassification of net securities (gains) losses included in net income | ' | ' | -15 | -3 | ||||
Impact of DAC, DSIC, benefit reserves and reinsurance recoverables | ' | ' | -258 | 436 | ||||
Balance at the end of the period | 1,201 | 1,129 | 1,201 | 1,129 | ||||
Deferred income tax [Member] | ' | ' | ' | ' | ||||
Rollforward of the net unrealized securities gains (losses) on Available-for-Sale securities included in accumulated other comprehensive income | ' | ' | ' | ' | ||||
Balance at the beginning of the period | ' | ' | -366 | -675 | ||||
Net unrealized securities (gains) losses arising during the period | ' | ' | -156 | [1] | 423 | [1] | ||
Reclassification of net securities gains (losses) included in net income | ' | ' | 6 | 1 | ||||
Impact of DAC, DSIC, benefit reserves and reinsurance recoverables | ' | ' | 90 | -153 | ||||
Balance at the end of the period | -426 | -404 | -426 | -404 | ||||
Net unrealized securities gains/losses, net of tax [Member] | ' | ' | ' | ' | ||||
Rollforward of the net unrealized securities gains (losses) on Available-for-Sale securities included in accumulated other comprehensive income | ' | ' | ' | ' | ||||
Balance at the beginning of the period | ' | ' | 667 | 1,255 | ||||
Net unrealized securities gains (losses) arising during the period, net of tax | ' | ' | 285 | [1] | -811 | [1] | ||
Reclassification of net securities (gains) losses included in net income, net of tax | ' | ' | -9 | -2 | ||||
Impact of DAC, DSIC, benefit reserves and reinsurance recoverables, net of tax | ' | ' | -168 | 283 | ||||
Balance at the end of the period | 775 | [2] | 725 | [2] | 775 | [2] | 725 | [2] |
Noncredit related impairments on securities and net unrealized securities losses on previously impaired securities, included in accumulated other comprehensive income | ($2) | ($10) | ($2) | ($10) | ||||
[1] | Includes other-than-temporary impairment losses on Available-for-Sale securities related to factors other than credit that were recognized in other comprehensive income (loss) during the period. | |||||||
[2] | Includes $2 million and $10 million of noncredit related impairments on securities and net unrealized securities losses on previously impaired securities at SeptemberB 30, 2014 and 2013, respectively. |
Investments_Investments_Realiz
Investments Investments (Realized GL info) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Millions, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Available-for-sale Securities, Gross Realized Gain (Loss) [Abstract] | ' | ' | ' | ' |
Gross realized investment gains | $15 | $6 | $24 | $8 |
Gross realized investment losses | -1 | 0 | -4 | -1 |
Other-than-temporary impairments | -4 | -2 | -5 | -4 |
Total | $10 | $4 | $15 | $3 |
Investments_AFS_contractual_ma
Investments (AFS contractual maturity) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Amortized Cost | ' | ' |
Due within one year | $965 | ' |
Due after one year through five years | 5,938 | ' |
Due after five years through 10 years | 4,701 | ' |
Due after 10 years | 3,573 | ' |
Total having single maturity dates | 15,177 | ' |
Amortized cost | 21,662 | 22,904 |
Fair Value | ' | ' |
Due within one year | 984 | ' |
Due after one year through five years | 6,521 | ' |
Due after five years through 10 years | 4,941 | ' |
Due after 10 years | 4,390 | ' |
Total having single maturity dates | 16,836 | ' |
Fair value | 23,577 | 24,393 |
Residential mortgage backed securities [Member] | ' | ' |
Amortized Cost | ' | ' |
Without single maturity dates | 3,466 | ' |
Amortized cost | 3,466 | 3,773 |
Fair Value | ' | ' |
Without single maturity dates | 3,557 | ' |
Fair value | 3,557 | 3,811 |
Commercial mortgage backed securities [Member] | ' | ' |
Amortized Cost | ' | ' |
Without single maturity dates | 2,121 | ' |
Amortized cost | 2,121 | 2,309 |
Fair Value | ' | ' |
Without single maturity dates | 2,232 | ' |
Fair value | 2,232 | 2,434 |
Asset backed securities [Member] | ' | ' |
Amortized Cost | ' | ' |
Without single maturity dates | 896 | ' |
Amortized cost | 896 | 938 |
Fair Value | ' | ' |
Without single maturity dates | 944 | ' |
Fair value | 944 | 981 |
Common stocks [Member] | ' | ' |
Amortized Cost | ' | ' |
Without single maturity dates | 2 | ' |
Amortized cost | 2 | 2 |
Fair Value | ' | ' |
Without single maturity dates | 8 | ' |
Fair value | $8 | $6 |
Investments_Net_Inv_Inc_summar
Investments (Net Inv Inc summary) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Millions, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Net Investment Income [Line Items] | ' | ' | ' | ' |
Gross investment income | $326 | $359 | $998 | $1,091 |
Less: investment expenses | 7 | 9 | 23 | 24 |
Total | 319 | 350 | 975 | 1,067 |
Fixed maturities [Member] | ' | ' | ' | ' |
Net Investment Income [Line Items] | ' | ' | ' | ' |
Gross investment income | 277 | 301 | 841 | 913 |
Mortgage loans [Member] | ' | ' | ' | ' |
Net Investment Income [Line Items] | ' | ' | ' | ' |
Gross investment income | 46 | 50 | 137 | 153 |
Other investments [Member] | ' | ' | ' | ' |
Net Investment Income [Line Items] | ' | ' | ' | ' |
Gross investment income | $3 | $8 | $20 | $25 |
Financing_Receivables_Allowanc
Financing Receivables (Allowance for Loan Losses) (Details) (USD $) | 3 Months Ended | 9 Months Ended | |||
In Millions, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Dec. 31, 2013 |
Rollforward of the allowance for loan losses | ' | ' | ' | ' | ' |
Beginning balance | ' | ' | $28 | $30 | ' |
Charge-offs | ' | ' | -3 | -2 | ' |
Provisions | ' | ' | 2 | ' | ' |
Ending balance | 27 | 28 | 27 | 28 | ' |
Individually evaluated for impairment | 8 | 7 | 8 | 7 | ' |
Collectively evaluated for impairment | 19 | 21 | 19 | 21 | ' |
Recorded investment in financing receivables by impairment method and type of loan | ' | ' | ' | ' | ' |
Individually evaluated for impairment | 37 | ' | 37 | ' | 45 |
Collectively evaluated for impairment | 3,739 | ' | 3,739 | ' | 3,666 |
Total | 3,776 | ' | 3,776 | ' | 3,711 |
Recorded investment in financing receivables individually evaluated for impairment with no related allowance for loan losses | 9 | ' | 9 | ' | 12 |
Commercial mortgage loans [Member] | ' | ' | ' | ' | ' |
Rollforward of the allowance for loan losses | ' | ' | ' | ' | ' |
Beginning balance | ' | ' | 24 | 26 | ' |
Charge-offs | ' | ' | -2 | -2 | ' |
Ending balance | 22 | 24 | 22 | 24 | ' |
Individually evaluated for impairment | 8 | 7 | 8 | 7 | ' |
Collectively evaluated for impairment | 14 | 17 | 14 | 17 | ' |
Recorded investment in financing receivables by impairment method and type of loan | ' | ' | ' | ' | ' |
Individually evaluated for impairment | 34 | ' | 34 | ' | 40 |
Collectively evaluated for impairment | 2,572 | ' | 2,572 | ' | 2,524 |
Total | 2,606 | ' | 2,606 | ' | 2,564 |
Residential mortgage loans [Member] | ' | ' | ' | ' | ' |
Recorded investment in financing receivables by impairment method and type of loan | ' | ' | ' | ' | ' |
Collectively evaluated for impairment | 716 | ' | 716 | ' | 786 |
Total | 716 | ' | 716 | ' | 786 |
Unamortized discount | 39 | ' | 39 | ' | 53 |
Syndicated loans [Member] | ' | ' | ' | ' | ' |
Rollforward of the allowance for loan losses | ' | ' | ' | ' | ' |
Beginning balance | ' | ' | 4 | 4 | ' |
Charge-offs | ' | ' | -1 | ' | ' |
Provisions | ' | ' | 2 | ' | ' |
Ending balance | 5 | 4 | 5 | 4 | ' |
Collectively evaluated for impairment | 5 | 4 | 5 | 4 | ' |
Recorded investment in financing receivables by impairment method and type of loan | ' | ' | ' | ' | ' |
Individually evaluated for impairment | 3 | ' | 3 | ' | 5 |
Collectively evaluated for impairment | 451 | ' | 451 | ' | 356 |
Total | 454 | ' | 454 | ' | 361 |
Loans purchased | 71 | 8 | 161 | 67 | ' |
Loans sold | $2 | $0 | $12 | $1 | ' |
Financing_Receivables_Financin
Financing Receivables Financing Receivables (Credit Quality Information Text) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
Financing Receivables | ' | ' |
Nonperforming loans | $10,000,000 | $20,000,000 |
Syndicated loans [Member] | ' | ' |
Financing Receivables | ' | ' |
Nonperforming loans | 3,000,000 | 3,000,000 |
Commercial mortgage loans [Member] | ' | ' |
Financing Receivables | ' | ' |
Percent of commercial mortgage loans with highest risk rating | 1.00% | 2.00% |
Residential mortgage loans [Member] | ' | ' |
Financing Receivables | ' | ' |
Allowance for loan losses on purchase of loans from affiliate | $0 | $0 |
Percentage of residential mortgage loans below specific FICO score | 4.00% | 4.00% |
FICO Score | 640 | ' |
Percentage of residential mortgage loans above specific LTV ratio | 1.00% | 1.00% |
LTV Ratio | 90.00% | ' |
Percentage of loan portfolio represented by state of California | 37.00% | 38.00% |
Financing_Receivables_Financin1
Financing Receivables Financing Receivables (Credit Quality Information Tables) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2013 | Dec. 31, 2012 |
In Millions, unless otherwise specified | ||||
Commercial mortgage loans [Line Items] | ' | ' | ' | ' |
Total loans, gross | $3,776 | $3,711 | ' | ' |
Less: allowance for loan losses | 27 | 28 | 28 | 30 |
Commercial mortgage loans [Member] | ' | ' | ' | ' |
Commercial mortgage loans [Line Items] | ' | ' | ' | ' |
Total loans, gross | 2,606 | 2,564 | ' | ' |
Less: allowance for loan losses | 22 | 24 | ' | ' |
Total loans, net | 2,584 | 2,540 | ' | ' |
Percentage of gross commercial mortgage loans | 100.00% | 100.00% | ' | ' |
Commercial mortgage loans [Member] | Retail [Member] | ' | ' | ' | ' |
Commercial mortgage loans [Line Items] | ' | ' | ' | ' |
Total loans, gross | 944 | 917 | ' | ' |
Percentage of gross commercial mortgage loans | 36.00% | 36.00% | ' | ' |
Commercial mortgage loans [Member] | Office [Member] | ' | ' | ' | ' |
Commercial mortgage loans [Line Items] | ' | ' | ' | ' |
Total loans, gross | 545 | 548 | ' | ' |
Percentage of gross commercial mortgage loans | 21.00% | 21.00% | ' | ' |
Commercial mortgage loans [Member] | Industrial [Member] | ' | ' | ' | ' |
Commercial mortgage loans [Line Items] | ' | ' | ' | ' |
Total loans, gross | 460 | 431 | ' | ' |
Percentage of gross commercial mortgage loans | 18.00% | 17.00% | ' | ' |
Commercial mortgage loans [Member] | Apartments [Member] | ' | ' | ' | ' |
Commercial mortgage loans [Line Items] | ' | ' | ' | ' |
Total loans, gross | 445 | 454 | ' | ' |
Percentage of gross commercial mortgage loans | 17.00% | 18.00% | ' | ' |
Commercial mortgage loans [Member] | Mixed use [Member] | ' | ' | ' | ' |
Commercial mortgage loans [Line Items] | ' | ' | ' | ' |
Total loans, gross | 45 | 36 | ' | ' |
Percentage of gross commercial mortgage loans | 2.00% | 1.00% | ' | ' |
Commercial mortgage loans [Member] | Hotel [Member] | ' | ' | ' | ' |
Commercial mortgage loans [Line Items] | ' | ' | ' | ' |
Total loans, gross | 33 | 32 | ' | ' |
Percentage of gross commercial mortgage loans | 1.00% | 1.00% | ' | ' |
Commercial mortgage loans [Member] | Other [Member] | ' | ' | ' | ' |
Commercial mortgage loans [Line Items] | ' | ' | ' | ' |
Total loans, gross | 134 | 146 | ' | ' |
Percentage of gross commercial mortgage loans | 5.00% | 6.00% | ' | ' |
Commercial mortgage loans [Member] | South Atlantic [Member] | ' | ' | ' | ' |
Commercial mortgage loans [Line Items] | ' | ' | ' | ' |
Total loans, gross | 703 | 679 | ' | ' |
Percentage of gross commercial mortgage loans | 27.00% | 26.00% | ' | ' |
Commercial mortgage loans [Member] | Pacific [Member] | ' | ' | ' | ' |
Commercial mortgage loans [Line Items] | ' | ' | ' | ' |
Total loans, gross | 653 | 631 | ' | ' |
Percentage of gross commercial mortgage loans | 25.00% | 25.00% | ' | ' |
Commercial mortgage loans [Member] | Mountain [Member] | ' | ' | ' | ' |
Commercial mortgage loans [Line Items] | ' | ' | ' | ' |
Total loans, gross | 252 | 248 | ' | ' |
Percentage of gross commercial mortgage loans | 10.00% | 10.00% | ' | ' |
Commercial mortgage loans [Member] | East North Central [Member] | ' | ' | ' | ' |
Commercial mortgage loans [Line Items] | ' | ' | ' | ' |
Total loans, gross | 232 | 248 | ' | ' |
Percentage of gross commercial mortgage loans | 9.00% | 10.00% | ' | ' |
Commercial mortgage loans [Member] | Middle Atlantic [Member] | ' | ' | ' | ' |
Commercial mortgage loans [Line Items] | ' | ' | ' | ' |
Total loans, gross | 213 | 202 | ' | ' |
Percentage of gross commercial mortgage loans | 8.00% | 8.00% | ' | ' |
Commercial mortgage loans [Member] | West North Central [Member] | ' | ' | ' | ' |
Commercial mortgage loans [Line Items] | ' | ' | ' | ' |
Total loans, gross | 204 | 194 | ' | ' |
Percentage of gross commercial mortgage loans | 8.00% | 7.00% | ' | ' |
Commercial mortgage loans [Member] | West South Central [Member] | ' | ' | ' | ' |
Commercial mortgage loans [Line Items] | ' | ' | ' | ' |
Total loans, gross | 153 | 153 | ' | ' |
Percentage of gross commercial mortgage loans | 6.00% | 6.00% | ' | ' |
Commercial mortgage loans [Member] | New England [Member] | ' | ' | ' | ' |
Commercial mortgage loans [Line Items] | ' | ' | ' | ' |
Total loans, gross | 131 | 138 | ' | ' |
Percentage of gross commercial mortgage loans | 5.00% | 5.00% | ' | ' |
Commercial mortgage loans [Member] | East South Central [Member] | ' | ' | ' | ' |
Commercial mortgage loans [Line Items] | ' | ' | ' | ' |
Total loans, gross | $65 | $71 | ' | ' |
Percentage of gross commercial mortgage loans | 2.00% | 3.00% | ' | ' |
Financing_Receivables_Financin2
Financing Receivables Financing Receivables (Troubled Debt Restructurings) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | |
item | item | item | item | |
Troubled Debt Restructurings | ' | ' | ' | ' |
Number of loans | 1 | 3 | 6 | 8 |
Recorded investment | $6,000,000 | $12,000,000 | $14,000,000 | $21,000,000 |
Commitments to lend additional funds to borrowers for restructured loans | 0 | 0 | 0 | 0 |
Commercial mortgage loans [Member] | ' | ' | ' | ' |
Troubled Debt Restructurings | ' | ' | ' | ' |
Number of loans | 1 | 3 | 3 | 6 |
Recorded investment | $6,000,000 | $12,000,000 | $14,000,000 | $21,000,000 |
Residential mortgage loans [Member] | ' | ' | ' | ' |
Troubled Debt Restructurings | ' | ' | ' | ' |
Number of loans | ' | ' | 2 | 2 |
Syndicated loans [Member] | ' | ' | ' | ' |
Troubled Debt Restructurings | ' | ' | ' | ' |
Number of loans | ' | ' | 1 | ' |
Deferred_Acquisition_Costs_and2
Deferred Acquisition Costs and Deferred Sales Inducement Costs (Details) (USD $) | 9 Months Ended | |
In Millions, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 |
Balances of and changes in DAC | ' | ' |
Balance at the beginning of the period | $2,633 | $2,373 |
Capitalization of acquisition costs | 196 | 200 |
Amortization, excluding the impact of valuation assumptions review | -219 | -180 |
Amortization, impact of valuation assumptions review | -7 | 78 |
Impact of change in net unrealized securities losses (gains) | -30 | 112 |
Balance at the end of the period | 2,573 | 2,583 |
Balances of and changes in DSIC | ' | ' |
Balance at the beginning of the period | 409 | 404 |
Capitalization of sales inducement costs | 4 | 4 |
Amortization, excluding the impact of valuation assumptions review | -40 | -39 |
Amortization, impact of valuation assumptions review | -2 | 25 |
Impact of change in net unrealized securities losses (gains) | -3 | 18 |
Balance at the end of the period | $368 | $412 |
Policyholder_Account_Balances_2
Policyholder Account Balances, Future Policy Benefits and Claims and Separate Account Liabilities (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 | ||
In Millions, unless otherwise specified | ||||
Policyholder account balances | $21,953 | $22,735 | ||
Future policy benefits | 7,199 | 6,258 | ||
Policy claims and other policyholdersb funds | 160 | 156 | ||
Policyholder account balances, future policy benefits and claims | 29,312 | 29,149 | ||
Separate account liabilities | ' | ' | ||
Variable annuity | 71,345 | 70,687 | ||
VUL insurance | 6,925 | 6,885 | ||
Other insurance | 43 | 44 | ||
Total | 78,313 | 77,616 | ||
Fixed annuities [Member] | ' | ' | ||
Policyholder account balances | 12,922 | 13,826 | ||
Variable annuity fixed sub-accounts [Member] | ' | ' | ||
Policyholder account balances | 4,869 | 4,926 | ||
VUL/UL insurance [Member] | ' | ' | ||
Policyholder account balances | 2,841 | 2,790 | ||
IUL [Member] | ' | ' | ||
Policyholder account balances | 475 | 315 | ||
Other life Insurance [Member] | ' | ' | ||
Policyholder account balances | 846 | 878 | ||
Variable annuity GMWB [Member] | ' | ' | ||
Future policy benefits | 145 | [1] | -383 | [1] |
Variable annuity GMAB [Member] | ' | ' | ||
Future policy benefits | -55 | [1] | -62 | [1] |
Other annuity liabilities [Member] | ' | ' | ||
Future policy benefits | 118 | 76 | ||
Fixed annuities life contingent liabilities [Member] | ' | ' | ||
Future policy benefits | 1,518 | 1,523 | ||
EIA [Member] | ' | ' | ||
Future policy benefits | 29 | 29 | ||
Llife, disability income and long term care insurance [Member] | ' | ' | ||
Future policy benefits | 5,041 | 4,739 | ||
VUL/UL and other life insurance additional liabilities [Member] | ' | ' | ||
Future policy benefits | $403 | $336 | ||
[1] | Includes the value of GMWB and GMAB embedded derivatives that was a net asset at both SeptemberB 30, 2014 and DecemberB 31, 2013 reported as a contra liability. |
Variable_Annuity_and_Insurance2
Variable Annuity and Insurance Guarantees (VA guarantee details) (Details) (USD $) | 9 Months Ended | 12 Months Ended | ||
In Millions, unless otherwise specified | Sep. 30, 2014 | Dec. 31, 2013 | ||
GMDB [Member] | ' | ' | ||
Variable Annuity Guarantees by Benefit Type | ' | ' | ||
Total contract value | $75,002 | [1] | $74,308 | [1] |
Contract value in separate accounts | 70,183 | [1] | 69,435 | [1] |
Net amount at risk | 182 | [1] | 145 | [1] |
Weighted average attained age | '64 years | [1] | '64 years | [1] |
GMDB [Member] | Return of premium [Member] | ' | ' | ||
Variable Annuity Guarantees by Benefit Type | ' | ' | ||
Total contract value | 54,378 | [1] | 52,616 | [1] |
Contract value in separate accounts | 52,566 | [1] | 50,790 | [1] |
Net amount at risk | 39 | [1] | 28 | [1] |
Weighted average attained age | '64 years | [1] | '64 years | [1] |
GMDB [Member] | Five/six-year reset [Member] | ' | ' | ||
Variable Annuity Guarantees by Benefit Type | ' | ' | ||
Total contract value | 10,465 | [1] | 11,220 | [1] |
Contract value in separate accounts | 7,925 | [1] | 8,663 | [1] |
Net amount at risk | 36 | [1] | 42 | [1] |
Weighted average attained age | '64 years | [1] | '64 years | [1] |
GMDB [Member] | One-year ratchet [Member] | ' | ' | ||
Variable Annuity Guarantees by Benefit Type | ' | ' | ||
Total contract value | 7,424 | [1] | 7,676 | [1] |
Contract value in separate accounts | 7,030 | [1] | 7,261 | [1] |
Net amount at risk | 64 | [1] | 38 | [1] |
Weighted average attained age | '66 years | [1] | '65 years | [1] |
GMDB [Member] | Five-year ratchet [Member] | ' | ' | ||
Variable Annuity Guarantees by Benefit Type | ' | ' | ||
Total contract value | 1,770 | [1] | 1,781 | [1] |
Contract value in separate accounts | 1,715 | [1] | 1,725 | [1] |
Net amount at risk | 3 | [1] | 1 | [1] |
Weighted average attained age | '62 years | [1] | '62 years | [1] |
GMDB [Member] | Other [Member] | ' | ' | ||
Variable Annuity Guarantees by Benefit Type | ' | ' | ||
Total contract value | 965 | [1] | 1,015 | [1] |
Contract value in separate accounts | 947 | [1] | 996 | [1] |
Net amount at risk | 40 | [1] | 36 | [1] |
Weighted average attained age | '70 years | [1] | '69 years | [1] |
GGU death benefit [Member] | ' | ' | ||
Variable Annuity Guarantees by Benefit Type | ' | ' | ||
Total contract value | 1,058 | [1] | 1,052 | [1] |
Contract value in separate accounts | 1,006 | [1] | 998 | [1] |
Net amount at risk | 121 | [1] | 121 | [1] |
Weighted average attained age | '67 years | [1] | '64 years | [1] |
GMIB [Member] | ' | ' | ||
Variable Annuity Guarantees by Benefit Type | ' | ' | ||
Total contract value | 359 | [1] | 413 | [1] |
Contract value in separate accounts | 336 | [1] | 389 | [1] |
Net amount at risk | 9 | [1] | 8 | [1] |
Weighted average attained age | '67 years | [1] | '66 years | [1] |
GMWB [Member] | ' | ' | ||
Variable Annuity Guarantees by Benefit Type | ' | ' | ||
Total contract value | 39,669 | [1] | 38,005 | [1] |
Contract value in separate accounts | 39,542 | [1] | 37,851 | [1] |
Net amount at risk | 93 | [1] | 78 | [1] |
Weighted average attained age | '65 years | [1] | '64 years | [1] |
GMWB [Member] | GMWB standard benefit [Member] | ' | ' | ||
Variable Annuity Guarantees by Benefit Type | ' | ' | ||
Total contract value | 3,702 | [1] | 3,936 | [1] |
Contract value in separate accounts | 3,689 | [1] | 3,921 | [1] |
Net amount at risk | 1 | [1] | 1 | [1] |
Weighted average attained age | '68 years | [1] | '67 years | [1] |
GMWB [Member] | GMWB for life [Member] | ' | ' | ||
Variable Annuity Guarantees by Benefit Type | ' | ' | ||
Total contract value | 35,967 | [1] | 34,069 | [1] |
Contract value in separate accounts | 35,853 | [1] | 33,930 | [1] |
Net amount at risk | 92 | [1] | 77 | [1] |
Weighted average attained age | '65 years | [1] | '64 years | [1] |
GMAB [Member] | ' | ' | ||
Variable Annuity Guarantees by Benefit Type | ' | ' | ||
Total contract value | 4,188 | [1] | 4,194 | [1] |
Contract value in separate accounts | 4,177 | [1] | 4,181 | [1] |
Net amount at risk | $3 | [1] | $2 | [1] |
Weighted average attained age | '58 years | [1] | '58 years | [1] |
[1] | Individual variable annuity contracts may have more than one guarantee and therefore may be included in more than one benefit type. Variable annuity contracts for which the death benefit equals the account value are not shown in this table. |
Variable_Annuity_and_Insurance3
Variable Annuity and Insurance Guarantees Variable Annuity and Insurance Guarantees (UL Secondary Guarantees) (Details) (UL secondary guarantees [Member], USD $) | 9 Months Ended | 12 Months Ended |
In Millions, unless otherwise specified | Sep. 30, 2014 | Dec. 31, 2013 |
UL secondary guarantees [Member] | ' | ' |
Variable Annuity Guarantees by Benefit Type | ' | ' |
Net amount at risk | $5,943 | $5,674 |
Weighted average attained age | '62 years | '62 years |
Variable_Annuity_and_Insurance4
Variable Annuity and Insurance Guarantees (Liability rollforward) (Details) (USD $) | 9 Months Ended | |||
In Millions, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | ||
GMDB & GGU [Member] | ' | ' | ||
Changes in additional liabilities for variable annuity and insurance guarantees | ' | ' | ||
Balance at the beginning of the period | $4 | $4 | ||
Incurred claims | 8 | 2 | ||
Paid claims | -3 | -3 | ||
Balance at the end of the period | 9 | 3 | ||
GMIB [Member] | ' | ' | ||
Changes in additional liabilities for variable annuity and insurance guarantees | ' | ' | ||
Balance at the beginning of the period | 6 | 9 | ||
Incurred claims | 1 | -2 | ||
Balance at the end of the period | 7 | 7 | ||
GMWB [Member] | ' | ' | ||
Changes in additional liabilities for variable annuity and insurance guarantees | ' | ' | ||
Balance at the beginning of the period | -383 | 799 | ||
Incurred claims | 528 | [1] | -908 | [1] |
Balance at the end of the period | 145 | -109 | ||
GMAB [Member] | ' | ' | ||
Changes in additional liabilities for variable annuity and insurance guarantees | ' | ' | ||
Balance at the beginning of the period | -62 | 103 | ||
Incurred claims | 7 | [1] | -127 | [1] |
Balance at the end of the period | -55 | -24 | ||
UL [Member] | ' | ' | ||
Changes in additional liabilities for variable annuity and insurance guarantees | ' | ' | ||
Balance at the beginning of the period | 206 | 155 | ||
Incurred claims | 46 | 45 | ||
Paid claims | -5 | -11 | ||
Balance at the end of the period | $247 | $189 | ||
[1] | The incurred claims for GMWB and GMAB represent the total change in the liabilities (contra liabilities). |
Variable_Annuity_and_Insurance5
Variable Annuity and Insurance Guarantees (Separate account balance by type) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Mutual funds | ' | ' |
Variable Annuity and Insurance Guarantees | ' | ' |
Total mutual funds | $70,118 | $69,478 |
Equity [Member] | ' | ' |
Variable Annuity and Insurance Guarantees | ' | ' |
Total mutual funds | 40,751 | 39,195 |
Bond [Member] | ' | ' |
Variable Annuity and Insurance Guarantees | ' | ' |
Total mutual funds | 25,218 | 26,519 |
Other [Member] | ' | ' |
Variable Annuity and Insurance Guarantees | ' | ' |
Total mutual funds | $4,149 | $3,764 |
Lines_of_Credit_Lines_of_Credi
Lines of Credit Lines of Credit (AMP Lender) (Details) (USD $) | 9 Months Ended | |
Sep. 30, 2014 | Dec. 31, 2013 | |
Line of Credit Facility | ' | ' |
Line of credit with Ameriprise Financial | $0 | $150,000,000 |
Line of credit agreement, one [Member] | Ameriprise Financial [Member] | ' | ' |
Line of Credit Facility | ' | ' |
Line of credit with Ameriprise Financial | 0 | 150,000,000 |
Maximum borrowing capacity under the line of credit | 800,000,000 | ' |
Prepayment penalty | $0 | ' |
London Interbank Offered Rate (LIBOR) [Member] | Line of credit agreement, one [Member] | Ameriprise Financial [Member] | ' | ' |
Line of Credit Facility | ' | ' |
Interest rate added to reference rate (as a percent) | 0.90% | ' |
Lines_of_Credit_Lines_of_Credi1
Lines of Credit Lines of Credit (RSL Lender) (Details) (RiverSource Life Insurance Company [Member], Loans receivable [Member], USD $) | 9 Months Ended | |
Sep. 30, 2014 | Dec. 31, 2013 | |
Line of Credit Facility | ' | ' |
Maximum borrowings under the loan receivable as a percentage of the lender's statutory admitted assets as of the prior year end | 3.00% | ' |
Percentage of additional interest to be accrued in the event of default | 1.00% | ' |
Line of credit with parent as borrower | $0 | $0 |
London Interbank Offered Rate (LIBOR) [Member] | ' | ' |
Line of Credit Facility | ' | ' |
Interest rate added to reference rate (as a percent) | 0.90% | ' |
Shortterm_Borrowings_Details
Short-term Borrowings (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Borrowings | ' | ' |
Amount of the company's liability including accrued interest | $200 | $500 |
Repurchase agreements [Member] | ' | ' |
Borrowings | ' | ' |
Fair value of securities pledged | 52 | 52 |
Amount of the company's liability including accrued interest | 50 | 50 |
Weighted average annual interest rate (as a percent) | 0.30% | 0.30% |
Federal Home Loan Bank (FHLB) advances [Member] | ' | ' |
Borrowings | ' | ' |
Fair value of securities pledged | 456 | 574 |
Amount of the company's liability including accrued interest | $150 | $450 |
Weighted average annual interest rate (as a percent) | 0.30% | 0.30% |
Fair_Values_of_Assets_and_Liab2
Fair Values of Assets and Liabilities (Assets & liabilities reported at FV) (Details) (USD $) | 9 Months Ended | 12 Months Ended | ||
In Millions, unless otherwise specified | Sep. 30, 2014 | Dec. 31, 2013 | ||
Assets and liabilities measured at fair value | ' | ' | ||
Cumulative change in embedded derivatives due to nonperformance | $238 | $150 | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 23,569 | 24,387 | ||
Common stocks | 8 | 6 | ||
Separate account assets | 78,313 | 77,616 | ||
Recurring basis [Member] | Level 1 [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 4 | 9 | ||
Common stocks | 3 | 3 | ||
Cash equivalents | 2 | 1 | ||
Other assets | 314 | 265 | ||
Total assets at fair value | 323 | 278 | ||
Liabilities | ' | ' | ||
Other liabilities | 472 | 549 | ||
Total liabilities at fair value | 472 | 549 | ||
Recurring basis [Member] | Level 1 [Member] | Equity derivative contracts [Member] | ' | ' | ||
Assets | ' | ' | ||
Other assets | 314 | 265 | ||
Liabilities | ' | ' | ||
Other liabilities | 472 | 549 | ||
Recurring basis [Member] | Level 1 [Member] | U.S. government and agencies obligations [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 4 | 9 | ||
Recurring basis [Member] | Level 2 [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 21,936 | 22,556 | ||
Common stocks | 5 | 3 | ||
Cash equivalents | 261 | 320 | ||
Other assets | 3,032 | 2,996 | ||
Separate account assets | 78,313 | 77,616 | ||
Total assets at fair value | 103,547 | 103,491 | ||
Liabilities | ' | ' | ||
Policyholder account balances, future policy benefits and claims | 6 | 5 | ||
Other liabilities | 3,392 | 4,083 | ||
Total liabilities at fair value | 3,398 | 4,088 | ||
Recurring basis [Member] | Level 2 [Member] | Interest rate derivative contracts [Member] | ' | ' | ||
Assets | ' | ' | ||
Other assets | 1,512 | 1,484 | ||
Liabilities | ' | ' | ||
Other liabilities | 1,208 | 1,672 | ||
Recurring basis [Member] | Level 2 [Member] | Equity derivative contracts [Member] | ' | ' | ||
Assets | ' | ' | ||
Other assets | 1,512 | 1,503 | ||
Liabilities | ' | ' | ||
Other liabilities | 2,171 | 2,382 | ||
Recurring basis [Member] | Level 2 [Member] | Credit derivative contracts [Member] | ' | ' | ||
Assets | ' | ' | ||
Other assets | 4 | 3 | ||
Recurring basis [Member] | Level 2 [Member] | Foreign exchange derivatives contracts [Member] | ' | ' | ||
Assets | ' | ' | ||
Other assets | 4 | 2 | ||
Recurring basis [Member] | Level 2 [Member] | Other contract [Member] | ' | ' | ||
Assets | ' | ' | ||
Other assets | ' | 4 | ||
Liabilities | ' | ' | ||
Other liabilities | 13 | 29 | ||
Recurring basis [Member] | Level 2 [Member] | EIA embedded derivatives [Member] | ' | ' | ||
Liabilities | ' | ' | ||
Policyholder account balances, future policy benefits and claims | 6 | 5 | ||
Recurring basis [Member] | Level 2 [Member] | Corporate debt securities [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 14,092 | 14,357 | ||
Recurring basis [Member] | Level 2 [Member] | Residential mortgage backed securities [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 3,547 | 3,753 | ||
Recurring basis [Member] | Level 2 [Member] | Commercial mortgage backed securities [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 2,139 | 2,404 | ||
Recurring basis [Member] | Level 2 [Member] | State and municipal obligations [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 1,073 | 998 | ||
Recurring basis [Member] | Level 2 [Member] | Asset backed securities [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 796 | 763 | ||
Recurring basis [Member] | Level 2 [Member] | Foreign government bonds and obligations [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 253 | 245 | ||
Recurring basis [Member] | Level 2 [Member] | U.S. government and agencies obligations [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 36 | 36 | ||
Recurring basis [Member] | Level 3 [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 1,629 | 1,822 | ||
Other assets | 1 | ' | ||
Total assets at fair value | 1,630 | 1,822 | ||
Liabilities | ' | ' | ||
Policyholder account balances, future policy benefits and claims | 125 | -450 | ||
Total liabilities at fair value | 125 | -450 | ||
Recurring basis [Member] | Level 3 [Member] | Other contract [Member] | ' | ' | ||
Assets | ' | ' | ||
Other assets | 1 | ' | ||
Recurring basis [Member] | Level 3 [Member] | IUL embedded derivatives [Member] | ' | ' | ||
Liabilities | ' | ' | ||
Policyholder account balances, future policy benefits and claims | 202 | 125 | ||
Recurring basis [Member] | Level 3 [Member] | GMWB and GMAB embedded derivatives [Member] | ' | ' | ||
Liabilities | ' | ' | ||
Policyholder account balances, future policy benefits and claims | -77 | -575 | ||
Recurring basis [Member] | Level 3 [Member] | Corporate debt securities [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 1,378 | 1,516 | ||
Recurring basis [Member] | Level 3 [Member] | Residential mortgage backed securities [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 10 | 58 | ||
Recurring basis [Member] | Level 3 [Member] | Commercial mortgage backed securities [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 93 | 30 | ||
Recurring basis [Member] | Level 3 [Member] | Asset backed securities [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 148 | 218 | ||
Recurring basis [Member] | Total [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 23,569 | 24,387 | ||
Common stocks | 8 | 6 | ||
Cash equivalents | 263 | 321 | ||
Other assets | 3,347 | 3,261 | ||
Separate account assets | 78,313 | 77,616 | ||
Total assets at fair value | 105,500 | 105,591 | ||
Liabilities | ' | ' | ||
Policyholder account balances, future policy benefits and claims | 131 | [1] | -445 | [2] |
Other liabilities | 3,864 | 4,632 | ||
Total liabilities at fair value | 3,995 | 4,187 | ||
Recurring basis [Member] | Total [Member] | Interest rate derivative contracts [Member] | ' | ' | ||
Assets | ' | ' | ||
Other assets | 1,512 | 1,484 | ||
Liabilities | ' | ' | ||
Other liabilities | 1,208 | 1,672 | ||
Recurring basis [Member] | Total [Member] | Equity derivative contracts [Member] | ' | ' | ||
Assets | ' | ' | ||
Other assets | 1,826 | 1,768 | ||
Liabilities | ' | ' | ||
Other liabilities | 2,643 | 2,931 | ||
Recurring basis [Member] | Total [Member] | Credit derivative contracts [Member] | ' | ' | ||
Assets | ' | ' | ||
Other assets | 4 | 3 | ||
Recurring basis [Member] | Total [Member] | Foreign exchange derivatives contracts [Member] | ' | ' | ||
Assets | ' | ' | ||
Other assets | 4 | 2 | ||
Recurring basis [Member] | Total [Member] | Other contract [Member] | ' | ' | ||
Assets | ' | ' | ||
Other assets | 1 | 4 | ||
Liabilities | ' | ' | ||
Other liabilities | 13 | 29 | ||
Recurring basis [Member] | Total [Member] | EIA embedded derivatives [Member] | ' | ' | ||
Liabilities | ' | ' | ||
Policyholder account balances, future policy benefits and claims | 6 | 5 | ||
Recurring basis [Member] | Total [Member] | IUL embedded derivatives [Member] | ' | ' | ||
Liabilities | ' | ' | ||
Policyholder account balances, future policy benefits and claims | 202 | 125 | ||
Recurring basis [Member] | Total [Member] | GMWB and GMAB embedded derivatives [Member] | ' | ' | ||
Liabilities | ' | ' | ||
Policyholder account balances, future policy benefits and claims | -77 | [3] | -575 | [4] |
Recurring basis [Member] | Total [Member] | Corporate debt securities [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 15,470 | 15,873 | ||
Recurring basis [Member] | Total [Member] | Residential mortgage backed securities [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 3,557 | 3,811 | ||
Recurring basis [Member] | Total [Member] | Commercial mortgage backed securities [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 2,232 | 2,434 | ||
Recurring basis [Member] | Total [Member] | State and municipal obligations [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 1,073 | 998 | ||
Recurring basis [Member] | Total [Member] | Asset backed securities [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 944 | 981 | ||
Recurring basis [Member] | Total [Member] | Foreign government bonds and obligations [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | 253 | 245 | ||
Recurring basis [Member] | Total [Member] | U.S. government and agencies obligations [Member] | ' | ' | ||
Assets | ' | ' | ||
Available-for-sale securities, fixed maturities | $40 | $45 | ||
[1] | The Companybs adjustment for nonperformance risk resulted in a $238 million cumulative decrease to the embedded derivatives. | |||
[2] | The Companybs adjustment for nonperformance risk resulted in a $150 million cumulative increase to the embedded derivatives. | |||
[3] | The fair value of the GMWB and GMAB embedded derivatives was a net asset at SeptemberB 30, 2014 and the amount is reported as a contra liability. | |||
[4] | The fair value of the GMWB and GMAB embedded derivatives was a net asset at December 31, 2013 and the amount is reported as a contra liability. |
Fair_Values_of_Assets_and_Liab3
Fair Values of Assets and Liabilities Fair Values of Assets and Liabilities (Level 3 rollforwards-Assets) (Details) (USD $) | 3 Months Ended | 9 Months Ended | |||||
In Millions, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | |||
Corporate debt securities [Member] | ' | ' | ' | ' | |||
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | ' | ' | ' | ' | |||
Balance, at the beginning of the period | $1,376 | $1,558 | $1,516 | $1,654 | |||
Total gains (losses) included in net income | ' | ' | 1 | -1 | |||
Total gains (losses) included in other comprehensive income (loss) | -11 | 2 | 3 | -34 | |||
Purchases | 37 | ' | 94 | 74 | |||
Sales | ' | ' | -11 | ' | |||
Settlements | -24 | -37 | -225 | -170 | |||
Balance, at the end of the period | 1,378 | 1,523 | 1,378 | 1,523 | |||
Changes in unrealized gains (losses) relating to assets and liabilities held at the end of the period included in: | ' | ' | ' | ' | |||
Net investment income | ' | ' | -1 | -1 | |||
Residential mortgage backed securities [Member] | ' | ' | ' | ' | |||
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | ' | ' | ' | ' | |||
Balance, at the beginning of the period | 10 | 50 | 58 | 23 | |||
Purchases | ' | 45 | 11 | 87 | |||
Settlements | ' | -5 | -2 | -5 | |||
Transfers out of Level 3 | 0 | ' | -57 | -15 | |||
Balance, at the end of the period | 10 | 90 | 10 | 90 | |||
Commercial mortgage backed securities [Member] | ' | ' | ' | ' | |||
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | ' | ' | ' | ' | |||
Balance, at the beginning of the period | 15 | 164 | 30 | 170 | |||
Total gains (losses) included in other comprehensive income (loss) | ' | ' | ' | -6 | |||
Purchases | ' | ' | 39 | ' | |||
Transfers into Level 3 | 78 | ' | 78 | ' | |||
Transfers out of Level 3 | ' | -149 | -54 | -149 | |||
Balance, at the end of the period | 93 | 15 | 93 | 15 | |||
Asset backed securities [Member] | ' | ' | ' | ' | |||
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | ' | ' | ' | ' | |||
Balance, at the beginning of the period | 149 | 154 | 218 | 156 | |||
Total gains (losses) included in net income | 1 | ' | 1 | 1 | |||
Total gains (losses) included in other comprehensive income (loss) | -1 | -2 | ' | 5 | |||
Purchases | ' | 29 | ' | 29 | |||
Settlements | -1 | ' | -2 | -1 | |||
Transfers out of Level 3 | ' | ' | -69 | -9 | |||
Balance, at the end of the period | 148 | 181 | 148 | 181 | |||
Changes in unrealized gains (losses) relating to assets and liabilities held at the end of the period included in: | ' | ' | ' | ' | |||
Net investment income | 1 | ' | 1 | 1 | |||
Available-for-sale securities [Member] | ' | ' | ' | ' | |||
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | ' | ' | ' | ' | |||
Balance, at the beginning of the period | 1,550 | 1,926 | 1,822 | 2,003 | |||
Total gains (losses) included in net income | 1 | [1] | ' | 2 | [1] | 0 | [1] |
Total gains (losses) included in other comprehensive income (loss) | -12 | 0 | 3 | -35 | |||
Purchases | 37 | 74 | 144 | 190 | |||
Sales | ' | ' | -11 | ' | |||
Settlements | -25 | -42 | -229 | -176 | |||
Transfers into Level 3 | 78 | ' | 78 | ' | |||
Transfers out of Level 3 | ' | -149 | -180 | -173 | |||
Balance, at the end of the period | 1,629 | 1,809 | 1,629 | 1,809 | |||
Changes in unrealized gains (losses) relating to assets and liabilities held at the end of the period included in: | ' | ' | ' | ' | |||
Net investment income | 1 | 0 | 0 | 0 | |||
Common stocks [Member] | ' | ' | ' | ' | |||
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | ' | ' | ' | ' | |||
Balance, at the beginning of the period | 1 | ' | 0 | ' | |||
Purchases | ' | ' | 1 | ' | |||
Transfers out of Level 3 | -1 | ' | -1 | ' | |||
Balance, at the end of the period | 0 | ' | 0 | ' | |||
Other contract [Member] | ' | ' | ' | ' | |||
Summary of changes in Level 3 assets measured at fair value on a recurring basis [Rollforward] | ' | ' | ' | ' | |||
Balance, at the beginning of the period | 1 | ' | 0 | ' | |||
Total gains (losses) included in net income | 1 | ' | -1 | ' | |||
Purchases | 1 | ' | 2 | ' | |||
Balance, at the end of the period | 1 | ' | 1 | ' | |||
Changes in unrealized gains (losses) relating to assets and liabilities held at the end of the period included in: | ' | ' | ' | ' | |||
Benefits, claims, losses and settlement expenses | ($1) | ' | ($1) | ' | |||
[1] | Included in net investment income in the Consolidated Statements of Income. |
Fair_Values_of_Assets_and_Liab4
Fair Values of Assets and Liabilities (Level 3 rollforwards-Liabilities) (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||||||
In Millions, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | ||||
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] | ' | ' | ' | ' | ||||
Net increase (decrease) to pretax income from embedded derivative liability | $59 | ($14) | $68 | ($104) | ||||
IUL embedded derivatives [Member] | ' | ' | ' | ' | ||||
Summary of changes in Level 3 liabilities measured at fair value on a recurring basis [Rollforward] | ' | ' | ' | ' | ||||
Balance at the beginning of the period | 184 | 76 | 125 | 45 | ||||
Net income | ' | 2 | [1] | 14 | [1] | 8 | [1] | |
Issues | 21 | 17 | 69 | 42 | ||||
Settlements | -3 | 1 | -6 | 1 | ||||
Balance at the end of the period | 202 | 96 | 202 | 96 | ||||
Changes in unrealized gains (losses) relating to assets and liabilities held at the end of the period included in: | ' | ' | ' | ' | ||||
Interest credited to fixed accounts | ' | 2 | 14 | 8 | ||||
GMWB and GMAB embedded derivatives [Member] | ' | ' | ' | ' | ||||
Summary of changes in Level 3 liabilities measured at fair value on a recurring basis [Rollforward] | ' | ' | ' | ' | ||||
Balance at the beginning of the period | -347 | 11 | -575 | 833 | ||||
Net income | 207 | [2] | -322 | [2] | 327 | [2] | -1,246 | [2] |
Issues | 65 | 60 | 184 | 163 | ||||
Settlements | -2 | -5 | -13 | -6 | ||||
Balance at the end of the period | -77 | -256 | -77 | -256 | ||||
Changes in unrealized gains (losses) relating to assets and liabilities held at the end of the period included in: | ' | ' | ' | ' | ||||
Benefits, claims, losses and settlement expenses | 208 | -321 | 327 | -1,229 | ||||
Policyholder account balances, future policy benefits and claims [Member] | ' | ' | ' | ' | ||||
Summary of changes in Level 3 liabilities measured at fair value on a recurring basis [Rollforward] | ' | ' | ' | ' | ||||
Balance at the beginning of the period | -163 | 87 | -450 | 878 | ||||
Net income | 207 | -320 | 341 | -1,238 | ||||
Issues | 86 | 77 | 253 | 205 | ||||
Settlements | -5 | -4 | -19 | -5 | ||||
Balance at the end of the period | 125 | -160 | 125 | -160 | ||||
Changes in unrealized gains (losses) relating to assets and liabilities held at the end of the period included in: | ' | ' | ' | ' | ||||
Benefits, claims, losses and settlement expenses | 208 | -321 | 327 | -1,229 | ||||
Interest credited to fixed accounts | ' | $2 | $14 | $8 | ||||
[1] | Included in interest credited to fixed accounts in the Consolidated Statements of Income. | |||||||
[2] | Included in benefits, claims, losses and settlement expenses in the Consolidated Statements of Income. |
Fair_Values_of_Assets_and_Liab5
Fair Values of Assets and Liabilities (Unobservable inputs) (Details) (USD $) | 9 Months Ended | 12 Months Ended | ||
In Millions, unless otherwise specified | Sep. 30, 2014 | Dec. 31, 2013 | ||
IUL embedded derivatives [Member] | Discounted cash flow technique [Member] | ' | ' | ||
Fair values of assets and liabilities | ' | ' | ||
Liabilities at fair value | $202 | $125 | ||
Nonperformance risk (as a percent) | 0.69% | [1] | 0.74% | [1] |
GMWB and GMAB embedded derivatives [Member] | Discounted cash flow technique [Member] | ' | ' | ||
Fair values of assets and liabilities | ' | ' | ||
Liabilities at fair value | -77 | -575 | ||
Nonperformance risk (as a percent) | 0.69% | [1] | 0.74% | [1] |
GMWB and GMAB embedded derivatives [Member] | Discounted cash flow technique [Member] | Minimum [Member] | ' | ' | ||
Fair values of assets and liabilities | ' | ' | ||
Utilization of guaranteed withdrawals (as a percent) | 0.00% | [2] | 0.00% | [2] |
Surrender rate (as a percent) | 0.00% | 0.10% | ||
Fair value assumptions, market volatility rate | 4.90% | [3] | 4.90% | [3] |
Fair value assumptions, elective contractholder strategy allocations | 0.00% | [4] | 0.00% | [4] |
GMWB and GMAB embedded derivatives [Member] | Discounted cash flow technique [Member] | Maximum [Member] | ' | ' | ||
Fair values of assets and liabilities | ' | ' | ||
Utilization of guaranteed withdrawals (as a percent) | 51.10% | [2] | 51.10% | [2] |
Surrender rate (as a percent) | 59.10% | 57.90% | ||
Fair value assumptions, market volatility rate | 19.40% | [3] | 18.80% | [3] |
Fair value assumptions, elective contractholder strategy allocations | 31.00% | [4] | 50.00% | [4] |
Corporate debt securities (private placement) [Member] | Discounted cash flow technique [Member] | ' | ' | ||
Fair values of assets and liabilities | ' | ' | ||
Assets at fair value | 1,341 | 1,487 | ||
Corporate debt securities (private placement) [Member] | Discounted cash flow technique [Member] | Minimum [Member] | ' | ' | ||
Fair values of assets and liabilities | ' | ' | ||
Yield/spread to U.S. Treasuries (as a percent) | 0.90% | 0.90% | ||
Corporate debt securities (private placement) [Member] | Discounted cash flow technique [Member] | Maximum [Member] | ' | ' | ||
Fair values of assets and liabilities | ' | ' | ||
Yield/spread to U.S. Treasuries (as a percent) | 3.50% | 5.30% | ||
Corporate debt securities (private placement) [Member] | Discounted cash flow technique [Member] | Weighted average [Member] | ' | ' | ||
Fair values of assets and liabilities | ' | ' | ||
Yield/spread to U.S. Treasuries (as a percent) | 1.30% | 1.60% | ||
Macro hedge program [Member] | Option pricing model technique [Member] | ' | ' | ||
Fair values of assets and liabilities | ' | ' | ||
Assets at fair value | $1 | ' | ||
Macro hedge program [Member] | Option pricing model technique [Member] | Minimum [Member] | ' | ' | ||
Fair values of assets and liabilities | ' | ' | ||
Fair value inputs correlation (as a percent) | -3.00% | [5] | ' | |
Macro hedge program [Member] | Option pricing model technique [Member] | Maximum [Member] | ' | ' | ||
Fair values of assets and liabilities | ' | ' | ||
Fair value inputs correlation (as a percent) | -84.00% | [5] | ' | |
Macro hedge program [Member] | Option pricing model technique [Member] | Weighted average [Member] | ' | ' | ||
Fair values of assets and liabilities | ' | ' | ||
Fair value inputs correlation (as a percent) | -60.00% | [5] | ' | |
[1] | The nonperformance risk is the spread added to the observable interest rates used in the valuation of the embedded derivatives. | |||
[2] | The utilization of guaranteed withdrawals represents the percentage of contractholders that will begin withdrawing in any given year. | |||
[3] | Market volatility is implied volatility of fund of funds and managed volatility funds. | |||
[4] | The elective allocation represents the percentage of contractholders that are assumed to electively switch their investment allocation to a different allocation model. | |||
[5] | Represents the correlation between equity returns and interest rates used in the valuation of the derivative contract. |
Fair_Values_of_Assets_and_Liab6
Fair Values of Assets and Liabilities (Financial Instruments not at FV) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Financial Assets | ' | ' |
Mortgage loans, net | $3,300 | $3,326 |
Policy loans | 804 | 773 |
Other investments | 968 | 915 |
Financial Liabilities | ' | ' |
Policyholder account balances, future policy benefits and claims | 29,312 | 29,149 |
Short-term borrowings | 200 | 500 |
Line of credit with Ameriprise Financial | 0 | 150 |
Other liabilities | 4,582 | 5,431 |
Separate account liabilities | 78,313 | 77,616 |
Level 2 [Member] | ' | ' |
Financial Assets | ' | ' |
Other investments | 419 | 346 |
Financial Liabilities | ' | ' |
Short-term borrowings | 200 | 500 |
Separate account liabilities | 394 | 400 |
Level 3 [Member] | ' | ' |
Financial Assets | ' | ' |
Mortgage loans, net | 3,386 | 3,372 |
Policy loans | 788 | 765 |
Other investments | 45 | 42 |
Financial Liabilities | ' | ' |
Policyholder account balances, future policy benefits and claims | 13,819 | 14,724 |
Line of credit with Ameriprise Financial | ' | 150 |
Other liabilities | 95 | 134 |
Total [Member] | ' | ' |
Financial Assets | ' | ' |
Mortgage loans, net | 3,386 | 3,372 |
Policy loans | 788 | 765 |
Other investments | 464 | 388 |
Financial Liabilities | ' | ' |
Policyholder account balances, future policy benefits and claims | 13,819 | 14,724 |
Short-term borrowings | 200 | 500 |
Line of credit with Ameriprise Financial | ' | 150 |
Other liabilities | 95 | 134 |
Separate account liabilities | 394 | 400 |
Carrying value [Member] | ' | ' |
Financial Assets | ' | ' |
Mortgage loans, net | 3,300 | 3,326 |
Policy loans | 804 | 773 |
Other investments | 465 | 385 |
Financial Liabilities | ' | ' |
Policyholder account balances, future policy benefits and claims | 13,203 | 14,106 |
Short-term borrowings | 200 | 500 |
Line of credit with Ameriprise Financial | ' | 150 |
Other liabilities | 96 | 137 |
Separate account liabilities | $394 | $400 |
Offsetting_Assets_and_Liabilit2
Offsetting Assets and Liabilities (Assets) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 | ||
In Millions, unless otherwise specified | ||||
Derivatives: | ' | ' | ||
Gross amounts of recognized assets | $3,347 | $3,261 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ' | ' | ||
Financial instruments | -2,926 | [1] | -3,154 | [1] |
Cash collateral | -160 | -18 | ||
Securities collateral | -176 | -16 | ||
Net amount | 85 | 73 | ||
OTC derivatives [Member] | ' | ' | ||
Derivatives: | ' | ' | ||
Gross amounts of recognized assets | 3,131 | 3,180 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ' | ' | ||
Financial instruments | -2,834 | [1] | -3,134 | [1] |
Cash collateral | -107 | -17 | ||
Securities collateral | -176 | -16 | ||
Net amount | 14 | 13 | ||
Over the counter cleared swaps [Member] | ' | ' | ||
Derivatives: | ' | ' | ||
Gross amounts of recognized assets | 145 | 21 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ' | ' | ||
Financial instruments | -92 | [1] | -20 | [1] |
Cash collateral | -53 | -1 | ||
Net amount | 0 | 0 | ||
Exchange-traded derivatives [Member] | ' | ' | ||
Derivatives: | ' | ' | ||
Gross amounts of recognized assets | 71 | 60 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ' | ' | ||
Net amount | $71 | $60 | ||
[1] | Represents the amount of assets that could be offset by liabilities with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets. |
Offsetting_Assets_and_Liabilit3
Offsetting Assets and Liabilities (Liabilities) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 | ||
In Millions, unless otherwise specified | ||||
Repurchase agreements | ' | ' | ||
Gross amounts of recognized liabilities | $50 | $50 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ' | ' | ||
Securities collateral | -50 | -50 | ||
Net amount | 0 | 0 | ||
Total | ' | ' | ||
Gross amounts of recognized liabilities | 3,914 | 4,682 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ' | ' | ||
Financial instruments | -2,926 | [1] | -3,154 | [1] |
Cash collateral | 0 | -2 | ||
Securities collateral | -988 | -1,515 | ||
Net amount | 0 | 11 | ||
OTC derivatives [Member] | ' | ' | ||
Derivatives | ' | ' | ||
Gross amounts of recognized liabilities | 3,772 | 4,610 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ' | ' | ||
Financial instruments | -2,834 | [1] | -3,134 | [1] |
Cash collateral | 0 | 0 | ||
Securities collateral | -938 | -1,465 | ||
Net amount | 0 | 11 | ||
Over the counter cleared swaps [Member] | ' | ' | ||
Derivatives | ' | ' | ||
Gross amounts of recognized liabilities | 92 | 22 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ' | ' | ||
Financial instruments | -92 | [1] | -20 | [1] |
Cash collateral | 0 | -2 | ||
Net amount | 0 | 0 | ||
Total over the counter derivatives [Member] | ' | ' | ||
Derivatives | ' | ' | ||
Gross amounts of recognized liabilities | 3,864 | 4,632 | ||
Gross Amounts Not Offset in the Consolidated Balance Sheets | ' | ' | ||
Financial instruments | -2,926 | [1] | -3,154 | [1] |
Cash collateral | 0 | -2 | ||
Securities collateral | -938 | -1,465 | ||
Net amount | $0 | $11 | ||
[1] | Represents the amount of liabilities that could be offset by assets with the same counterparty under master netting or similar arrangements that management elects not to offset on the Consolidated Balance Sheets. |
Derivatives_and_Hedging_Activi2
Derivatives and Hedging Activities (Balance Sheet) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 | ||
In Millions, unless otherwise specified | ||||
Derivatives and Hedging Activities | ' | ' | ||
Asset | $3,347 | $3,261 | ||
Derivatives not designated as hedging instruments [Member] | ' | ' | ||
Derivatives and Hedging Activities | ' | ' | ||
Asset | 3,347 | 3,261 | ||
Liability | 3,995 | 4,187 | ||
Derivatives not designated as hedging instruments [Member] | GMWB and GMAB [Member] | ' | ' | ||
Derivatives and Hedging Activities | ' | ' | ||
Asset | 3,318 | 3,230 | ||
Liability | 3,767 | 4,015 | ||
Derivatives not designated as hedging instruments [Member] | GMWB and GMAB [Member] | Interest rate contracts [Member] | Other assets [Member] | ' | ' | ||
Derivatives and Hedging Activities | ' | ' | ||
Asset | 1,512 | 1,484 | ||
Derivatives not designated as hedging instruments [Member] | GMWB and GMAB [Member] | Interest rate contracts [Member] | Other liabilities [Member] | ' | ' | ||
Derivatives and Hedging Activities | ' | ' | ||
Liability | 1,208 | 1,672 | ||
Derivatives not designated as hedging instruments [Member] | GMWB and GMAB [Member] | Equity contracts [Member] | Other assets [Member] | ' | ' | ||
Derivatives and Hedging Activities | ' | ' | ||
Asset | 1,798 | 1,741 | ||
Derivatives not designated as hedging instruments [Member] | GMWB and GMAB [Member] | Equity contracts [Member] | Other liabilities [Member] | ' | ' | ||
Derivatives and Hedging Activities | ' | ' | ||
Liability | 2,636 | 2,918 | ||
Derivatives not designated as hedging instruments [Member] | GMWB and GMAB [Member] | Credit contracts [Member] | Other assets [Member] | ' | ' | ||
Derivatives and Hedging Activities | ' | ' | ||
Asset | 4 | 3 | ||
Derivatives not designated as hedging instruments [Member] | GMWB and GMAB [Member] | Foreign exchange contracts [Member] | Other assets [Member] | ' | ' | ||
Derivatives and Hedging Activities | ' | ' | ||
Asset | 4 | 2 | ||
Derivatives not designated as hedging instruments [Member] | GMWB and GMAB [Member] | GMWB and GMAB embedded derivatives [Member] | Policyholder account balances, future policy benefits and claims [Member] | ' | ' | ||
Derivatives and Hedging Activities | ' | ' | ||
Liability | -77 | [1],[2] | -575 | [1],[2] |
Derivatives not designated as hedging instruments [Member] | EIA embedded derivatives [Member] | Equity contracts [Member] | Policyholder account balances, future policy benefits and claims [Member] | ' | ' | ||
Derivatives and Hedging Activities | ' | ' | ||
Liability | 6 | 5 | ||
Derivatives not designated as hedging instruments [Member] | IUL [Member] | Equity contracts [Member] | Other assets [Member] | ' | ' | ||
Derivatives and Hedging Activities | ' | ' | ||
Asset | 28 | 27 | ||
Derivatives not designated as hedging instruments [Member] | IUL [Member] | Equity contracts [Member] | Other liabilities [Member] | ' | ' | ||
Derivatives and Hedging Activities | ' | ' | ||
Liability | 7 | 13 | ||
Derivatives not designated as hedging instruments [Member] | IUL embedded derivatives [Member] | Equity contracts [Member] | Policyholder account balances, future policy benefits and claims [Member] | ' | ' | ||
Derivatives and Hedging Activities | ' | ' | ||
Liability | 202 | 125 | ||
Derivatives not designated as hedging instruments [Member] | Macro hedge program [Member] | Other contract [Member] | Other assets [Member] | ' | ' | ||
Derivatives and Hedging Activities | ' | ' | ||
Asset | 1 | 4 | ||
Derivatives not designated as hedging instruments [Member] | Macro hedge program [Member] | Other contract [Member] | Other liabilities [Member] | ' | ' | ||
Derivatives and Hedging Activities | ' | ' | ||
Liability | 13 | 29 | ||
Derivatives not designated as hedging instruments [Member] | Other derivatives [Member] | ' | ' | ||
Derivatives and Hedging Activities | ' | ' | ||
Asset | 29 | 31 | ||
Liability | $228 | $172 | ||
[1] | The fair value of the GMWB and GMAB embedded derivatives was a net asset at SeptemberB 30, 2014 and December 31, 2013 and the amount is reported as a contra liability. | |||
[2] | The fair values of GMWB and GMAB embedded derivatives fluctuate based on changes in equity, interest rate and credit markets. |
Derivatives_and_Hedging_Activi3
Derivatives and Hedging Activities (Income Statement) (Details) (Derivatives not designated as hedging instruments [Member], USD $) | 3 Months Ended | 9 Months Ended | ||||||
In Millions, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | ||||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ' | ' | ' | ' | ||||
Amount of gain (loss) on derivatives recognized in income | ($42) | ($108) | ($143) | ($252) | ||||
GMWB and GMAB [Member] | ' | ' | ' | ' | ||||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ' | ' | ' | ' | ||||
Amount of gain (loss) on derivatives recognized in income | -41 | -114 | -170 | -269 | ||||
Other derivatives [Member] | ' | ' | ' | ' | ||||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ' | ' | ' | ' | ||||
Amount of gain (loss) on derivatives recognized in income | -1 | 6 | 27 | 17 | ||||
Benefits, claims, losses and settlement expenses [Member] | GMWB and GMAB [Member] | Interest rate contracts [Member] | ' | ' | ' | ' | ||||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ' | ' | ' | ' | ||||
Amount of gain (loss) on derivatives recognized in income | 100 | -63 | 609 | -575 | ||||
Benefits, claims, losses and settlement expenses [Member] | GMWB and GMAB [Member] | Equity contracts [Member] | ' | ' | ' | ' | ||||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ' | ' | ' | ' | ||||
Amount of gain (loss) on derivatives recognized in income | 143 | -323 | -244 | -803 | ||||
Benefits, claims, losses and settlement expenses [Member] | GMWB and GMAB [Member] | Credit contracts [Member] | ' | ' | ' | ' | ||||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ' | ' | ' | ' | ||||
Amount of gain (loss) on derivatives recognized in income | -1 | -3 | -23 | 5 | ||||
Benefits, claims, losses and settlement expenses [Member] | GMWB and GMAB [Member] | Foreign exchange contracts [Member] | ' | ' | ' | ' | ||||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ' | ' | ' | ' | ||||
Amount of gain (loss) on derivatives recognized in income | -13 | 8 | -14 | 15 | ||||
Benefits, claims, losses and settlement expenses [Member] | GMWB and GMAB [Member] | GMWB and GMAB embedded derivatives [Member] | ' | ' | ' | ' | ||||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ' | ' | ' | ' | ||||
Amount of gain (loss) on derivatives recognized in income | -270 | [1] | 267 | [1] | -498 | [1] | 1,089 | [1] |
Benefits, claims, losses and settlement expenses [Member] | Macro hedge program [Member] | Other contract [Member] | ' | ' | ' | ' | ||||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ' | ' | ' | ' | ||||
Amount of gain (loss) on derivatives recognized in income | -1 | ' | 2 | ' | ||||
Net investment income [Member] | Tax hedge [Member] | Interest rate contracts [Member] | ' | ' | ' | ' | ||||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ' | ' | ' | ' | ||||
Amount of gain (loss) on derivatives recognized in income | ' | ' | 3 | ' | ||||
Interest credited to fixed accounts [Member] | EIA [Member] | Equity contracts [Member] | ' | ' | ' | ' | ||||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ' | ' | ' | ' | ||||
Amount of gain (loss) on derivatives recognized in income | ' | 1 | 1 | 2 | ||||
Interest credited to fixed accounts [Member] | EIA embedded derivatives [Member] | Equity contracts [Member] | ' | ' | ' | ' | ||||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ' | ' | ' | ' | ||||
Amount of gain (loss) on derivatives recognized in income | ' | ' | -1 | -1 | ||||
Interest credited to fixed accounts [Member] | IUL [Member] | Equity contracts [Member] | ' | ' | ' | ' | ||||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ' | ' | ' | ' | ||||
Amount of gain (loss) on derivatives recognized in income | 2 | 2 | 13 | 8 | ||||
Interest credited to fixed accounts [Member] | IUL embedded derivatives [Member] | Equity contracts [Member] | ' | ' | ' | ' | ||||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ' | ' | ' | ' | ||||
Amount of gain (loss) on derivatives recognized in income | ($2) | $3 | $9 | $8 | ||||
[1] | The fair values of GMWB and GMAB embedded derivatives fluctuate based on changes in equity, interest rate and credit markets. |
Derivatives_and_Hedging_Activi4
Derivatives and Hedging Activities Derivatives and Hedging Activities (Notional and Related Party Information) (Details) (USD $) | 12 Months Ended | ||||||
In Millions, unless otherwise specified | Dec. 31, 2013 | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2014 | Dec. 31, 2013 |
Derivatives not designated as hedging instruments [Member] | Derivatives not designated as hedging instruments [Member] | Macro hedge program [Member] | Macro hedge program [Member] | Freestanding non-VA derivatives [Member] | Freestanding non-VA derivatives [Member] | ||
GMWB and GMAB embedded derivatives [Member] | GMWB and GMAB embedded derivatives [Member] | Derivatives not designated as hedging instruments [Member] | Derivatives not designated as hedging instruments [Member] | ||||
Impact of derivatives not designated as hedging instruments on the Consolidated Statements of Income | ' | ' | ' | ' | ' | ' | ' |
Derivative, notional amount | ' | $135,800 | $142,400 | $1,200 | $710 | ' | ' |
Related party transaction, amounts of transaction | 94 | ' | ' | ' | ' | ' | ' |
Notional amounts of index options and futures contracts | ' | ' | ' | ' | ' | $804 | $512 |
Derivatives_and_Hedging_Activi5
Derivatives and Hedging Activities (Option Pay/Rec) (Details) (USD $) | Sep. 30, 2014 | |
In Millions, unless otherwise specified | ||
Summary of option premiums payable and receivable | ' | |
Premiums payable | $1,730 | |
Premiums receivable | 440 | |
2014 [Member] | ' | |
Summary of option premiums payable and receivable | ' | |
Premiums payable | 109 | [1] |
Premiums receivable | 49 | [1] |
2015 [Member] | ' | |
Summary of option premiums payable and receivable | ' | |
Premiums payable | 349 | |
Premiums receivable | 69 | |
2016 [Member] | ' | |
Summary of option premiums payable and receivable | ' | |
Premiums payable | 316 | |
Premiums receivable | 53 | |
2017 [Member] | ' | |
Summary of option premiums payable and receivable | ' | |
Premiums payable | 240 | |
Premiums receivable | 69 | |
2018 [Member] | ' | |
Summary of option premiums payable and receivable | ' | |
Premiums payable | 190 | |
Premiums receivable | 68 | |
2019-2026 [Member] | ' | |
Summary of option premiums payable and receivable | ' | |
Premiums payable | 526 | |
Premiums receivable | $132 | |
[1] | 2014 amounts represent the amounts payable and receivable for the period from October 1, 2014 to DecemberB 31, 2014. |
Derivatives_and_Hedging_Activi6
Derivatives and Hedging Activities Derivatives and Hedging Activities (Cash Flow Hedge Info) (Details) (USD $) | 9 Months Ended | |||
In Millions, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | ||
Summary of Cash Flow Hedge Activity [Abstract] | ' | ' | ||
Derivatives designated as cash flow hedges | $0 | ' | ||
Cash flow hedge loss to be reclassified within twelve months | 6 | ' | ||
Longest period of time over which the entity hedges exposure to the variability in future cash flows | '4 years | ' | ||
Rollforward of unrealized derivative losses included in accumulated other comprehensive income related to cash flow hedges | ' | ' | ||
Net unrealized derivative losses at the beginning of the period | -17 | -21 | ||
Reclassification of realized losses | 5 | [1] | 6 | [1] |
Income tax benefit | -2 | -2 | ||
Net unrealized derivative losses at the end of the period | ($14) | ($17) | ||
[1] | Loss reclassified from AOCI to net investment income on the Consolidated Statements of Income |
Derivatives_and_Hedging_Activi7
Derivatives and Hedging Activities (Credit Risk) (Details) (USD $) | Sep. 30, 2014 | Dec. 31, 2013 |
In Millions, unless otherwise specified | ||
Derivatives liabilities, credit risk related contingent features | ' | ' |
Aggregate fair value of all derivative instruments containing credit risk features | $494 | $950 |
Aggregate fair value of assets posted as collateral | 494 | 940 |
Additional fair value of assets needed to settle derivative liabilities | $0 | $10 |
Shareholders_Equity_Details
Shareholder's Equity (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Millions, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 |
Amounts Reclassified from AOCI | ' | ' | ' | ' |
Net realized investment gains | $7 | $5 | $12 | $3 |
Net investment income | 319 | 350 | 975 | 1,067 |
Income tax provision | 38 | 59 | 125 | 143 |
Net income | 224 | 265 | 765 | 691 |
Net unrealized gains on Available-for-Sale securities [Member] | Amount reclassified from AOCI [Member] | ' | ' | ' | ' |
Amounts Reclassified from AOCI | ' | ' | ' | ' |
Net realized investment gains | -10 | -4 | -15 | -3 |
Income tax provision | 4 | 1 | 6 | 1 |
Net income | -6 | -3 | -9 | -2 |
Losses on cash flow hedges [Member] | Amount reclassified from AOCI [Member] | ' | ' | ' | ' |
Amounts Reclassified from AOCI | ' | ' | ' | ' |
Net investment income | 2 | 2 | 5 | 6 |
Income tax provision | -1 | -1 | -2 | -2 |
Net income | $1 | $1 | $3 | $4 |
Income_Taxes_Details
Income Taxes (Details) (USD $) | 3 Months Ended | 9 Months Ended | |||
In Millions, unless otherwise specified | Sep. 30, 2014 | Sep. 30, 2013 | Sep. 30, 2014 | Sep. 30, 2013 | Dec. 31, 2013 |
Operating Loss Carryforwards [Line Items] | ' | ' | ' | ' | ' |
Effective tax rate (as a percent) | 14.50% | 18.20% | 14.00% | 17.10% | ' |
Benefits tax planning and completion of audits | ' | ' | $18 | ' | ' |
Maximum period for recognizing capital losses | ' | ' | '5 years | ' | ' |
Valuation allowance | 6 | ' | 6 | ' | 6 |
Gross unrecognized tax benefits | 155 | ' | 155 | ' | 144 |
Unrecognized tax benefits, net of federal tax benefits that would affect the effective tax rate if recognized | 6 | ' | 6 | ' | 23 |
Significant change in unrecognized tax benefits is reasonably possible, estimated range of change, lower bound | 140 | ' | 140 | ' | ' |
Significant change in unrecognized tax benefits is reasonably possible, estimated range of change, upper bound | 150 | ' | 150 | ' | ' |
Net increase (decrease) in interest and penalties | 1 | 2 | 3 | 5 | ' |
Payable (receivable) related to accrued interest and penalties | 39 | ' | 39 | ' | 36 |
State and local jurisdiction [Member] | ' | ' | ' | ' | ' |
Operating Loss Carryforwards [Line Items] | ' | ' | ' | ' | ' |
Operating loss carryforwards | $6 | ' | $6 | ' | ' |
Guarantees_and_Contingencies_D
Guarantees and Contingencies (Details) (USD $) | 9 Months Ended | 12 Months Ended | 3 Months Ended |
Sep. 30, 2014 | Dec. 31, 2013 | Sep. 30, 2014 | |
Future guaranty fund assessments [Member] | Future guaranty fund assessments [Member] | Unfavorable regulatory action [Member] | |
Commitments and Contingencies | ' | ' | ' |
Liability related to guaranty fund assessments | $13,000,000 | $14,000,000 | ' |
Premium tax asset | 11,000,000 | 11,000,000 | ' |
Litigation settlement, amount | ' | ' | $800,000 |